Tetrahydrocarbazole derivative, pharmaceutical composition, and use thereof

By optimizing the structure of tetrahydrocarbazole compounds, especially the rings A, Y1, Y2, R1 and other parts, it significantly improved its inhibitory effect on human tumor cells, and the IC50 was reduced to below 0.2μM, solving the existing tetrahydrocarbazole compounds The problem of insufficient antitumor activity of azoles compounds provides more effective antitumor drug candidates.

WO2024230729A1PCT designated stage expired Publication Date: 2024-11-14NAIN BIOTECH (HANGZHOU) CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/091697
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-09-28
Filing Date
2024-05-08
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

The existing tetrahydrocarbazole compounds generally have IC50 on human tumor cells above 1μM, and their anti-tumor activity has not yet achieved ideal results.

Method used

A new tetrahydrocarbazole compound was designed. The structure significantly improved the inhibitory and proliferation effect of human tumor cells by optimizing the rings A, Y1, Y2, R1 and other parts. IC50 was reduced to below 0.2μM and passed the specific Synthesis routes such as diazotization, ring-closing reaction, etc. obtain the compound.

Benefits of technology

It significantly improved the inhibitory effect of tetrahydrocarbazoles on human tumor cells, with IC50 reaching below 0.2μM, which has potential drug application value for the treatment and cancer prevention.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024091697_14112024_PF_FP_ABST
    Figure CN2024091697_14112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a tetrahydrocarbazole compound, and a pharmaceutical composition and a use thereof. The tetrahydrocarbazole compound is a compound represented by formula (I) or formula (II), an optical isomer, a geometric isomer, a hydrate, a solvate, a prodrug, or a pharmaceutically acceptable salt thereof. The compound provided by the present invention can be used to prepare a medicament for treating and / or preventing cancer.
Need to check novelty before this filing date? Find Prior Art

Description

Tetrahydrocarbazole derivatives, pharmaceutical compositions and uses thereof Technical Field

[0001] The present invention relates to the field of medical technology, and in particular to a tetrahydrocarbazole compound, a pharmaceutical composition and use thereof. Background Art

[0002] Tetrahydrocarbazoles are a class of synthetic carbazole alkaloids that can be used as advanced intermediates to synthesize a variety of naturally occurring carbazole alkaloids and other small molecule lead compounds with biological activity. Tetrahydrocarbazole derivatives are a very important part of them. In recent years, tetrahydrocarbazole compounds have become a hot area in drug development due to their wide range of biological activities. Their main physiological effects and pharmacological activities include anti-tumor activity, antiviral activity, antifungal activity and treatment of neurodegenerative diseases (Chaudhari et al., 2021, Org Biomol Chem 19:1926).

[0003] The derivatization of tetrahydrocarbazole skeletons to obtain anti-tumor lead compounds with novel structures and unique mechanisms has always been a key research direction for this type of compound. In recent years, tetrahydrocarbazole compounds targeting different sites have been continuously synthesized. In 2013, Tunbridge et al. found that the inhibitory activity of the carbazole derivative indanocine against HeLa cell lines was better than that of the control drug ellipticine (Tunbridge et al., 2013, MedChemComm 4:1452). In 2018, Murali et al. synthesized a series of carbazole derivatives that showed a better inhibitory effect on the IC of A549 and MCF7 cells. 50 In the range of 13-20 μM (Murali et al., 2018, Eur J Med Chem 143:292). In 2019, Saravanabhavan et al. synthesized a series of pyridocarbazole pentacyclic compounds with antitumor and antioxidant activities from tetrahydrocarbazolone, and the in vitro cytotoxicity IC values ​​of HeLa, MCF7 and HEp-2 cell lines were 50 In the range of 4-100 μM, it also has higher antioxidant activity than ascorbic acid (Saravanabhavan et al., 2019, New J Chem 43:17231).

[0004] In summary, tetrahydrocarbazole derivatives have certain inhibitory and cytotoxic effects on a variety of human tumor cell lines and can be used as valuable lead compounds or precursor compounds for the development of new anti-tumor drugs. However, the IC values ​​of tetrahydrocarbazole derivatives on human tumor cell lines reported in the literature are limited. 50 The concentrations of ATP and ATP are generally above 1 μM, and their anti-tumor activity still needs to be further improved.

[0005] Summary of the Invention

[0006] In view of all or part of the deficiencies of the above-mentioned prior art, the present invention provides a tetrahydrocarbazole compound, a pharmaceutical composition and use thereof, wherein the efficacy of the provided tetrahydrocarbazole compounds is significantly improved, and the IC 50 The concentration of the compound was below 0.2 μM, and it can be used as an ideal lead compound for the development of drugs for the treatment and / or prevention of cancer.

[0007] In the first aspect of the present invention, there is provided a compound as shown in formula (I) or formula (II), its stereoisomers, geometric isomers, hydrates, solvates, prodrugs, or pharmaceutically acceptable salts thereof,

[0008] in,

[0009] Ring A is selected from the following groups: C3-C7 saturated or partially unsaturated carbocyclic ring, 3-8 membered saturated or partially unsaturated heterocyclic ring, C6-C 10 Aromatic ring, 5-12 membered heteroaromatic ring; Ring A can be a monocyclic, spirocyclic, fused or bridged ring structure;

[0010] Y1 and Y2 are each independently selected from the following groups: chemical bonds, C1-C6 alkylene, C3-C 10 Saturated or partially unsaturated carbon ring, 3-10 membered saturated or partially unsaturated heterocyclic ring, C6-C 10 Aromatic ring, 5-12 membered heteroaromatic ring, -NH-, O or S; and, Y1, Y2 are each independently optionally substituted by 0-4 substituents selected from the group consisting of deuterium, hydroxyl, halogen, oxo Carboxyl, NH2, mercapto, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C4 acyl, C2-C6 ester, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 haloalkyl, C2-C4 haloacyl, C1-C4 haloalkoxy, C1-C4 haloalkylthio, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, C5-C 12 heteroaryl;

[0011] R1 is selected from the following groups: hydrogen, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkylamino (C1-C6 alkyl-NH-), C1-C6 alkoxy, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C1-C6 haloalkylamino, C1-C6 haloalkoxy, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10Aryl, 5-12 membered heteroaryl, C1-C4 alkyl-C3-C7 saturated or partially unsaturated carbocyclic group, C1-C4 alkyl-3-8 membered saturated or partially unsaturated heterocyclic group, C1-C4 alkyl-C6-C 10 Aryl, C1-C4 alkyl-5-12 membered heteroaryl, S(O)2(C1-C6 alkyl); wherein the alkyl, alkenyl, alkynyl, alkylamino, alkoxy, haloalkyl, haloalkenyl, haloalkynyl, haloalkylamino, haloalkoxy, carbocyclyl, heterocyclyl, aryl, heteroaryl are each independently optionally substituted with 0, 1, 2, 3 or 4 substituents selected from the group consisting of deuterium, hydroxyl, halogen, oxo Carboxyl, NH2, mercapto, C1-C4 alkyl, C2-C4 acyl, C2-C6 ester, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 haloalkyl, C2-C4 haloacyl, C1-C4 haloalkoxy, C1-C4 haloalkylthio, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, C5-C 12 Heteroaryl; the carbocyclic group, heterocyclic group, aryl group, heteroaryl group may be a monocyclic, spirocyclic, fused ring or bridged ring structure;

[0012] X1 is selected from the following group: O, NR2, S; wherein R2 is selected from the following group: H, C1-C4 alkyl, S(=O)2R 11 、S(=O)2(C1-C6 alkylene)R 11 、C(O)R 11 、C(O)(C1-C6 alkylene)R 11 , 3-12 membered saturated or partially unsaturated heterocyclic group, 5-12 membered heteroaryl; and one or more hydrogen atoms on R2 may be optionally substituted by a substituent selected from the group consisting of C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, -C0-C4 alkylene-C6-C 10 Aryl; or two substituents on R2 together form -(CH2) s - structure; said s is 2 or 3;

[0013] X2 is selected from the following group: CH2, CD2, CHR b , NH, NR b , S, S(=O), S(=O)2, S(=O)(=NH);

[0014] Each R aEach is independently selected from the following groups: deuterium, hydroxyl, halogen, amino, nitro, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C6 ester, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclic group, -NH-CH2-5-12 membered heteroaryl, -P(O)R c1 R d1 、-S(O)2R c1 、-S(O)2NH2、-S(O)(NH2)(R c1 )、-C(O)C(O)2R c1 、-C(O)NHR c1 、-NH-C(O)R c1 、-C(O)OR c1 、-NH-S(O)2R c1 、-N=S(O)R c R d1 、-CH2-S(O)(NH)(R c1 ),-NR c1 R d1 、 Among them, the R c1 、R d1 Each independently selected from the group consisting of deuterium, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl; or, R c1 、R d1 and the atoms to which they are connected together constitute a 3-8 membered saturated or partially unsaturated heterocyclic group or a 5-12 membered heteroaryl group; wherein, R a One or more hydrogen atoms on the alkyl group may be optionally substituted by a substituent selected from the group consisting of a deuterium atom, a hydroxyl group, a halogen group, an oxo group C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, S(O)2CH3, C3-C7 saturated or partially unsaturated carbocyclic group, -C(O)N(C1-C4 alkyl)2, -N(C1-C4 alkyl)2;

[0015] Each R a' are each independently selected from the following groups: deuterium, hydroxyl, halogen, amino, nitro, cyano, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C6 ester, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C4 amide, C3-C7 saturated or partially unsaturated carbocyclic group, 3-12 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclic group, -NH-CH2-5-12 membered heteroaryl, -P(O)R c R d 、-S(O)2R c 、-S(O)2NH2、-S(O)(NH2)(R c )、-C(O)C(O)2R c 、-C(O)NHR c 、-C(O)NR c R d 、-NH-C(O)R c 、-OC(O)R c 、-C(O)OR c 、-C(O)O(C1-C4 alkylene)R c 、-NH-S(O)2R c 、-C(O)NH(C1-C4 alkylene)R c 、-N=S(O)R c R d 、-CH2-S(O)(NH)(R c ),-NR c R d 、

[0016] Among them, the R c 、R d Each independently selected from the group consisting of deuterium, C1-C4 alkyl, C1-C4 alkoxy, C2-C4 alkenyl, C2-C4 alkynyl, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 8-12 membered fused bicyclic, 5-12 membered heteroaryl, -N(C1-C4 alkyl)2, -CONH2, -CON(C1-C4 alkyl)2; or, R c 、R d and the N atom to which it is connected together form a 3-8 membered saturated or partially unsaturated heterocyclic group or a 5-12 membered heteroaryl group; wherein, R a One or more hydrogen atoms on the ' can be optionally substituted by a substituent selected from the group consisting of a deuterium atom, a hydroxyl group, a halogen group, an amino group, a cyano group, a carboxylic acid group, an oxo group C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, C2-C4 alkynyl, C1-C4 alkoxy, HO-(C1-C4 alkylene)-, C1-C4 alkylthio, C2-C4 alkenyl, C2-C6 ester, S(O)2CH3, C3-C7 saturated or partially unsaturated carbocyclic group, -C(O)N(C1-C4 alkyl)2, -N(C1-C4 alkyl)2, C6-C 10 aryl;

[0017] n is 0, 1, 2, 3 or 4;

[0018] Each R b Each independently selected from the group consisting of deuterium, hydroxyl, halogen, amino, nitro, oxo C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, -NH-(C1-C4 alkyl), -NH-(C1-C4 alkylhydroxy), 4-7 membered heterocyclyl; or, two R b and the carbon atoms connected thereto together constitute a C3-C7 saturated or partially unsaturated carbocyclic group, a 3-8 membered saturated or partially unsaturated heterocyclic group, a C6-C 10 Aryl, 5-12 membered heteroaryl;

[0019] R 11 Selected from the group consisting of amino, C1-C 10 Alkyl, C1-C 10 Alkoxy, C2-C -10 Alkenyl, C2-C 10 Alkynyl, C3-C7 saturated or partially unsaturated carbocyclic group, -3-12 membered saturated or partially unsaturated heterocyclic group, -C2-C4 alkynylene-3-12 membered saturated or partially unsaturated heterocyclic group, -O-3-12 membered saturated or partially unsaturated heterocyclic group, -C6-C 10 Aryl, -C2-C4 alkenylene-C6-C 10 Aryl, 5-12 membered heteroaryl, 8-12 membered fused bicyclic, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclic, -NH-CH2-5-12 membered heteroaryl; wherein, R 11 One or more hydrogen atoms on the alkyl group may be optionally substituted by a substituent selected from the group consisting of a deuterium atom, a hydroxyl group, a halogen group, an amino group, a carboxylic acid group, an oxo group, C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C4 alkyl, C2-C4 alkynyl, C1-C4 alkoxy, C1-C4 alkylthio, C2-C4 alkenyl, C2-C6 ester, S(O)2CH3, C3-C7 saturated or partially unsaturated carbocyclic group, -C(O)N(C1-C4 alkyl)2, -N(C1-C4 alkyl)2, C6-C 10 Aryl, 3-12 membered saturated or partially unsaturated heterocyclic group;

[0020] m is 0, 1, 2, 3 or 4;

[0021] p is 0, 1, 2, or 3;

[0022] Furthermore, when Ra is methyl, n is 1 and m is 0, -Y1-Y2-R1 is not a group selected from the group consisting of OH, NH2,

[0023] In some embodiments, Ring A is C6-C 10 aromatic ring or 5-12 membered heteroaromatic ring.

[0024] In another preferred embodiment, ring A is a benzene ring, a pyrimidine ring or a pyridine ring.

[0025] In some embodiments, R1 is selected from the following groups: C1-C5 alkyl, C1-C5 alkylamino, C1-C5 alkoxy, C1-C5 haloalkyl, C3-C6 saturated or partially unsaturated carbocyclic group, 4-7 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-10 membered heteroaryl, C1-C4 alkyl-C3-C6 saturated or partially unsaturated carbocyclic group, C1-C4 alkyl-4-7 membered saturated or partially unsaturated heterocyclic group, C1-C4 alkyl-C6-C 10 Aryl, C1-C4 alkyl-5-10 membered heteroaryl; wherein the alkyl, haloalkyl, alkylamino, carbocyclyl, heterocyclyl, aryl, heteroaryl are each independently optionally substituted with 0-4 substituents selected from the group consisting of deuterium, hydroxyl, halogen, oxo Carboxyl, thiol, C1-C4 alkyl, C2-C4 acyl, C1-C4 alkoxy, C1-C4 alkylthio, C3-C6 saturated or partially unsaturated carbocyclic group, 4-7 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, C5-C 10 Heteroaryl.

[0026] In another preferred embodiment, the R2 is selected from the following group: H, C1-C4 alkyl, S(=O)2R 11 、C(O)R 11 、C(O)(C0-C4alkylene)R 11, 4-7 membered saturated or partially unsaturated heterocyclic group, 5-7 membered heteroaryl group.

[0027] In another preferred embodiment, the R2 is selected from the following group: H, C1-C4 alkyl, S(=O)2R 11 、C(O)R 11 、S(=O)2(CH2)R 11 、C(O)(CH2)R 11 , 4-7 membered saturated or partially unsaturated heterocyclic group, 5-7 membered heteroaryl group.

[0028] In another preferred embodiment, Y1 and Y2 are chemical bonds, and R1 is selected from the following groups: 4-7 membered saturated or partially unsaturated heterocyclic group, 5-10 membered heteroaryl group, C1-C4 alkyl-4-7 membered saturated or partially unsaturated heterocyclic group, C1-C4 alkyl-5-10 membered heteroaryl group.

[0029] In another preferred embodiment, Y is wherein q is 0, 1, 2 or 3, and R1 is not H.

[0030] In another preferred embodiment, R1 has a structure selected from the following group:

[0031] In some embodiments, X1 is NH;

[0032] X2 is CH2, S or NH.

[0033] In some embodiments, the compound has a structure as described in Formula (IA), Formula (IVA) or Formula (IIA):

[0034] Among them, Y1, Y2, R1, R2, R a 、R a '、R b ,X2,m,p are defined as above;

[0035] X4, X5 and X6 are each independently selected from the group consisting of CR a1 , N; wherein, the R a1 Selected from the group consisting of H, D, hydroxy, halogen, amino, nitro, C1-C4 alkyl, C2-C4 alkenyl, and C2-C4 alkynyl.

[0036] In another preferred embodiment, R a Having a structure selected from the group consisting of: C1-C4 alkyl, C1-C4 alkoxy, -C(O)OR c1 、-NR c1 R d1 ; where R c1、R d1 The definition of is as above.

[0037] In another preferred embodiment, R a 'having a structure selected from the group consisting of: deuterium, hydroxyl, halogen, amino, nitro, cyano, C1-C4 alkyl, C2-C6 ester, C1-C4 haloalkyl, C3-C7 saturated or partially unsaturated carbocyclic group, 3-12 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclic group, -NH-CH2-5-12 membered saturated or partially unsaturated heteroaryl, -P(O)R c R d 、-S(O)2R c 、-S(O)2NH2、-S(O)(NH2)(R c )、-NH-S(O)2R c 、-N=S(O)R c R d 、-CH2-S(O)(NH)(R c ),-C(O)NHR c 、-C(O)NR c R d 、-C(O)OR c 、-C(O)O(CH2)R c 、-C(O)NH(C1-C4 alkylene)R c 、-NR c R d ; where R c 、R d The definition of is as above;

[0038] Among them, R a1 、R a and R a One or more hydrogen atoms on the ' can be optionally substituted by a substituent selected from the group consisting of a deuterium atom, a hydroxyl group, a halogen group, an amino group, a cyano group, a carboxylic acid group, an oxo group C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, HO-(C1-C4 alkylene)-, C1-C4 alkylthio, C2-C4 alkenyl, C2-C6 ester, S(O)2CH3, C3-C7 saturated or partially unsaturated carbocyclic group, -C(O)N(C1-C4 alkyl)2, -N(C1-C4 alkyl)2, C6-C 10 Aryl.

[0039] In another preferred embodiment, the R c 、R dEach independently selected from the group consisting of deuterium, C1-C4 alkyl, C1-C4 alkoxy, C2-C4 alkenyl, C2-C4 alkynyl, C3-C7 saturated or partially unsaturated carbon monocyclic group, C3-C7 saturated or partially unsaturated carbon bridged ring group, C3-C7 saturated or partially unsaturated carbon spirocyclic group, 3-8 membered saturated or partially unsaturated heteromonocyclic group, 3-8 membered saturated or partially unsaturated heterobridged ring group, 3-8 membered saturated or partially unsaturated heterospirocyclic group, C6-C 10 Aryl, benzo C5-C8 carbocyclyl, benzo 5-8 membered heterocyclyl, benzo 5-7 membered heteroaryl, 5-7 membered heteroaryl and C5-C7 carbocyclyl, 5-7 membered heteroaryl and 5-7 membered heterocyclyl, C4-C7 carbocyclyl and 5-7 membered heterocyclyl, 5-12 membered heteroaryl, -N(C1-C4 alkyl)2, -CONH2, -CON(C1-C4 alkyl)2; or, R c 、R d and the nitrogen atom to which it is connected together form a 3-8 membered saturated or partially unsaturated heterocyclic group or a 5-12 membered heteroaryl group.

[0040] In another preferred embodiment, the R 11 Selected from the group consisting of amino, C1-C 10 Alkyl, C1-C 10 Alkoxy, C2-C 10 Alkenyl, C2-C 10 Alkynyl, C3-C7 saturated or partially unsaturated carbon monocyclic group, C3-C7 saturated or partially unsaturated carbon bridged ring group, C3-C7 saturated or partially unsaturated carbon spirocyclic group, -3-8 membered saturated or partially unsaturated heteromonocyclic group, 3-8 membered saturated or partially unsaturated heterobridged ring group, 3-8 membered saturated or partially unsaturated heterospirocyclic group, -0-3-12 membered saturated or partially unsaturated heterocyclic group, -C0-C4 alkenylene-C6-C 10 Aryl, 5-12 membered heteroaryl, benzo C5-C8 carbocyclyl, benzo 5-8 membered heterocyclyl, benzo 5-7 membered heteroaryl, 5-7 membered heteroaryl and C5-C7 carbocyclyl, 5-7 membered heteroaryl and 5-7 membered heterocyclyl, C4-C7 carbocyclyl and 5-7 membered heterocyclyl, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclyl, -NH-CH2-5-12 membered heteroaryl.

[0041] In some embodiments, the compound has a structure as described in Formula (IIIA) or Formula (IVA):

[0042] Among them, Y1, Y2, R1, R2, R a 、R a '、R b , X2, X4, X5, X6, m, and p are defined as above.

[0043] In some embodiments, the compound has a structure selected from the group consisting of:

[0044] In some embodiments, the compound has a structure selected from the group consisting of:

[0045] In some embodiments, the compound has a structure selected from the examples.

[0046] Another aspect of the present disclosure relates to a method for preparing a compound represented by general formula (II) or a pharmaceutically acceptable salt thereof, the method comprising the following steps:

[0047] The compound represented by general formula (II-1) is diazotized to obtain the compound represented by general formula (II-2), which is then reacted with the compound represented by general formula (II-3) or its alkali metal salt to obtain the compound represented by general formula (II-4), and finally a ring-closure reaction is performed to obtain the compound represented by general formula (II) or a pharmaceutically acceptable salt thereof.

[0048] in:

[0049] M is halogen or BF4;

[0050] Ring A, R a ',n,R b , m, p, X1 and X2 are as defined in the general formula (II).

[0051] The compound represented by the above general formula (II-3) or its alkali metal salt can be replaced by a compound represented by the general formula (II-3a) or its alkali metal salt:

[0052] Wherein: L is an aldehyde group or a carboxyl group.

[0053] Another aspect of the present disclosure relates to a method for preparing a compound represented by general formula (II) or a pharmaceutically acceptable salt thereof, the method comprising the following steps:

[0054] The compound represented by the general formula (II-2a) or its acid salt undergoes a ring-closure reaction with the compound represented by the general formula (II-3b) to obtain the compound represented by the general formula (II) or its pharmaceutically acceptable salt; the compound represented by the general formula (II-2a) can also react with the compound represented by the general formula (II-3c) to obtain the compound represented by the general formula (II-5), and then undergo an oxidation reaction to obtain the compound represented by the general formula (II) or its pharmaceutically acceptable salt.

[0055] in:

[0056] Ring A, R a ',n,R b , m, p, X1 and X2 are as defined in the general formula (II).

[0057] Another aspect of the present disclosure relates to a method for preparing a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, the method comprising the following steps:

[0058] The compound represented by the general formula (I-1) undergoes a condensation reaction with the compound represented by the general formula (I-2) to obtain the compound represented by the general formula (II) or a pharmaceutically acceptable salt thereof.

[0059] in:

[0060] Ring A, R a ,n,R b , m, p, X1, X2, Y1, Y2 and R1 are as defined in the general formula (I).

[0061] In another aspect of the present invention, a pharmaceutical composition is provided, comprising:

[0062] (1) the compound according to the first aspect of the present invention, its stereoisomers, geometric isomers, hydrates, solvates, prodrugs, or pharmaceutically acceptable salts thereof; and optionally (2) a pharmaceutically acceptable carrier, excipient or other active drug.

[0063] In another preferred embodiment, the pharmaceutical composition further comprises a second therapeutic component, and the second therapeutic component is selected from the following group: PARP (poly ADP ribose polymerase) inhibitors, proteasome inhibitors, kinase inhibitors, DNA methyltransferase inhibitors, histone deacetylase inhibitors, nucleoside drugs that interfere with the nucleic acid metabolism of tumor cells, viruses and bacteria, chemotherapy drugs that inhibit tumor cell DNA replication such as platinum drugs, paclitaxel and its derivatives, drugs and treatment regimens that inhibit the uptake and metabolism of glucose, amino acids, fatty acids, etc., or other therapeutic components and treatment regimens that can produce synergistic anti-tumor effects with the above-mentioned tetrahydrocarbazole compounds.

[0064] In another preferred embodiment, the PARP inhibitor is Olaparib, Rucaparib, Niraparib, Talazoparib, Fluzoparib, Pamiparib, and Saruparib; the proteasome inhibitor is Ixazomib and Bortezomib; the kinase inhibitor is a MEK inhibitor; the MEK inhibitor is Cobimetinib; the DNA methyltransferase inhibitor is SGI-1027; the histone deacetylase inhibitor is Trichostatin A; the nucleoside drug is 6-Mercaptopurine (6-MP); the chemotherapy drugs are cisplatin and Cabazitaxel; the metabolic inhibitor is the GLUT1 / GLUT3 inhibitor KL-11743 and BAY-876, and the metabolic treatment regimen is intermittent fasting.

[0065] In the third aspect of the present invention, there is provided a use of the compound as described in the first aspect of the present invention, its stereoisomers, geometric isomers, hydrates, solvates, prodrugs or pharmaceutically acceptable salts, or the pharmaceutical composition as described in the second aspect of the present invention, characterized in that it is used to prepare a drug for treating and / or preventing cancer.

[0066] In another preferred embodiment, the cancer is selected from the following group: liver cancer, lung cancer, breast cancer, pancreatic cancer, gastric cancer, colorectal cancer, kidney cancer, prostate cancer, cervical cancer, ovarian cancer, anal and perianal cancer, vulvar cancer, vaginal cancer, penile cancer, head and neck cancer, glioma, skin cancer, mesothelioma, muscle cancer, leukemia, lymphoma, and cancers and related lesions caused by oncogenic viruses, such as herpes virus, adenovirus, hepatitis virus, retrovirus, and papovavirus family.

[0067] In some embodiments, the treatment and / or prevention of cancer comprises: using the compound of formula (I) or formula (II) according to the first aspect of the present invention, its stereoisomers, geometric isomers, hydrates, solvates, prodrugs or pharmaceutically acceptable salts, or the pharmaceutical composition according to the second aspect of the present invention in combination with a component selected from the group consisting of: PARP inhibitors, proteasome inhibitors, MEK inhibitors, DNA methyltransferase inhibitors, histone deacetylase inhibitors, nucleoside drugs that interfere with the metabolism of tumor cell, viral and bacterial nucleic acids, chemotherapy drugs such as platinum drugs that inhibit tumor cell DNA replication, paclitaxel and its derivatives, drugs and treatment regimens that inhibit the uptake and metabolism of glucose, amino acids, fatty acids, etc., or other therapeutic components and treatment regimens that can produce synergistic anti-tumor effects with the compound of formula (I) or formula (II).

[0068] In some embodiments, the PARP inhibitor is Olaparib, Rucaparib, Niraparib, Talazoparib, Fluzoparib, Pamiparib, and Saruparib; the proteasome inhibitor is Ixazomib and Bortezomib; the kinase inhibitor is Cobimetinib; the DNA methyltransferase inhibitor is SGI-1027; the histone deacetylase inhibitor is Trichostatin A; the nucleoside drug is 6-Mercaptopurine (6-MP); the chemotherapy drugs are cisplatin and Cabazitaxel; the metabolic inhibitor is the GLUT1 / GLUT3 inhibitor KL-11743 and BAY-876, and the metabolic treatment regimen is intermittent fasting.

[0069] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features described in detail below (such as in the embodiments) can be combined with each other to form new or preferred technical solutions. Due to space limitations, they will not be listed here one by one. DETAILED DESCRIPTION

[0070] the term

[0071] As used herein, the term "alkyl" includes straight-chain or branched alkyl groups. For example, C1-C6 alkyl groups represent straight-chain or branched alkyl groups having 1, 2, 3, 4, 5, or 6 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclobutyl, n-pentyl, isopentyl, neopentyl, and the like.

[0072] As used herein, the term "alkenyl" includes straight or branched alkenyl groups. For example, C2-C6 alkenyl refers to a straight or branched alkenyl group having 2, 3, 4, 5 or 6 carbon atoms, such as vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, or the like.

[0073] As used herein, the term "alkynyl" includes straight or branched chain alkynyl groups. For example, C2-C6 alkynyl refers to a straight or branched chain alkynyl group having 2, 3, 4, 5 or 6 carbon atoms, such as ethynyl, propynyl, butynyl, or the like.

[0074] As used herein, the term "carbocyclyl" refers to a cyclic saturated or partially unsaturated aliphatic hydrocarbon group having a specific number of carbon atoms. 10Carbocyclyl refers to a cyclic saturated or partially unsaturated aliphatic hydrocarbon radical having 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms. It can be a monocyclic ring, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, or similar groups. "Carbocyclyl" can also be a bicyclic or polycyclic form, such as a cyclic (i.e., multiple rings fused to each other), a bridged ring or a spirocyclic form.

[0075] As used herein, the term "alkylamino" refers to an amino group substituted by an alkyl group. For example, a "C1-C6 alkylamino" refers to an amino group substituted by a C1-C6 alkyl group, which may be monosubstituted or disubstituted; for example, methylamino, ethylamino, propylamino, isopropylamino, butylamino, isobutylamino, tert-butylamino, dimethylamino, diethylamino, dipropylamino, diisopropylamino, dibutylamino, diisobutylamino, di-tert-butylamino, and the like.

[0076] As used herein, the term "alkoxy" refers to a group having an alkyl-oxy structure. For example, "C1-C6 alkoxy" refers to a linear or branched alkoxy group having 1, 2, 3, 4, 5, or 6 carbon atoms, including methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, tert-butoxy, sec-butoxy, pentoxy, neopentoxy, and the like.

[0077] As used herein, the term "alkylthio" refers to a group having an alkyl-oxy structure. For example, "C1-C6 alkoxy" refers to a linear or branched alkoxy group having 1, 2, 3, 4, 5, or 6 carbon atoms, including methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, tert-butylthio, sec-butylthio, pentylthio, neopentylthio, and the like.

[0078] As used herein, the term "haloalkyl" represents an alkyl group wherein one or more hydrogen atoms are replaced by a halogen, wherein alkyl is as defined above.

[0079] As used herein, the term "haloalkoxy" represents an alkoxy group having one or more hydrogen atoms replaced by a halogen, wherein alkoxy is as defined above.

[0080] As used herein, the term "carbonyl" represents a group containing a specified number of carbon atoms and having an alkyl-C(=O)- or alkyl-C(=O)-alkyl- structure.

[0081] As used herein, the term "heterocyclyl" or "heterocycloalkyl" refers to a saturated or partially saturated cyclic group having a specific number of ring atoms (e.g., 3-10 ring atoms), wherein 1-4 atoms are heteroatoms selected from N, S, and O. It can be a monocyclic, bicyclic, or polycyclic ring, such as a paracyclic ring (i.e., having multiple rings fused to each other), a bridged ring, or a spirocyclic ring. Specific examples include oxetanyl, azetidinyl, tetrahydro-2H-pyranyl, piperidinyl, tetrahydrofuranyl, morpholinyl, and pyrrolidinyl.

[0082] As used herein, the term "aryl", "aromatic ring" or "aromatic ring" refers to a cyclic group having aromaticity, for example, the term "C6-C 10 "Aryl" refers to an aromatic group having 6 to 10 carbon atoms, such as phenyl or naphthyl and the like. "Aryl" may also be a fused aromatic group.

[0083] As used herein, the term "heteroaryl" or "heteroaromatic ring" refers to a cyclic aromatic group in which 1 to 3 atoms are heteroatoms selected from the group consisting of N, S, and O. For example, the term "5-12 membered heteroaryl" refers to a heteroaryl group having 5 to 12 atoms. It may be a single ring or a fused ring. Specific examples may include furyl, thienyl, pyrrolyl, thiazolyl, thiadiazolyl, oxazolyl, oxadiazolyl, imidazolyl, pyrazolyl, pyridyl, pyrimidinyl, 1,4-dioxadienyl, 2H-1,2-oxazinyl, 4H-1,2-oxazinyl, 6H-1,2-oxazinyl, 4H-1,3-oxazinyl, 6H-1,3-oxazinyl, 4H-1,4-oxazinyl, pyridazinyl, pyrazinyl, 1,2,3-triazinyl, 1,2,4-triazinyl, 1,3,5-triazinyl, 1,2,4,5-tetrazinyl, oxep ... 1,3-Diazacycloheptene, ...

[0084] As used herein, the term "fused bicyclic ring" refers to two rings fused together to form a bicyclic structure; preferably, one ring is a benzene ring or a 5-6 membered heteroaromatic ring, and the other ring is a partially saturated 5-8 membered carbocyclic ring or a partially saturated 5-8 membered heterocyclic ring, but the fused bicyclic ring system as a whole is not aromatic. The fused bicyclic ring can be attached to other groups at any possible position. Examples of fused bicyclic rings include, but are not limited to, for example: wait.

[0085] As used herein, the terms “benzo C5-C8 carbocyclyl,” “benzo 5-8 membered heterocyclyl,” “benzo 5-7 membered heteroaryl,” and the like have similar definitions and refer to a condensed ring formed by a benzene ring and a C5-C8 carbocyclyl, a 5-8 membered heterocyclyl, or a 5-7 membered heteroaryl. The terms “5-7 membered heteroaryl-C5-C7 carbocyclyl,” “5-7 membered heteroaryl-5-7 membered heterocyclyl,” and “C4-C7 carbocyclyl-5-7 membered heterocyclyl” have similar definitions and refer to a condensed ring formed by a 5-7 membered heteroaryl and a C5-C8 carbocyclyl, a 5-8 membered heterocyclyl, or a 5-7 membered heteroaryl. The term “C4-C7 carbocyclyl-5-7 membered heterocyclyl” refers to a condensed ring formed by a C4-C7 carbocyclyl and a 5-7 membered heterocyclyl.

[0086] As used herein, "halogen" or "halogen atom" refers to F, Cl, Br, and I. More preferably, the halogen or halogen atom is selected from F, Cl, and Br. "Halogenated" means substituted with an atom selected from F, Cl, Br, and I.

[0087] Unless otherwise specified, the structural formulas described herein are intended to include all isomeric forms (e.g., enantiomers, diastereomers, and geometric isomers (or conformers)): for example, R and S configurations containing asymmetric centers, (Z) and (E) isomers of double bonds, etc. Therefore, single stereochemical isomers of the compounds of the present invention or mixtures of their enantiomers, diastereomers, or geometric isomers (or conformers) are all within the scope of the present invention.

[0088] As used herein, the term "tautomer" refers to structural isomers of different energies that can interconvert across a low energy barrier. For example, proton tautomers (i.e., prototropy) include interconversion via proton migration, such as 1H-indazole and 2H-indazole. Valence tautomers include interconversion via reorganization of some of the bonding electrons.

[0089] As used herein, the term "solvate" refers to a complex in which the compound of the present invention is coordinated with solvent molecules to form a specific ratio.

[0090] As used herein, the term "hydrate" refers to a complex formed by coordination of a compound of the present invention with water.

[0091] As used herein, *" refers to a chiral center.

[0092] After extensive and in-depth research, the inventors unexpectedly discovered a tetrahydrocarbazole compound that significantly improved the inhibitory effect on human tumor cell lines. The IC values ​​of several compounds were 50 Reached below 0.2μM.

[0093] abbreviation:

[0094] Bu=butyl

[0095] tBu = tert-butyl

[0096] Boc = tert-butyloxycarbonyl

[0097] DMF=N,N-dimethylformamide

[0098] DMSO = dimethyl sulfoxide

[0099] Et = Ethyl

[0100] HATU = O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate

[0101] Me = methyl

[0102] PMB = 4-methoxybenzyl

[0103] Tf = trifluoromethanesulfonyl

[0104] TFA = trifluoroacetic acid

[0105] TMS = trimethylsilyl

[0106] The main advantages of the present invention are:

[0107] 1. The tetrahydrocarbazole compounds of the present invention significantly enhance the inhibitory effect on the proliferation of human tumor cell lines. The IC values ​​of several compounds are 50 Reached below 0.2μM.

[0108] 2. The tetrahydrocarbazole compounds of the present invention have good safety and low toxicity and side effects, and the prepared drugs can be taken orally.

[0109] 3. The tetrahydrocarbazole compounds of the present invention can be used in combination with other targeted drugs or chemotherapy drugs to achieve the goal of synergistic enhancement, and have the potential to significantly increase the survival of cancer patients and even cure certain types of cancer.

[0110] Below, the scheme of the present invention will be explained in conjunction with embodiment.It will be understood by those skilled in the art that the following examples are only used to illustrate the present invention and should not be regarded as limiting the scope of the present invention.In the embodiment, if specific technology or conditions are not indicated, the technology or conditions described in the literature in this area or the product instructions are used.The reagents or instruments used are not indicated by the manufacturer, and are all conventional products that can be obtained by commercial purchase.

[0111] Example

[0112] Example 1: Synthesis of Compound E01

[0113] A xylene solution (5 mL) of compound INT-A (199.3 mg, 1.000 mmol, synthesized using the method described in patent WO2006065480) and compound E01-1 (455.6 mg, 5 mmol, racemate) was stirred at 130°C for 2 hours, then heated to 165°C and stirred for 4 hours. The reaction solution was cooled to room temperature, and the precipitated solid was filtered and purified twice with ethanol to obtain a white solid E01 (134.3 mg, 49.31%, racemate). ESI / MS (m / z) 273.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ10.80 (s, 1H), 7.28 (s, 1H), 7.25 (d, J = 8.3Hz, 1H), 6.96 (dd, J=8.3,0.8Hz,1H),4.52(s,2H),3.78-3.74(m,1H),3.53-3.48(m,2H),3.45-3.40 (m,2H),2.76(t,J=5.9Hz,2H),2.57-2.54(m,2H),2.36(s,3H),2.00-1.94(m,2H).

[0114] Example 2: Synthesis of Compound E02

[0115] A xylene solution (5 mL) of compound INT-A (199.3 mg, 1.000 mmol) and compound E02-1 (257.8 mg, 2.5 mmol, racemate) was stirred at 130°C for 2 hours, then heated to 165°C and stirred for 4 hours. The reaction solution was cooled to room temperature and concentrated in vacuo to remove the solvent. The mixture was dissolved in a small amount of ethanol and a large amount of water was added. The precipitated solid was filtered and dried in vacuo to obtain compound E02 (130.5 mg, 45.89%, racemate) as a pale yellow solid. ESI / MS (m / z) 285.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ10.61 (s, 1H), 7.29 (d, J = 8.5Hz, 1H), 7.27 (s, 1H), 6. 96(d,J=8.3Hz,1H),4.35(s,1H),3.65-3.61(m,1H),3.51-3.48(m,1H),3.43- 3.38(m,1H),2.76(t,J=6.0Hz,2H),2.68-2.63(m,1H),2.55-2.52(m,1H),2. 36(s,3H),1.99-1.93(m,2H),1.91-1.83(m,1H),0.90(dd,J=6.7,2.2Hz,6H).

[0116] Example 3: Synthesis of Compound E03

[0117] A toluene solution (5 mL) of compound INT-A (199.3 mg, 1.000 mmol) and compound E03-1 (267.2 mg, 3.000 mmol) was stirred at 130°C for 5 hours. The reaction mixture was cooled to room temperature and concentrated in vacuo to remove the solvent. The mixture was dissolved in a small amount of ethanol and a large amount of water was added. The precipitated solid was filtered and dried in vacuo to obtain compound E03 (200.7 mg, 74.23%) as a pale yellow solid. ESI / MS (m / z) 271.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ10.79(s,1H),7.29(s,1H),7.27(d,J=8.3Hz,1H),6.98(dd,J=8.3,1.1Hz,1H),4.29(s ,1H),3.27(s,2H),2.76(t,J=6.0Hz,2H),2.52(d,J=5.8Hz,2H),2.36(s,3H),2.00-1.95(m,2H),1.19(s,6H).

[0118] Example 4: Synthesis of Compound E04-R

[0119] Under nitrogen, compound E04-R-1 (300 mg, 3.483 mmol) was added to a solution of compound INT-A (231 mg, 1.161 mmol) in toluene (2 mL) at room temperature. The reaction mixture was heated to 140°C and stirred overnight. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure and washed with n-hexane (3 × 10 mL) to obtain compound E04-R (140 mg, 41.12%) as a brown solid. ESI / MS (m / z): 268.3 [M+H] + . 1H NMR (400MHz, DMSO-d6): δ10.80-10.55(m,1H),7.25(d,J=8.3Hz,2H),6.95(dd,J=8.1,1.8 Hz,1H),4.16(dq,J=7.6,5.2Hz,1H),3.01(dt,J=11.5,5.7Hz,1H),2.97-2.91(m,1H),2.84 (ddd,J=10.8,7.9,6.0Hz,2H),2.75(t,J=6.1Hz,2H),2.65(dd,J=10.8,5.1Hz,1H),2.60-2 .55(m,2H),2.35(s,3H),1.98(dt,J=12.9,6.4Hz,3H),1.59(ddt,J=12.9,8.2,5.6Hz,1H).

[0120] Example 5: Synthesis of Compound E05-R

[0121] Compound E05-R-1 (151 mg, 1.506 mmol) was added to a toluene (5 mL) solution of compound INT-A (100 mg, 0.502 mmol) at room temperature. The reaction solution was stirred at 140°C overnight, cooled to room temperature, and concentrated under reduced pressure. The crude product was separated by triethylamine-protected silica gel column chromatography (1% triethylamine in methanol) to afford solid E05-R (25 mg, crude product). This was then dissolved in n-hexane (5 mL) and dried to afford a light yellow solid compound E05-R (19.4 mg, 13.01%). ESI / MS (m / z): 282.15 [M+H] + . 1 H NMR(300MHz,DMSO-d6)δ10.65(s,1H),7.22-7.14(m,2H),6.91-6.83(m,1H),4.20(dq,J=12.0,5.1Hz,1H),2. 76-2.71(m,1H),2.70-2.64(m,2H),2.47(t,J=6.8Hz,4H),2.39-2.32(m,1H),2.27(s,3H),2.19(s,3H),2.15 -2.02(m,1H),1.88(p,J=6.0Hz,2H),1.56(dq,J=12.2,7.0Hz,1H).

[0122] Example 6: Synthesis of Compound E06-SR

[0123] Tetraethyl titanate (114.48 mg, 0.502 mmol) was added to a toluene (3 mL) solution of compound INT-A (50 mg, 0.251 mmol) and compound E06-SR-1 (27.92 mg, 0.276 mmol) at room temperature. The reaction solution was stirred at 100°C for 3 hours, then cooled to room temperature and dried under reduced pressure. The crude product was separated by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: methanol) to give compound E06-SR (5.7 mg, 7.49%) as a reddish-brown solid. ESI / MS (m / z): 283.15 [M+H] + . 1 H NMR(400MHz,DMSO-d6)δ10.72(s,1H),7.29-7.23(m,2H),6.95(dd,J=8.4,1.5Hz,1 H),4.16(p,J=5.8Hz,1H),4.05(p,J=7.1Hz,1H),2.75(t,J=6.0Hz,2H),2.55(td,J= 6.0,3.7Hz,2H),2.38(s,3H),2.15(dt,J=13.3,6.9Hz,1H),1.95(p,J=6.3Hz,2H),1 .81(ddd,J=15.7,7.0,2.9Hz,2H),1.76-1.63(m,2H),1.50(dt,J=13.0,6.5Hz,1H).

[0124] Example 7: Synthesis of Compound E07

[0125] To a solution of ammonium chloride (0.99 g, 18.476 mmol) and ammonium carbonate (6.66 g, 69.285 mmol) in water (4 mL) was added a solution of compound E07-1 (800 mg, 4.619 mmol) in ethanol (4 mL) at room temperature. The reaction mixture was stirred at room temperature for 15 minutes, followed by the addition of trimethylsilyl cyanide (2.06 g, 20.785 mmol). The reaction mixture was stirred at 65°C for 24 hours, then extracted with ethyl acetate (3 × 100 mL). The organic layer was washed with saturated brine (3 × 50 mL), dried over anhydrous sodium sulfate, and the solvent removed under reduced pressure to yield compound E07-2 (600 mg, 53.40%) as a yellow solid. ESI / MS (m / z): 244.15 [M+H] + .

[0126] Trifluoroacetic acid (3 mL) was added to a solution of compound E07-2 (550 mg, 2.261 mmol) in dichloromethane (5 mL) at room temperature. The reaction mixture was stirred at room temperature for 3 hours and then concentrated to dryness. The residue was separated by reverse-phase preparative chromatography (mobile phase A: water (20 mmol / L formic acid); mobile phase B: acetonitrile) to afford compound E07-3 (280 mg, 86.52%) as a brown solid. ESI / MS (m / z): 144.15 [M+H] + .

[0127] Tetraethyl titanate (114 mg, 0.502 mmol) was added to a toluene (4 mL) solution of compound E07-3 (50 mg, 0.251 mmol) and compound INT-A (108 mg, 0.753 mmol) at room temperature. The reaction solution was stirred at 80°C for 4 hours and then cooled to room temperature. The solid was collected by filtration and washed with toluene (3 × 2 mL) and ethanol (3 mL), and dried to obtain an off-white solid compound E07 (35.2 mg, 43.24%). ESI / MS (m / z): 325.20 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ10.49(s,1H),7.83(s,1H),7.32-7.27(m,2H),6.99(dd,J=8.4,1.5Hz,1H),3.64-3.50(m,2H),2. 77(t,J=6.0Hz,2H),2.59(dt,J=16.3,6.2Hz,1H),2.46(d,J=6.1Hz,1H),2.36(s,3H),1.97(p,J=6.3Hz,2H),1.35(s,3H).

[0128] Example 8: Synthesis of Compound E08

[0129] Tetraethyl titanate (228.97 mg, 1.004 mmol) was added to a toluene (4 mL) solution of compound INT-A (100 mg, 0.502 mmol) and compound E08-1 (101.53 mg, 1.004 mmol) at room temperature. The reaction mixture was stirred at 100°C for 3 hours, then cooled to room temperature and concentrated under reduced pressure. The resulting crude product was washed with ethyl acetate (10 mL), n-hexane (10 mL), and acetonitrile (10 mL) to afford compound E08 (19.5 mg, 12.85%) as a light yellow solid. ESI / MS (m / z): 283.15 [M+H] + . 1H NMR (400MHz, DMSO-d6): δ10.68(s,1H),7.24(d,J=6.8Hz,2H),6.93(d,J=8.5Hz,1H),4.88(s,1H),3.55(s,2H),2.73(t,J=5. 7Hz,2H),2.53(s,2H),2.35(s,3H),2.33-2.25(m,2H),2.25-2.16(m,2H),1.91(q,J=10.6,7.9Hz,2H),1.68(q,J=8.7Hz,2H).

[0130] Example 9: Synthesis of Compound E09

[0131] Aqueous ammonia (3 mL) was added to compound E09-1 (250 mg, 1.936 mmol) at room temperature. The mixture was stirred at room temperature overnight and then concentrated under reduced pressure. The residue was separated by reverse-phase preparative chromatography (mobile phase A: water (5 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound E09-2 as a white solid. ESI / MS (m / z): 115.35 [M+H] + .

[0132] Tetraethyl titanate (228.97 mg, 1.004 mmol) was added to a toluene (6 mL) solution of compound INT-A (100 mg, 0.502 mmol) and compound E09-2 (143.22 mg, 1.255 mmol) at room temperature. The reaction mixture was stirred at 100°C overnight, filtered, and the filter cake was washed with toluene (5 mL), ethyl acetate (5 mL), and n-hexane (10 mL). The filter cake was then dissolved and filtered with dichloromethane (3×50 mL). The filtrate was concentrated under reduced pressure and washed with n-hexane (10 mL) to obtain compound E09 (19.4 mg, 12.79%) as a reddish-brown solid. ESI / MS (m / z): 296.15 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ12.83(d,J=46.6Hz,1H),12.52(d,J=16.3Hz,1H),7 .52(s,1H),7.43-7.33(m,2H),7.31(d,J=8.5Hz,1H),6.90(t,J=4.8Hz,1H), 4.65-4.49(m,1H),3.03-2.89(m,4H),2.80(h,J=8.2,7.5Hz,1H),2.60(dd,J =8.4, 3.9Hz, 1H), 2.56 (t, J = 8.5Hz, 2H), 2.39 (s, 3H), 2.09 (p, J = 6.2Hz, 2H).

[0133] Example 10: Synthesis of Compound E10

[0134] A toluene solution (5 mL) of compound INT-A (149.4 mg, 0.750 mmol) and compound E10-1 (393.5 mg, 3.000 mmol) was stirred at 130°C for 6 hours. The reaction mixture was cooled to room temperature, concentrated, filtered, and washed with ethanol to obtain compound E10 (95.4 mg, 40.72%) as a white solid. ESI / MS (m / z) 313.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ10.93(s,1H),7.29(s,1H),7.25(d,J=8.3Hz,1H),6.98(dd,J=8.3,1.0Hz,1H), 4.27(s,2H),2.78(t,J=6.0Hz,2H),2.52(d,J=6.1Hz,2H),2.36(s,3H),1.99-1.93(m,2H),1.44(s,9H).

[0135] Example 11: Synthesis of Compound E11

[0136] A toluene solution (5 mL) of compound INT-A (99.6 mg, 0.500 mmol) and compound E11-1 (156.2 mg, 1.500 mmol) was stirred at 130°C for 4 hours. The reaction mixture was cooled to room temperature and concentrated in vacuo to remove the solvent. The residue was dissolved in a small amount of ethanol and added to a large amount of water. The precipitated solid was filtered and dried to obtain compound E11 (59.7 mg, 41.84%) as a light green solid. ESI / MS (m / z) 286.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ10.78(s,1H),7.28(s,1H),7.25(d,J=8.3Hz,1H),6.96(d,J=8.3Hz,1H),4.45(s,1H),3.52(t,J=6.2Hz,2H),3.47( t,J=5.8Hz,2H),2.83(t,J=6.3Hz,2H),2.76(t,J=6.0Hz,2H),2.64(t,J=5.8Hz,2H),2.56(t,J=6.2Hz,2H),2.35(s,3H),2.00-1.95(m,2H).

[0137] Example 12: Synthesis of Compound E12

[0138] A toluene solution (5 mL) of compound INT-A (99.6 mg, 0.500 mmol) and compound E12-1 (172.8 mg, 1.500 mmol) was stirred at 135°C for 6 hours. After the reaction solution was cooled to room temperature, the precipitated solid was filtered and washed with ethanol to obtain compound E12 (56.2 mg, 37.79%) as a white solid. ESI / MS (m / z) 297.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ10.65(s,1H),7.26-7.23m,2H),6.95-6.92(m,1H),4.54(d,J=4.0Hz,1H),3.56-3.49(m,1H),3.49-3.43(m,1H),2.75(t ,J=5.9Hz,2H),2.60-2.56(m,2H),2.35(s,3H),1.99-1.94(m,2H),1.91 -1.86(m,2H),1.69-1.63(m,2H),1.52-1.42(m,2H),1.35-1.27(m,2H).

[0139] Example 13: Synthesis of Compound E13

[0140] A toluene solution (5 mL) of compound INT-A (99.6 mg, 0.500 mmol) and compound E13-1 (285.5 mg, 2.500 mmol) was stirred at 135°C for 3 hours. The reaction solution was concentrated to obtain a solid which was purified twice with ethanol to give compound E13 (89.3 mg, 60.45%) as a white solid. ESI / MS (m / z) 296.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ10.69(s,1H),7.27-7.25(m,2H),6.96-6.93(m,1H),3.58-3.50(m,1H),2.83-2.78(m, 2H), 2.76 (t, J = 6.0Hz, 2H), 2.62-2.57 (m, 2H), 2.35 (s, 3H), 2.19 (s, 3H), 2.05-1.94 (m, 4H), 1.71-1.60 (m, 4H).

[0141] Example 14: Synthesis of Compound E14

[0142] A xylene solution (4 mL) of compound INT-A (199.3 mg, 1.000 mmol) and compound E14-1 (273.3 mg, 3 mmol) was stirred at 165°C for 3 hours. The reaction solution was concentrated in vacuo and dissolved in a small amount of ethanol. A large amount of water was added. The resulting turbid solution was vacuum-evaporated to remove ethanol and precipitate a solid. The precipitated solid was washed with a small amount of ethyl acetate to yield compound E14 (84.5 mg, 31.03%) as a pale yellow solid. ESI / MS (m / z) 273.2 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ10.76(s,1H),7.28(s,1H),7.25(d,J=8.3Hz,1H),6.95(d,J=8.3Hz,1H),4.49(t,J=5.2Hz,2H),3.83-3 .78(m,1H),3.63-3.59(m,2H),3.43-3.38(m,2H),2.76(t,J=5.4Hz,2H),2.64(t,J=5.6Hz,2H),2.35(s,3H),1.98-1.93(m,2H).

[0143] Example 15: Synthesis of Compound E15

[0144] A toluene solution (5 mL) of compound INT-A (199.3 mg, 1.000 mmol) and compound E15-1 (378.0 mg, 2.500 mmol) was stirred at 130°C for 2 hours. The reaction solution was cooled to room temperature and concentrated in vacuo to remove the solvent. The residue was washed with acetonitrile to obtain compound E15 (245.4 mg, 63.99%) as a white solid. ESI / MS (m / z) 384.1 [M+H] + .

[0145] Example 16: Synthesis of Compound E16

[0146] Under nitrogen protection, compound E16-1 (138 mg, 1.004 mmol) was added to a toluene (3 mL) solution of compound INT-A (100 mg, 0.502 mmol) and tetraethyl titanate (229 mg, 1.004 mmol) at room temperature. The reaction solution was stirred at 80°C overnight, cooled to room temperature, concentrated, and purified by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to obtain compound E16 (21.5 mg, 13.14%) as a yellow solid. ESI / MS (m / z): 319.10 [M+H] + . 1H NMR (400MHz, DMSO-d6): δ10.82(s,1H),7.54-7.48(m,2H),7.31(q,J=6.6,5.6Hz,4H),7.22(dd,J=8.4,6.2Hz,1H),6.98(dd,J=8.3,1.7Hz,1H) ,4.85(dd,J=7.6,5.0Hz,1H),4.73(t,J=5.8Hz,1H),3.74-3.57(m,2H) ,2.83-2.71(m,3H),2.48-2.40(m,1H),2.36(s,3H),2.03-1.86(m,2H).

[0147] Example 17: Synthesis of Compound E17

[0148] To a solution of compound E17-1 (2 g, 7.959 mmol) in DMF (20 mL of N,N-dimethylformamide) at room temperature were added HOBT (1-hydroxybenzotriazole, 1.61 g, 11.938 mmol) and EDCI (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 2.29 g, 11.938 mmol). The reaction mixture was stirred at room temperature for one hour, followed by the addition of triethylamine (3.22 g, 31.836 mmol) and compound E17-2 (1.16 g, 11.938 mmol), and stirring was continued for another two hours. The reaction mixture was diluted with distilled water and extracted with ethyl acetate. The combined organic phases were washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and then purified by spin-drying. The mixture was then separated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to afford compound E17-3 (2.21 g, 94.33%) as a white solid. ESI / MS (m / z): 295.2 [M+H] + .

[0149] Under nitrogen, a 1M solution of methylmagnesium bromide in tetrahydrofuran (10.19 mL) was slowly added dropwise to a solution of compound E17-3 (1 g, 3.397 mmol) in tetrahydrofuran (8 mL) at 0°C. The reaction mixture was stirred at room temperature for 2 hours, quenched with saturated ammonium chloride, extracted with ethyl acetate, and the combined organic phases were washed with saturated brine. The organic phases were dried over anhydrous sodium sulfate and then concentrated to dryness to afford compound E17-4 (730 mg, 86.19%) as a colorless oil. ESI / MS (m / z): 250.2 [M+H] + .

[0150] Under nitrogen protection, NaBH4 (sodium borohydride, 221.54 mg, 5.856 mmol) was added to a solution of compound E17-4 (730 mg, 2.928 mmol) in methanol (10 mL) at 0°C. The reaction solution was stirred at room temperature for 1 hour. After completion of the reaction, the reaction was quenched with distilled water and extracted with ethyl acetate. The combined organic phases were washed with saturated brine, dried over anhydrous sodium sulfate, and directly concentrated to obtain compound E17-5 (680 mg, 92.40%). ESI / MS (m / z): 252.2 [M+H] + .

[0151] To a solution of compound E17-5 (670 mg, 2.666 mmol) in dichloromethane (15 mL) was slowly added dropwise trifluoroacetic acid (1.5 mL, 20.195 mmol) at room temperature. The reaction solution was stirred at room temperature for two hours, then concentrated to dryness and separated by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound E17-6 (350 mg, 86.83%) as a white solid. ESI / MS (m / z): 152.2 [M+H] + .

[0152] Compound INT-A (150 mg, 0.753 mmol) was added to a toluene (8 mL) solution of compound E17-6 (227.66 mg, 1.506 mmol) at room temperature. The reaction mixture was stirred at 130°C for 5 hours, concentrated, and then separated by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to afford compound E17 (19.6 mg, 7.83%) as a white solid. ESI / MS (m / z): 333.20 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ10.86(s,1H),7.43(d,J=7.4Hz,2H),7.29(q,J=7.6,7.1Hz,4H),7.19(t,J=7.3Hz,1H),6.99(d,J=8.2Hz,1H),4.57(t,J =5.8Hz,2H),3.93-4.04(m,1H),2.65-2.81(m,3H),2.36(s,3H),2.24-2 .33(m,1H),1.90-2.01(m,1H),1.79-1.90(m,1H).1.05(d,J=6.2Hz,3H).

[0153] Example 18: Synthesis of Compound E18

[0154] To a solution of compound E18-1 (2 g, 11.160 mmol) and triethylamine (3.39 g, 33.480 mmol) in dichloromethane (15 mL) was added dropwise (Boc)2O (di-tert-butyl dicarbonate, 3.04 g, 13.950 mmol) at room temperature. After stirring at room temperature for two hours, the reaction solution was directly concentrated to dryness and separated by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to obtain compound E18-2 (2.5 g, 76.19%) as a colorless oil. ESI / MS (m / z): 280.25 [M+H] + .

[0155] Under nitrogen, a 3.4M solution of methylmagnesium bromide in tetrahydrofuran (4.21 mL, 14.320 mmol) was added dropwise to a solution of compound E18-2 (1 g, 3.580 mmol) in tetrahydrofuran (15 mL) at room temperature. The reaction was stirred at room temperature for two hours, then quenched with water. The mixture was extracted with dichloromethane (3 × 30 mL) and the organic phase was washed with saturated brine (2 × 30 mL). The mixture was dried over anhydrous sodium sulfate, concentrated to dryness, and isolated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to afford compound E18-3 (800 mg, 80.00%) as a yellow solid. ESI / MS (m / z): 266.25 [M+H] + .

[0156] Trifluoroacetic acid (5 mL) was added dropwise to a solution of compound E18-3 (1 g, 3.769 mmol) in dichloromethane (5 mL) at room temperature. After stirring at room temperature for 1 hour, the reaction solution was directly concentrated and dried to obtain crude compound E18-4 (1 g). ESI / MS (m / z): 166.25 [M+H] + .

[0157] Under nitrogen, glacial acetic acid (12.06 mg, 0.201 mmol) was added dropwise to a toluene (3 mL) solution of compound INT-A (200 mg, 1.004 mmol) and compound E18-4 (331.71 mg, 2.008 mmol) at room temperature. The reaction solution was stirred at 120°C overnight. After cooling to room temperature, the reaction solution was directly concentrated to dryness and washed with n-hexane (3 × 5 mL). The crude product was separated by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to obtain compound E18 (16.8 mg, 4.61%) as a yellow solid. ESI / MS (m / z): 347.10 [M+H] + . 1H NMR (400MHz, DMSO-d6): δ11.01(s,1H),7.40(d,J=7.5Hz,2H),7.32-7.27(m,2H),7.24(t,J=7.4Hz,2 H),7.18(t,J=7.1Hz,1H),7.01(dd,J=8.0,1.6Hz,1H),4.48(s,1H),4.43(s,1H),2.76-2.66(m,2H), 2.66-2.59(m,1H),2.36(s,3H),2.17-2.06(m,1H),1.90(s,1H),1.82(s,1H),1.13(s,3H),1.00(s,3H).

[0158] Example 19: Synthesis of Compound E19

[0159] To a solution of compound E19-1 (1 g, 3.397 mmol) in tetrahydrofuran (8 mL) was slowly added dropwise a 3.4 M solution of ethylmagnesium bromide in tetrahydrofuran (3.00 mL, 10.191 mmol) under a nitrogen atmosphere at 0°C. The reaction mixture was stirred at room temperature for 2 hours and then quenched with saturated aqueous ammonium chloride. The mixture was extracted with ethyl acetate (3 × 30 mL). The combined organic layers were washed with saturated brine (3 × 20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to afford compound E19-2 (710 mg, 79.36%) as a colorless oil. ESI / MS (m / z): 264.2 [M+H] + .

[0160] Under a nitrogen atmosphere, NaBH4 (sodium borohydride, 203 mg, 5.392 mmol) was added to a solution of compound E19-2 (710 mg, 2.696 mmol) in methanol (10 mL) at 0°C. The reaction solution was stirred at room temperature for 1 hour. The reaction was quenched with water (10 mL) at 0°C and extracted with ethyl acetate (3×20 mL). The organic phases were combined and washed with saturated brine (3×10 mL). The organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to obtain compound E19-3 (650 mg, 90.85%). ESI / MS (m / z): 266.2 [M+H] + .

[0161] To a solution of compound E19-3 (640 mg, 2.412 mmol) in dichloromethane (15 mL) was added dropwise trifluoroacetic acid (1.5 mL, 20.195 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 hours, concentrated in vacuo, and then separated by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound E19-4 (350 mg, 87.82%) as a white solid. ESI / MS (m / z): 166.2 [M+H] + .

[0162] Under nitrogen atmosphere, compound INT-A (150 mg, 0.753 mmol) was added to a toluene (8 mL) solution of compound E19-4 (248 mg, 1.506 mmol) at room temperature. The reaction mixture was stirred at 130°C for 5 hours, cooled to room temperature, concentrated in vacuo, and then separated by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to afford compound E19 (30.7 mg, 11.77%) as an off-white solid. ESI / MS (m / z): 347.25 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ10.84(s,1H),7.43(d,J=7.4Hz,2H),7.28(q,J=7.7Hz,4H),7 .18(t,J=7.2Hz,1H),6.99(d,J=8.2Hz,1H),4.60(d,J=6.1Hz,1H),4.48(d,J=5.1Hz,1 H),3.67-3.77(m,1H),2.64-2.84(m,3H),2.36(s,3H),2.24-2.31(m,1H),1.89-2.01( m,1H),1.79-1.89(m,1H),1.44-1.57(m,1H),1.20-1.35(m,1H),0.88(t,J=7.3Hz,3H).

[0163] Example 20: Synthesis of Compound E20

[0164] Under nitrogen, a 3.4M solution of ethylmagnesium bromide in tetrahydrofuran (4.21 mL, 14.320 mmol) was added dropwise to a solution of compound E20-1 (1 g, 3.580 mmol, racemate) in tetrahydrofuran (15 mL) at room temperature. The reaction was stirred at room temperature for 2 hours, then quenched with water. The mixture was extracted with dichloromethane (3 × 30 mL). The organic layer was washed with saturated brine (2 × 30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound E20-2 (900 mg, 81.40%, racemate) as a yellow solid. ESI-MS (m / z): 294.25 [M+H] + .

[0165] Trifluoroacetic acid (5 mL) was added dropwise to a solution of compound E20-2 (900 mg, 0.003 mmol, racemate) in dichloromethane (5 mL) at room temperature. The mixture was stirred at room temperature for 1 hour and then concentrated to dryness to give crude compound E20-3 (1.1 g, racemate). ESI-MS (m / z): 194.25 [M+H] + .

[0166] Under nitrogen, glacial acetic acid (12 mg, 0.201 mmol) was added dropwise to a toluene (3 mL) solution of compound E20-3 (388 mg, 2.008 mmol, racemate) and compound INT-A (200 mg, 1.004 mmol) at room temperature. The reaction solution was stirred at 120°C overnight and then concentrated to dryness. The crude product was washed with n-hexane (3 × 5 mL) and separated by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to afford compound E20 (37.2 mg, 9.90%, racemate) as a yellow solid. ESI-MS (m / z): 375.15 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ11.11(s,1H),7.42(d,J=7.5Hz,2H),7.28(t,J=4.0Hz,2H),7 .24(t,J=7.3Hz,2H),7.18(t,J=7.2Hz,1H),7.02(d,J=8.4Hz,1H),4.55(s,1H),4.38(s ,1H),2.81-2.59(m,3H),2.37(s,3H),2.11(dt,J=17.1,4.6Hz,1H),1.98-1.76(m,2H), 1.53-1.38(m,2H),1.16(h,J=7.0Hz,2H),0.83(t,J=7.4Hz,3H),0.77(t,J=7.5Hz,3H).

[0167] Example 21: Synthesis of Compound E21

[0168] Under nitrogen atmosphere, E21-1 (293 mg, 3.012 mmol) was added to a toluene (20 mL) solution of compound INT-A (200 mg, 1.004 mmol) at room temperature. The reaction solution was stirred at 80°C overnight and cooled to room temperature, filtered, and the filter cake was washed with toluene (15 mL). The filtrate was concentrated in vacuo and dried, then dissolved in n-hexane (60 mL), filtered, and the filtrate was concentrated in vacuo and dried to obtain a yellow-green solid compound E21 (127.5 mg, 36.64%, a mixture of E and Z isomers). ESI / MS (m / z): 243.3 [M+H] + .

[0169] Example 22: Synthesis of Compound E22

[0170] To a solution of compound INT-A (100 mg, 0.502 mmol) in toluene (10 mL) was added E22-1 (137 mg, 0.502 mmol) at room temperature, and the reaction mixture was stirred at 80°C overnight. After cooling to room temperature, the mixture was concentrated under reduced pressure and dried. The mixture was separated by silica gel column chromatography (n-hexane) to obtain compound E22 (61 mg, 16.18%) as a pale yellow solid. ESI / MS (m / z): 455.3 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ10.92(d,J=41.3Hz,1H),7.72-7.64(m,2H),7.60(t,J=7.9Hz,1H),7.45-7.18(m,2H),7.01(d dd,J=39.8,8.3,1.6Hz,1H),5.23(s,2H),2.88-2.66(m,4H),2.47(t,J=6.1Hz,1H),2.37(d,J=13.1Hz,3H),1.90(p,J= 7.0, 6.3Hz, 2H), 1.85-1.76 (m, 2H), 1.69 (d, J = 13.3Hz, 3H), 1.51 (q, J = 12.3Hz, 2H), 1.34 (q, J = 10.9, 9.3Hz, 3H).

[0171] Example 23: Synthesis of Compound E23

[0172] To a solution of compound INT-A (200 mg, 1.004 mmol) in toluene (20 mL) was added compound E23-1 (312 mg, 2.008 mmol) under nitrogen at room temperature. The reaction mixture was stirred at 80°C overnight, cooled to room temperature, and filtered. The filter cake was washed with toluene (5 mL) and n-hexane (20 mL). The filter cake was dissolved and filtered with dichloromethane (100 mL). The filtrate was concentrated in vacuo and dried to give compound E23 (30 mg, 10.11%, a mixture of Z and E isomers) as a yellow-green solid. ESI / MS (m / z): 301.3 [M+H] + .

[0173] Example 24: Synthesis of Compound E24

[0174] To a solution of compound E24-1 (1 g, 3.902 mmol) in methanol (15 mL) was slowly added hydrazine hydrate (390 mg, 7.804 mmol) at room temperature. The reaction mixture was stirred at 65°C for two hours and cooled to room temperature. The reaction mixture was concentrated in vacuo to dryness and then separated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:4) to obtain compound E24-2 (420 mg, 44.43%) as a white solid. ESI / MS (m / z): 243.1 [M+H] + .

[0175] To a solution of compound E24-2 (182 mg, 0753 mmol) and compound INT-A (150 mg, 0.753 mmol) in toluene (8 mL) was added acetic acid (9 mg, 0.151 mmol) under nitrogen at room temperature. The reaction mixture was stirred at 100°C overnight and cooled to room temperature. The mixture was filtered, and the filter cake was washed with toluene (30 mL), ether (30 mL), and methanol (30 mL). The solid was dried under vacuum to afford compound E24 (28 mg, 8.97%) as a yellow solid. ESI / MS (m / z): 424.20 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ11.06(s,1H),10.41(s,1H),7.46(d,J=7.1Hz,4H),7.37(s,1H),7.36(s,2H),7.34(s,1H),7.32(s,1H) ,7.31(d,1H),7.28(s,1H),7.25(d,1H),7.11(s,1H),6.97(d,J=8.4Hz,1H),2.78(t,2H),2.67(t,2H),2.35(s,3H),1.99(p,2H).

[0176] Example 25: Synthesis of Compound E25

[0177] To a solution of E25-1 (600 mg, 2.501 mmol) and compound E25-2 (408 mg, 2.501 mmol) in N,N-dimethylformamide (5 mL) was added sodium hydroxide (120 mg, 3.001 mmol) at room temperature, and the reaction mixture was stirred at room temperature overnight. The reaction mixture was quenched with water at 0°C, and the solid was collected by filtration and washed with water (3 × 5 mL) to give compound E25-3 (700 mg, 86.89%) as a white solid. ESI / MS (m / z): 322.1 [M+H] + .

[0178] To a solution of compound E25-3 (200 mg, 0.621 mmol) in methanol (5.5 mL) was added hydrazine hydrate (62 mg, 1.242 mmol) at room temperature. The reaction mixture was reacted at 70°C for 6 hours and then cooled to room temperature. The reaction mixture was filtered and washed with methanol (3×5 mL). The filtrate was collected and concentrated in vacuo to dryness. Ethyl ether (10 mL) was added and stirred at room temperature for half an hour. The mixture was filtered and the filter cake was washed with ether (2×5 mL). The filtrate was collected and concentrated in vacuo to dryness to obtain compound E25-4 (75 mg, 62.90%) as a white liquid. ESI / MS (m / z): 192.1 [M+H] + .

[0179] Under nitrogen atmosphere, tetraethyl titanate (103 mg, 0.451 mmol) was added to a toluene (2 mL) solution of compound E25-4 (75 mg, 0.391 mmol) and compound INT-A (60 mg, 0.300 mmol) at room temperature. The reaction solution was stirred at 80°C for three hours. The reaction solution was cooled to room temperature, concentrated in vacuo and dried, extracted with ethyl acetate (3×30 mL), and the organic phase was washed with saturated brine (2×20 mL), dried over anhydrous sodium sulfate, concentrated in vacuo and dried, and separated by reverse phase preparative column (mobile phase A: water; mobile phase B: acetonitrile) to obtain compound E25 (17 mg, 15.61%) as a yellow oil. ESI / MS (m / z): 372.9 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ10.90(d,J=37.7Hz,1H),7.64(dd,J=8.6,2.0Hz,1H),7.55-7.17(m,4H),7.01(ddd,J=41.6,8.4, 1.7Hz, 1H), 5.27 (d, J = 9.9Hz, 2H), 2.78 (ddt, J = 17.1, 12.0, 6.0Hz, 4H), 2.37 (d, J = 14.3Hz, 3H), 1.93 (q, J = 7.1, 6.3Hz, 2H).

[0180] Example 26: Synthesis of Compound E26

[0181] Under a nitrogen atmosphere, acetic acid (12 mg, 0.201 mmol) was added to a toluene (10 mL) solution of compound INT-A (200 mg, 1.004 mmol) and compound E26-1 (301 mg, 2.008 mmol) at room temperature. The reaction solution was stirred at 100°C overnight and then cooled to room temperature. The precipitated solid was filtered and washed with toluene (15 mL), ether (15 mL), n-hexane (15 mL), and methanol (15 mL), and dried to give compound E26 (85.3 mg, 25.64%) as a yellow solid. ESI / MS (m / z): 332.15 [M+H] + . 1 H NMR (300MHz, DMSO-d6): δ10.94(s,1H),7.29(s,1H),7.25(d,J=8.3Hz,1H),7.00(dd,J=8.4,1. 3Hz, 1H), 3.34 (s, 4H), 3.31 (s, 4H), 2.78 (t, J = 5.9Hz, 4H), 2.37 (s, 3H), 1.95 (p, J = 6.0Hz, 2H).

[0182] Example 27: Synthesis of Compound E27

[0183] Under nitrogen, compound E27-1 (228 mg, 1.506 mmol) was added to a solution of compound INT-A (150 mg, 0.753 mmol) in toluene (3 mL) at room temperature. The reaction solution was stirred at 140°C overnight and then cooled to room temperature. The mixture was concentrated under reduced pressure. The crude product was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain a yellow solid. The solid was further washed with n-hexane (3 × 5 mL) to obtain compound E27 (15 mg, 6.72%) as a yellow solid. ESI / MS (m / z): 297.10 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ11.14(s,1H),11.11(s,1H),7.32(s,1H),7.26(d,J=8.3Hz,1H),7.02(dd,J=8.4,1.7 Hz, 1H), 4.29 (s, 2H), 2.81 (t, J = 5.9Hz, 2H), 2.74 (t, J = 6.3Hz, 2H), 2.37 (s, 3H), 1.96 (dd, J = 12.8, 6.5Hz, 2H).

[0184] Example 28: Synthesis of Compound E28

[0185] Compound E28-2 (5.13 g, 32.920 mmol) was added dropwise to a solution of compound E28-1 (2 g, 21.947 mmol) in ethanol (38 mL) at 57°C. The reaction mixture was stirred at 57°C for 7 hours, then cooled to -20°C and a small amount of n-hexane was added. The precipitated solid was filtered and washed with diethyl ether (4 × 10 mL) to obtain compound E28-3 (2.4 g, 91.75%) as a white solid. ESI / MS (m / z): 120.15 [M+H] + .

[0186] Compound E28-4 (2.81 mL, 24.163 mmol) was added dropwise to a solution of compound E28-3 (2.4 g, 3.580 mmol) in methanol (15 mL) at 60°C. The reaction mixture was stirred at 60°C overnight, cooled to room temperature, and concentrated under reduced pressure. The crude product was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to give compound E28-5 (1.9 g, 65.43%) as a brown oil. ESI / MS (m / z): 145.05 [M+H] + .

[0187] Compound E28-5 (289.53 mg, 2.008 mmol) was added dropwise to a toluene (10 mL) solution of compound INT-A (200 mg, 1.004 mmol) and tetraethyl titanate (420.89 μL, 2.008 mmol) at room temperature. The reaction mixture was stirred at 100°C for 3 hours and then cooled to room temperature. The mixture was concentrated under reduced pressure, and the crude product was washed sequentially with toluene (2 × 10 mL), diethyl ether (3 × 10 mL), n-hexane (3 × 10 mL), and water (2 × 10 mL) to obtain compound E28 (151.0 mg, 46.22%) as a brown solid. ESI / MS (m / z): 326.25 [M+H] + . 1H NMR (400MHz, DMSO-d6): δ10.98(s,1H),10.43(s,1H),7.94(s,2H),7.36-7 .24(m,2H),7.04(dd,J=8.4,1.7Hz,1H),3.34(s,1H),3.31(s,1H),2.79(t ,J=6.0Hz,2H),2.62(t,J=6.3Hz,2H),2.37(s,3H),2.01(p,J=6.0Hz,2H), 1.59(p,J=7.2Hz,2H), 1.41-1.27(m,J=6.5,5.9Hz,4H), 0.94-0.86(m,3H).

[0188] Example 29: Synthesis of Compound B10 and Compound B11

[0189] To a solution of compound B10-1 (500 mg, 3.308 mmol) in water (30 mL) and concentrated hydrochloric acid (1.5 mL) at 0°C was added a solution of sodium nitrite (457 mg, 6.616 mmol) in water (10 mL). A mixed solution of compound B01-2 (417 mg, 3.308 mmol) and sodium acetate (597 mg, 7.278 mmol) in methanol (10 mL) and water (10 mL) was then added. The reaction solution was stirred at 0°C for 30 minutes, then filtered and the solid was washed with water (3×20 mL) to obtain compound B10-3 (400 mg, 46.46%) as a yellow solid. ESI / MS (m / z): 261.1 [M+H] + .

[0190] A solution of compound B10-3 (100 mg, 0.384 mmol), concentrated sulfuric acid (0.2 mL), and water (2 mL) was stirred at 65°C for half an hour, then cooled to room temperature. The pH was adjusted to 8 using potassium hydroxide, extracted with ethyl acetate (3 × 10 mL), washed with saturated brine (10 mL), and the organic phase was dried over anhydrous sodium sulfate. The organic phase was concentrated and dried, then separated on a silica gel column (petroleum ether:ethyl acetate = 5:1) to obtain the crude product. The crude product was then separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to obtain compound B10 (26.1 mg, 27.93%) and compound B11 (30.8 mg, 32.96%) as white solids.

[0191] Compound B10: ESI / MS (m / z): 244.1 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ12.01(s,1H),7.66(d,J=8.3Hz,1H),7.60(d,J=7.3Hz,1H),7.37(t, J=7.8Hz,1H),3.90(s,3H),3.08(t,J=5.8Hz,2H),2.63-2.54(m,2H),2.11(p,J=5.4Hz,2H).

[0192] Compound B11: ESI / MS (m / z): 244.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.88(s,1H),8.06(s,1H),7.78(d,J=8.4Hz,1H),7.66(dd,J=8. 4,1.4Hz,1H),3.88(s,3H),2.97(t,J=5.8Hz,2H),2.66-2.55(m,2H),2.23-2.12(m,2H).

[0193] Example 30: Synthesis of Compound E29

[0194] Under a nitrogen atmosphere, compound E29-1 (216 mg, 1.644 mmol) was added to a toluene (4 mL) solution of compound B10 (100 mg, 0.411 mmol) at room temperature. The reaction mixture was stirred at 140°C overnight and then cooled to room temperature. The reaction mixture was concentrated under reduced pressure, and the crude product was separated and purified by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to obtain compound E29 (39.5 mg, 26.15%) as a yellow solid. ESI / MS (m / z): 357.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.52(s,1H),7.64(d,J=8.1Hz,1H),7.51(dd,J=7.4,1.0Hz,1H),7.25-7.20(m,1H) ,4.32(s,2H),3.87(s,3H),2.96(t,J=6.0Hz,2H),2.54(t,J=6.0Hz,2H),1.93(p,J=6.2Hz,2H),1.45(s,9H).

[0195] Example 31: Synthesis of Compound E30

[0196] To a solution of compound B10 (180 mg, 0.740 mmol) in toluene (5 mL) was added E30-1 (226 mg, 3.700 mmol) under nitrogen atmosphere at room temperature. The reaction mixture was stirred at 130°C under nitrogen atmosphere for 6 hours. The reaction mixture was cooled to room temperature and concentrated under reduced pressure. The crude product was washed with ethanol (3×5 mL). The resulting solid was dried under vacuum to give compound E30 (38.7 mg, 17.59%) as an orange solid. ESI / MS (m / z): 287.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.39(s,1H),7.63(dd,J=8.1,0.9Hz,1H),7.49(dd,J=7.4,0.9Hz,1H),7.25-7.15(m,1H),4.57(s,1H) ,3.87(s,3H),3.71(t,J=6.2Hz,2H),3.58(t,J=6.2Hz,2H),2.94(t,J=6.0Hz,2H),2.58(t,J=6.0Hz,2H),1.93(p,J=6.2Hz,2H).

[0197] Example 32: Synthesis of Compound B01

[0198] To a solution of compound B01-1 (1 g, 9.081 mmol) and concentrated hydrochloric acid (2.70 mL, 88.903 mmol) in water (83 mL) was slowly added an aqueous solution (20 mL) of sodium nitrite (1.25 g, 18.162 mmol) at 0°C. The reaction solution was stirred at 0°C for 0.5 hours, followed by the slow addition of a methanol-water solution (80 mL, 1:1) of compound B01-2 (1.15 g, 9.081 mmol) and sodium acetate (1.64 g, 19.978 mmol). The reaction solution was stirred at 0°C for another 0.5 hours. The pH was adjusted to 8 with saturated sodium bicarbonate aqueous solution, and the reaction solution was concentrated under reduced pressure. The crude product was isolated and purified by silica gel column chromatography (dichloromethane:methanol = 5:1) to obtain compound B01-3 (400 mg, 20.09%) as a yellow solid. ESI / MS (m / z): 220.1 [M+H] + .

[0199] Acetic acid (12 mL, 209.359 mmol) and concentrated sulfuric acid (1.20 mL, 22.508 mmol) were added to a methanol solution (3 mL) of compound B01-3 at room temperature. The reaction solution was stirred at 65°C for two hours and then cooled to room temperature. The pH of the reaction solution was adjusted to 8 with saturated sodium bicarbonate aqueous solution. The mixture was concentrated under reduced pressure, and the crude product was separated and purified by silica gel column chromatography (dichloromethane: methanol = 5:1) to obtain a yellow solid compound B01-4 (300 mg, 43.42%). ESI / MS (m / z): 203.1 [M+H] + .

[0200] To a mixture of compound B01-4 (300 mg, 1.484 mmol) in dichloromethane (10 mL) was added pyridine (587 mg, 7.420 mmol) and trifluoromethanesulfonic anhydride (935 mg, 4.452 mmol) (Tf: trifluoromethanesulfonyl) at room temperature and stirred for 2 hours. The reaction solution was concentrated under reduced pressure, and the crude product was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B01-5 (Tf: trifluoromethanesulfonyl) (210 mg, 42.35%) as a yellow solid. ESI / MS (m / z): 334.8 [M+H] + .

[0201] Under a nitrogen atmosphere, trimethylaluminum (226 mg, 3.143 mmol) was slowly added to a mixture of compound B01-5 (150 mg, 0.449 mmol) and Pd(PPh3)4 (52 mg, 0.045 mmol) in tetrahydrofuran (5 mL) at 0°C. The reaction solution was refluxed at 80°C for 1 hour. The reaction solution was concentrated under reduced pressure, and the crude product was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B01 (70 mg, 77.90%) as a yellow solid. ESI / MS (m / z): 200.9 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.69(s,1H),7.68(d,J=8.5Hz,1H),7.17(d,J=8.5Hz,1 H),2.98(t,J=6.0Hz,2H),2.64-2.57(m,2H),2.55(s,3H),2.16(p,J=6.1Hz,2H).

[0202] Example 33: Synthesis of Compound B02

[0203] At 0 ° C, sodium nitrite (423 mg, 6.134 mmol) was added to a solution of compound B02-1 (500 mg, 3.067 mmol) and concentrated hydrochloric acid (1.25 mL) in water (12.5 mL). After the reaction solution was stirred at 0 ° C for 10 minutes, a solution of methanol (12.5 mL) and water (12.5 mL) of B01-2 (387 mg, 3.067 mmol) and sodium acetate (554 mg, 6.747 mmol) was added. The reaction solution was stirred at room temperature for 30 minutes. Filter, collect the filter cake and wash with water (3×30 mL) to obtain yellow solid compound B02-3 (300 mg, 35.94%). ESI / MS (m / z): 272.2 [M+H] + .

[0204] Concentrated hydrochloric acid (0.5 mL) was added to a solution of compound B02-3 (300 mg, 1.102 mmol) in methanol (5 mL) at room temperature. The reaction solution was stirred at 65°C overnight and then cooled to room temperature. The reaction solution was concentrated and dried by spin-drying, and then purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to obtain compound B02 (4.7 mg, 1.65%) as a white solid. ESI / MS (m / z): 255.0 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.75 (s, 1H), 7.90-7.81 (m, 1H), 2.94 (td, J = 6.0, 2.6Hz, 2H), 2.65 (t, J = 6.3Hz, 2H), 2.17 (p, J = 6.1Hz, 2H).

[0205] Example 34: Synthesis of Compound B03

[0206] To a solution of compound B02 (60 mg, 0.235 mmol) and 10% Pd / C (24 mg, 0.0226 mmol) in ethyl acetate (5 mL) at 0°C under nitrogen protection was added ammonium formate (60 mg, 0.952 mmol). The reaction solution was stirred overnight at room temperature under nitrogen protection, the reaction solution was filtered, and the filter cake was washed with ethyl acetate (2×10 mL). The filtrate was spin-dried and purified by reverse phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to obtain compound B03 (1.5 mg, 2.86%) as a light yellow solid. ESI / MS (m / z): 221.0 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ12.25(s,1H),8.60(s,1H),7.89-7.72(m,1H),2.95(t,J=6.0Hz,2H),2.70-2.60(m,2H),2.17(p,J=6.2Hz,2H).

[0207] Example 35: Synthesis of Compound B04

[0208] Zinc cyanide (176 mg, 1.496 mmol) was added to a solution of compound B01-5 (250 mg, 0.748 mmol) (Tf: trifluoromethanesulfonyl) and Pd(PPh3)4 (87 mg, 0.075 mmol) in N,N-dimethylformamide (4 mL) under nitrogen atmosphere at room temperature. The reaction mixture was stirred at 130°C for 4 hours under nitrogen, cooled to room temperature, and quenched with water (40 mL). The mixture was extracted with ethyl acetate (3 × 15 mL), and the combined organic layers were washed with saturated brine (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The crude product was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B04 (29.8 mg, 18.79%) as a light yellow solid. ESI / MS (m / z): 212.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.42(s,1H),7.98(d,J=8.6Hz,1H),7.84(d,J=8.6Hz,1H),3.02(t,J=6.0Hz,2H),2.72-2.64(m,2H),2.26-2.16(m,2H).

[0209] Example 36: Synthesis of Compound B05

[0210] To a solution of compound B01-5 (150 mg, 0.449 mmol) (Tf: trifluoromethanesulfonyl) and the catalyst Pd(dppf)Cl2.CH2Cl2 (73 mg, 0.090 mmol) in methanol (20 mL) was added triethylamine (0.19 mL, 1.347 mmol) at room temperature. Under a carbon monoxide atmosphere, the reaction solution was stirred at 80°C overnight. The reaction solution was concentrated under reduced pressure and purified by silica gel column chromatography (petroleum ether:ethyl acetate) to afford compound B05 (70 mg, 63.87%) as a light yellow solid. ESI / MS (m / z): 245.0 [M+H] + . 1H NMR (400MHz, DMSO-d6): δ12.19(s,1H),8.02(d,J=8.7Hz,1H),7.92(d,J=8.7Hz,1H ), 3.91 (s, 3H), 3.05 (t, J = 5.7Hz, 2H), 2.66 (t, J = 6.2Hz, 2H), 2.21 (p, J = 5.8Hz, 2H).

[0211] Example 37: Preparation of Compound B06

[0212] Concentrated hydrochloric acid (0.10 mL) was added to a solution of compound B06-1 (50 mg, 0.265 mmol) and 1,2-cyclohexanedione (60 mg, 0.530 mmol) in water (4.00 mL) at room temperature. The reaction solution was stirred at 120°C overnight, cooled to room temperature, filtered, and the resulting solid was washed with water (3 × 20 mL). The crude compound was separated by reverse phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to give a light brown solid compound B06 (22.4 mg, 35.83%). ESI / MS (m / z): 230.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.95(s,1H),8.35(s,1H),7.89(d,J=8.7Hz,1H),7.45(d, J=8.7Hz, 1H), 3.01 (t, J=5.8Hz, 2H), 2.59 (t, J=6.2Hz, 2H), 2.18 (q, J=5.7Hz, 2H).

[0213] Example 38: Synthesis of Compound B07

[0214] To a solution of compound B06 (300 mg, 1.309 mmol) and ammonium bicarbonate (310 mg, 3.927 mmol) in N,N-dimethylformamide (10 mL) was added triethylamine (397 mg, 3.927 mmol) and 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (746.42 mg, 1.963 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 hours, quenched with saturated aqueous ammonium chloride, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B07 (150 mg, 50.22%) as a gray solid. ESI / MS (m / z): 226.9 [MH] - . 1H NMR (400MHz, DMSO-d6): δ11.82(s,1H),8.31(s,1H),7.92(s,1H),7.84(s,1H),7.40(d,J= 8.7Hz, 1H), 7.20 (s, 1H), 2.99 (t, J = 5.9Hz, 2H), 2.64-2.55 (m, 2H), 2.19 (q, J = 6.0Hz, 2H).

[0215] Example 39: Synthesis of Compound B08

[0216] To a solution of compound B06 (300 mg, 1.309 mmol) and B08-1 (106 mg, 1.571 mmol) in N,N-dimethylformamide (3 mL) were added N,N-diisopropylethylamine (1.14 mL, 6.545 mmol) and 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (597 mg, 1.571 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 hours. After quenching with water, the mixture was extracted with ethyl acetate (3 × 10 mL). The organic layer was concentrated under reduced pressure, and the crude product was purified by silica gel column chromatography (dichloromethane:methanol = 10:1) to obtain a brown compound B08 (180 mg, 56.77%). ESI / MS (m / z): 243.0 [M+H] + . 1 H NMR (400MHz, DMSO-d6): δ11.84(s,1H),8.39(d,J=4.4Hz,1H),8.25(s,1H),7.83(dd,J=8.7,1.4Hz,1H),7. 43(d,J=8.7Hz,1H),2.99(t,J=5.9Hz,2H),2.82(d,J=4.5Hz,3H),2.66-2.55(m,2H),2.18(p,J=5.9Hz,2H).

[0217] Example 40: Synthesis of Compound B09

[0218] To a solution of compound B09-1 (1.2 g, 6.833 mmol) and 1,2-cyclohexanedione (0.92 g, 8.200 mmol) in water (100 mL) was added concentrated hydrochloric acid (2.40 mL, 78.989 mmol) at room temperature. The reaction mixture was stirred at 120°C overnight. The reaction mixture was concentrated under reduced pressure, and the crude product was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B09 (400 mg, 27.07%) as a yellow solid. ESI / MS (m / z): 217.1 [M+H] + .1 H NMR (400MHz, DMSO-d6) δ11.46(s,1H),7.73(d,J=8.9Hz,1H),6.79(d,J=8.9Hz,1 H), 3.91 (s, 3H), 2.94 (t, J = 6.0Hz, 2H), 2.63-2.54 (m, 2H), 2.14 (p, J = 6.2Hz, 2H).

[0219] Example 41: Synthesis of Compound B12 and Compound B13

[0220] Concentrated hydrochloric acid (2.8 mL) was added dropwise to a solution of compound B12-1 (1 g, 3.979 mmol) and 1,2-cyclohexanedione (0.89 g, 7.958 mmol) in water (130 mL) at room temperature. The reaction solution was stirred at 120°C overnight. The reaction solution was cooled to room temperature, filtered, and the solid was collected and washed with water (2×100 mL). The resulting solid was separated by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to give a mixture of compound B12 and compound B13 as a light yellow solid (97.1 mg, 11.57%). ESI / MS (m / z): 211.2 [M+H] + .

[0221] Example 42: Preparation of Compound B14

[0222] To a solution of compound INT-A (500 mg, 2.509 mmol) and sodium hydride (66 mg, 2.760 mmol) in N,N-dimethylformamide (8 mL) was added p-methoxybenzyl chloride (PMBCl, 472 mg, 3.011 mmol) at 0°C. The reaction mixture was stirred at room temperature for four hours, and then the pH was adjusted to 7 using 2M dilute hydrochloric acid. The compound was extracted with ethyl acetate (3×50 mL), washed with saturated brine (100 mL), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting crude product was purified by silica gel column chromatography to obtain compound B14-1 (650 mg, 81.10%) as a yellow oil. ESI / MS (m / z): 320.1 [M+H] + .

[0223] To a solution of sodium hydride (188 mg, 7.825 mmol) and compound B14-1 (500 mg, 1.565 mmol) in N,N-dimethylformamide (25 mL) at room temperature was added B14-2 (295 mg, 1.17 mmol). The reaction mixture was stirred at room temperature for 3 hours and then quenched with water (10 mL). The mixture was extracted with ethyl acetate (40 mL), washed with saturated brine (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting crude product was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 6:1) to obtain compound B14-3 (44 mg, 8.14%) as a brown solid. ESI / MS (m / z): 346.2 [M+H] + .

[0224] Trifluoroacetic acid (3 mL) was added to a solution of compound B14-3 (44 mg, 0.127 mmol) in dichloromethane (3 mL) at room temperature. The reaction mixture was stirred at room temperature for three hours, concentrated, and purified by reverse-phase preparative column chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to obtain compound B14 (3.9 mg, 13.59%) as a white solid. ESI / MS (m / z): 226.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.43(s,1H),7.46-7.43(m,1H),7.29(dd,J=8.4,0.7Hz,1H),7.13(dd,J=8.5,1.6H z,1H),2.95(t,J=6.2Hz,2H),2.38(d,J=0.8Hz,3H),2.04(t,J=6.2Hz,2H),1.12(q,J=3.5Hz,2H),0.83(q,J= 3.5Hz,2H).

[0225] Example 43: Preparation of Compound B15

[0226] Under a nitrogen atmosphere, deuterated iodomethane (6.98 g, 48.180 mmol) and catalyst Pd(AMPHOS)2Cl2 (1.14 g, 1.606 mmol) were added to a solution of compound B15-1 (4 g, 16.060 mmol) and potassium tert-butoxide (3.60 g, 32.120 mmol) in tri-amyl alcohol (60 mL) at room temperature. The reaction solution was stirred at 60°C overnight under a nitrogen atmosphere. After cooling to room temperature, the reaction was quenched by adding water (50 mL). The mixture was extracted with ethyl acetate (3 × 100 mL). The combined organic layers were washed with saturated brine (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The crude product was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to obtain compound B15-2 (1.6 g, 71.08%) as a yellow solid.

[0227] Zinc powder (5.97 g, 91.328 mmol) was added to a solution of compound B15-2 (1.6 g, 11.416 mmol) and glacial acetic acid (6.54 mL, 114.160 mmol) in ethanol (30 mL) at 0°C. The reaction mixture was stirred at room temperature for 1 hour and then quenched with water. The mixture was extracted with ethyl acetate (3×100 mL). The combined organic layers were washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to obtain compound B15-3 (1.3 g, 82.69%) as a yellow oil. ESI-MS (m / z): 111.1 [M+H] + .

[0228] At 0°C, concentrated hydrochloric acid (3.05 mL) was added to a solution of compound B15-3 (1.3 g, 11.800 mmol) in water (45.5 mL). A solution of sodium nitrite (1.63 g, 23.600 mmol) in water (10 mL) was then added to the above solution. Finally, a solution of B15-4 (1.49 g, 11.800 mmol) and sodium acetate (2.13 g, 25.960 mmol) in water (45.5 mL) and methanol (45.5 mL) was added to the above solution. The reaction mixture was stirred at room temperature for 1 hour. The reaction mixture was filtered, washed with water (50 mL), and the collected solid was spin-dried to obtain compound B15-5 (2.1 g, 81.15%) as a red solid. ESI / MS (m / z): 220.1 [M+H] + .

[0229] At room temperature, concentrated sulfuric acid (4 mL) was added to a solution of compound B15-5 (2 g, 9.120 mmol) in methanol (40 mL). The reaction solution was stirred at 60 ° C for 1 hour and then cooled to room temperature. The pH was adjusted to 7 using saturated sodium bicarbonate aqueous solution. The mixture was extracted with ethyl acetate (3×150 mL), and the combined organic layer was washed with saturated brine (200 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The crude product was separated and purified by reverse phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to obtain a pink solid compound B15 (369.2 mg, 20.01%). ESI / MS (m / z): 203.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.44(s,1H),7.43(d,J=1.7Hz,1H),7.29(dd,J=8.4,0.7Hz,1 H), 7.13 (dd, J = 8.4, 1.7Hz, 1H), 2.91 (t, J = 6.0Hz, 2H), 2.54 (m, 2H), 2.182.10 (m, 2H).

[0230] Example 44: A similar procedure as in Example 1 was used to obtain the following compound.

[0231] Example 45: Synthesis of Compound B16

[0232] Compound B10 (1.18 g, 4.754 mmol) was dissolved in a mixture of methanol (40 mL) and water (8 mL), and lithium hydroxide (1 g, 3.580 mmol) was added at room temperature. The reaction solution was stirred at 60°C for 1.5 hours, cooled to room temperature, and the pH was adjusted to 7 with 1M hydrochloric acid solution. The liquid was concentrated to dryness and separated using a reverse phase preparative column (mobile phase A: water, mobile phase B: acetonitrile) to obtain a white solid compound B16-1 (950 mg, 86.22%). ESI-MS (m / z): 230.1 [M+H] + .

[0233] Compound B16-1 (100 mg, 0.431 mmol) was dissolved in ethanol (2 mL), and concentrated sulfuric acid (100 μL) was added dropwise at room temperature. The reaction solution was stirred at 70°C for 24 hours. The reaction solution was cooled to room temperature, quenched with water, and adjusted to pH 6 with saturated sodium bicarbonate solution. The mixture was extracted with ethyl acetate (3×30 mL), and the combined organic layers were washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The crude product was separated and purified by reverse phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to give compound B16 (69.1 mg, 61.50%) as a white solid. ESI-MS (m / z): 258.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.00(s,1H),7.65(dd,J=8.3,1.0Hz,1H),7.59(dd,J=7.3,1.0Hz,1H),7.37(dd,J=8.3,7.3H z, 1H), 4.37 (q, J = 7.1Hz, 2H), 3.09 (t, J = 6.0Hz, 2H), 2.57 (t, J = 5.9Hz, 2H), 2.14-2.07 (m, 2H), 1.36 (t, J = 7.1Hz, 3H).

[0234] Example 46: Synthesis of Compound B17

[0235] Compound B10 (1.18 g, 4.754 mmol) was dissolved in a mixture of methanol (40 mL) and water (8 mL), and lithium hydroxide (1 g, 3.580 mmol) was added at room temperature. The reaction solution was stirred at 60°C for 1.5 hours, cooled to room temperature, and the pH was adjusted to 7 with 1M hydrochloric acid solution. The liquid was concentrated to dryness and separated and purified by reverse phase preparative chromatography (mobile phase A: water, mobile phase B: acetonitrile) to obtain compound B16-1 (950 mg, 86.22%) as a white solid. ESI-MS (m / z): 230.1 [M+H] + .

[0236] Compound B16-1 (100 mg, 0.431 mmol) was dissolved in isopropanol (3 mL), and concentrated sulfuric acid (300 μL) was added dropwise at room temperature. The reaction solution was stirred at 85°C for 24 hours. The reaction solution was cooled to room temperature, quenched with water, and adjusted to pH 6 with saturated sodium bicarbonate solution. The mixture was extracted with ethyl acetate (3×30 mL), and the combined organic layers were washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The crude product was separated and purified by reverse phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to give compound B17 (32.7 mg, 27.66%) as a white solid. ESI-MS (m / z): 272.0 [M+H]+ . 1 H NMR (400MHz, DMSO-d6) δ11.99(s,1H),7.65(dd,J=8.2,1.1Hz,1H),7.56(dd,J=7.4,1.1Hz,1H),7.37(dd,J=8.3,7. 3Hz, 1H), 5.22-5.16 (m, 1H), 3.09 (t, J = 6.0Hz, 2H), 2.57 (t, J = 7.4Hz, 2H), 2.14-2.07 (m, 2H), 1.37 (d, J = 6.3Hz, 6H).

[0237] Example 47: Synthesis of Compound E42

[0238] To a solution of compound E42-1 (1.5 g, 7.489 mmol) and compound E42-2 (2.61 g, 11.233 mmol) in tetrahydrofuran (20 mL) was slowly added dropwise triethylamine (1.52 g, 14.978 mmol) at room temperature. The reaction mixture was stirred at 70°C for 4 hours. After cooling to room temperature, the mixture was quenched with water (20 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed with saturated aqueous sodium chloride solution (3 × 10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 4:1) to obtain compound E42-3 (1.888 g, 89.30%) as a white solid. ESI / MS (m / z): 238.2 [M+H] + .

[0239] To a solution of compound E42-3 (600 mg, 2.125 mmol) in 1,4-dioxane (5 mL) was slowly added dropwise a 4M solution of hydrogen chloride in 1,4-dioxane (5 mL, 20.000 mmol) at room temperature and stirred at room temperature for 2 hours. After the reaction was complete, n-hexane (15 mL) was added and filtered, and the filter cake was washed with n-hexane (3 × 5 mL). The resulting solid was dried under vacuum to give compound E42-4 (470 mg, crude) as a white solid. ESI / MS (m / z): 183.2 [M+H] + .

[0240] Sodium bicarbonate (323 mg, 3.842 mmol) was added to a 6 mL aqueous solution of compound E42-4 (420 mg, 1.921 mmol) at room temperature and stirred for 30 minutes. After completion of the reaction, the mixture was concentrated under reduced pressure, and the residue was purified by reverse phase column chromatography (mobile phase A: 10 mmol / L ammonium bicarbonate; mobile phase B: acetonitrile) to obtain compound E42-5 (170 mg, 48.58%). ESI / MS (m / z): 183.2 [M+H] +.

[0241] Tetraethyl titanate (206.42 mg, 0.904 mmol) was slowly added dropwise to a toluene (4 mL) solution of compound E42-5 (130.16 mg, 0.678 mmol) and compound INT-A (95 mg, 0.452 mmol) at room temperature. After the addition was complete, the mixture was stirred at 100°C for 6 hours. The reaction solution was cooled to room temperature and quenched with water (20 mL), diluted with dichloromethane (20 mL), filtered, and the resulting filter cake was washed with dichloromethane (5 mL). The filtrate was extracted with dichloromethane (20 mL). The organic phase was washed with saturated aqueous sodium chloride solution (10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was slurried with ethanol (10 mL), filtered, and the filter cake was dried under vacuum to give an off-white solid compound E42 (25 mg, 14.76%). ESI / MS (m / z): 364.1 [M+H] + .

[0242] Example 48: Synthesis of Compound E43

[0243] To a solution of compound E43-1 (600 mg, 2.996 mmol) in dichloromethane (10 mL) at 0°C under a nitrogen atmosphere were added N,N-diisopropylethylamine (522 μL, 2.996 mmol) and compound E43-2 (336 μL, 2.996 mmol), and stirred at room temperature overnight. After the reaction, dichloromethane (60 mL) was added for dilution, and the mixture was washed sequentially with 0.1 M hydrochloric acid (30 mL), saturated sodium carbonate solution (30 mL), and saturated sodium chloride aqueous solution (30 mL). The resulting organic phase was dried over anhydrous sodium sulfate and then concentrated under reduced pressure to obtain compound E43-3 (560 mg, 61.00%) as a white solid. ESI / MS (m / z): 251.1 [M+H-56] + .

[0244] To a solution of compound E43-3 (550 mg, 1.795 mmol) in methanol (1.5 mL) was added diethyl ether (10 mL) and concentrated hydrochloric acid (1.6 mL) at 0°C. The mixture was stirred at room temperature overnight, and the filter cake was collected by filtration and washed with diethyl ether (5 mL). After drying, compound E43-4 (260 mg, 70.21%) was obtained as a white solid. ESI / MS (m / z): 207.0 [M+H] + .

[0245] To a toluene (5 mL) solution of compound E43-4 (100 mg, 0.309 mmol) and compound INT-A (65 mg, 0.309 mmol) was added tetraethyl titanate (106 mg, 0.464 mmol) dropwise under a nitrogen atmosphere at room temperature. The reaction solution was stirred at 100°C for 4 hours, cooled to room temperature, and concentrated under reduced pressure. The residue was quenched with water at room temperature, filtered, and the filter cake was washed with N,N-dimethylformamide (2×10 mL). The filtrate was concentrated under reduced pressure, and the residue was slurried with ethanol (4×4 mL) to obtain a yellow solid compound E43 (60.3 mg, 44.84%). ESI / MS (m / z): 388.0 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.70(s,1H),12.43(d,J=8.4Hz,1H),7.54(s,1H),7.40(d,J=8.5Hz,1H),7.31(dd,J=8.6,1.6Hz,1H),4.3 9-4.25(m,1H),3.82-3.73(m,2H),3.42-3.34(m,1H),3.14(t,J=6.3Hz,2H),3.10-3.01(m,2H),2.99(t,J=6.2Hz,2H),2.39(s,3H), 2.18-2.10(m,2H),2.09-2.02(m,2H),1.94-1.82(m,2H),1.25(d,J=6.8Hz,6H).

[0246] Example 49: Synthesis of Compound E44

[0247] Under a nitrogen atmosphere, a toluene solution (4 mL) of compound INT-A (199.3 mg, 1.000 mmol) and (S)-tert-butyl-2-aminopropyl ester (435.6 mg, 3.000 mmol) was stirred at 130°C for 4 hours, cooled to room temperature, and filtered. The resulting filtrate was concentrated under reduced pressure, and the residue was washed sequentially with acetonitrile (2 mL), ethyl acetate, and a mixture of n-hexane (V:V = 1:4, 3 mL) to afford E44 (78.8 mg, 24.14%) as a pink solid. ESI / MS (m / z) 327.2 [M+H] + . 1H NMR (500MHz, DMSO-d6) δ10.82(s,1H),7.29(s,1H),7.27(d,J=8.3Hz,1H),6.97(dd,J=8.3,1.0Hz,1H),4.42(q,J=6.6 Hz,1H),2.78(t,J=6.0Hz,2H),2.63-2.53(m,2H),2.36(s,3H),2.00-1.94(m,2H),1.40(s,9H),1.37(d,J=6.6Hz,3H).

[0248] Example 50: Synthesis of Compound E45

[0249] A toluene solution (4 mL) of compound INT-A (199.3 mg, 1.000 mmol) and 2-methoxyethane-1-amine (450.7 mg, 6 mmol) was stirred at 130°C for 6 hours and then cooled to room temperature. The reaction solution was concentrated under reduced pressure, and a 4M solution of hydrogen chloride in ethyl acetate (3 mL) was added to the residue, which was then filtered and dried to afford compound E45 (115.0 mg, 39.27%) as a brown solid. ESI / MS (m / z) 257.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.47(s,1H),12.38(s,1H),7.54(s,1H),7.42(d,J=8.5Hz,1H),7.32(dd,J=8.6,1.3Hz,1H),3.95-3 .91(m,2H),3.73(t,J=5.1Hz,2H),3.32(s,3H),3.07(t,J=6.2Hz,2H),2.99(t,J=6.2Hz,2H),2.40(s,3H),2.13-2.08(m,2H).

[0250] Example 51: Synthesis of Compound E46

[0251] A xylene solution (4 mL) of compound INT-A (199.3 mg, 1.000 mmol) and trans-4-(2-methoxyethoxy)-cyclohexylamine (519.8 mg, 3 mmol) was stirred at 150°C for 5 hours and then cooled to room temperature. The reaction solution was concentrated under reduced pressure, and n-hexane (10 mL) was added to the residue. The precipitated solid was washed with a small amount of a mixed solvent (ethyl acetate:n-hexane = 1:5) to obtain a pale yellow solid E46 (179.0 mg, 50.50%, trans, relative configuration). ESI / MS (m / z) 355.2 [M+H] + . 1H NMR (500MHz, DMSO-d6) δ10.65 (s, 1H), 7.25 (d, J = 8.5Hz, 2H), 6.94 (dd, J = 8. 3,1.4Hz,1H),3.60-3.54(m,3H),3.44-3.42(m,2H),3.30-3.28(m,1H),3.25 (s,3H),2.75(t,J=6.0Hz,2H),2.61-2.57(m,2H),2.35(s,3H),2.06-2.02(m,2 H),1.99-1.94(m,2H),1.73-1.67(m,2H),1.50-1.42(m,2H),1.34-1.26(m,2H).

[0252] Example 52: Synthesis of Compound E47

[0253] A mixture of compound B10 (243.3 mg, 0.500 mmol), isopropylamine hydrochloride (191.1 mg, 2.000 mmol), and sodium acetate (164.1 mg, 2.000 mmol) in 2-methyltetrahydrofuran (5 mL) was stirred at 95°C for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL). The organic phase was washed with water (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. A 4M solution of hydrogen chloride in ethyl acetate (3 mL) was added to the residue, filtered, and the solid was washed with a small amount of a mixed solvent (ethyl acetate:n-hexane = 1:1) to obtain compound E47 (60.3 mg, 37.59%) as a light brown solid. ESI / MS (m / z) 285.1 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ13.29(s,1H),12.57(s,1H),7.75(dd,J=8.3,0.7Hz,1H),7.67-7.64(m,1H),7.55-7 .51(m,1H),4.48-4.40(m,1H),3.91(s,3H),3.14-3.08(m,4H),2.11-2.05(m,2H),1.44(s,3H),1.43(s,3H).

[0254] Example 53: Synthesis of Compound E48

[0255] A solution of compound B10 (73.0 mg, 0.300 mmol), ethylamine hydrochloride (98.0 mg, 1.200 mmol), and sodium acetate (98.4 mg, 1.200 mmol) in 2-methyltetrahydrofuran (4 mL) was stirred at 90°C for 3 hours and cooled to room temperature. The reaction solution was diluted with ethyl acetate (100 mL), washed with pure water (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. A 4M solution of hydrogen chloride in ethyl acetate (1 mL) was added to the crude product, and the precipitated solid was filtered and dried to give compound E48 (40.8 mg, 44.33%) as a light yellow solid. ESI / MS (m / z) 271.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ13.11(s,1H),12.64(s,1H),7.76(dd,J=8.3,0.8Hz,1H),7.66(dd,J=7.2,0.8Hz,1H),7.53(d d,J=8.3,7.2Hz,1H),3.91(s,3H),3.81(q,J=7.1Hz,2H),3.12-3.06(m,4H),2.10-2.04(m,2H),1.40(t,J=7.3Hz,3H).

[0256] Example 54: Synthesis of Compound E49

[0257] To a solution of 4-methylaniline (0.93 g, 8.703 mmol) in concentrated hydrochloric acid (5 mL) and water (25 mL) at 0°C were added a solution of sodium nitrite (1.20 g, 17.406 mmol) in water (25 mL), a solution of compound E49-1 (1.22 g, 8.703 mmol) in methanol (25 mL), and a solution of sodium acetate (1.57 g, 19.147 mmol) in water (25 mL). The reaction mixture was stirred at 0°C for 1 hour and then filtered. The filter cake was washed with water (3 × 50 mL) to obtain compound E49-2 (500 mg, 24.95%) as a yellow solid. ESI / MS (m / z): 231.1 [M+H] + .

[0258] A solution of compound E49-2 (50 mg, 0.217 mmol) and concentrated sulfuric acid (0.2 mL) in methanol (2 mL) was stirred at 65°C for 4 hours and then cooled to room temperature. The reaction solution was adjusted to pH = 8 with aqueous potassium hydroxide solution and extracted with ethyl acetate (3 × 10 mL). The combined organic phases were washed with saturated aqueous sodium chloride solution (5 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound E49-3 (10.3 mg, 22.24%) as a white solid. ESI / MS (m / z): 214.0 [M+H] + . 1 H NMR (400MHz, Methanol-d4) δ7.51(s,1H),7.30(d,J=8.5Hz,1H),7.15(d,J=8.5Hz,1H),3.37(dt,J=12.5,6.3Hz,1H),2.73(ddd,J=14.4,9.6,4.4Hz ,1H),2.50(ddd,J=17.2,6.4,4.2Hz,1H),2.41(s,3H),2.35(ddt,J=14.0, 9.5, 4.7Hz, 1H), 1.98 (dq, J = 11.6, 6.1, 5.4Hz, 1H), 1.48 (d, J = 7.0Hz, 3H).

[0259] Compound E49-4 (464.97 mg, 3.544 mmol) was added to a solution of compound E49-3 (200 mg, 0.886 mmol) in toluene (4 mL) at room temperature. The reaction mixture was stirred at 130°C under nitrogen for 5 hours. After cooling to room temperature, the mixture was concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to afford compound E49 (34.4 mg, 10.80%) as a yellow solid. ESI / MS (m / z): 327.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ10.93(s,1H),7.39(s,1H),7.26(d,J=8.3Hz,1H),6.97(dd,J=8.4,1.6Hz,1H),4.27(s,2 H), 3.19 (h, J = 6.6Hz, 1H), 2.59-2.46 (m, 2H), 2.36 (s, 3H), 2.07-1.73 (m, 2H), 1.44 (s, 9H), 1.35 (d, J = 6.9Hz, 3H).

[0260] Example 55: Synthesis of Compound E50

[0261] To a solution of compound B01 (100 mg, 0.474 mmol) in toluene (4 mL) was added ethanolamine (116 mg, 1.896 mmol) at room temperature under a nitrogen atmosphere. The reaction mixture was stirred at 130°C for 4 hours, cooled to room temperature, and concentrated under reduced pressure. The residue was washed with a mixture of n-hexane and ethanol (V:V = 3:1, 3 x 2 mL) to obtain compound E50 (27.2 mg, 22.38%) as a brown solid. ESI / MS (m / z): 244.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.05(s,1H),7.57(d,J=8.3Hz,1H),7.00(d,J=8.4Hz,1H),4.56(s,1H),3.70(t,J=6.3 Hz, 2H), 3.58 (t, J = 6.3 Hz, 2H), 2.83 (t, J = 6.0 Hz, 2H), 2.61 (t, J = 6.3 Hz, 2H), 2.51 (s, 3H), 1.98 (p, J = 5.9 Hz, 2H).

[0262] Example 56: Synthesis of Compound E51

[0263] To a solution of compound E51-1 (20 g, 163.70 mmol) and 1,2-cyclohexanedione (22 g, 196.44 mmol) in water (2000 mL) was added concentrated hydrochloric acid (80 mL) at room temperature. The reaction mixture was stirred at 120°C overnight, cooled to room temperature, and filtered. The filter cake was washed with water (2 × 1000 mL). The crude product was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate + 0.1% ammonia water); mobile phase B: acetonitrile) to obtain compound E51-2 (268 mg, 0.82%) as a light yellow solid. ESI / MS (m / z): 200.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.53(s,1H),11.44(s,1H),7.53(s,1H),7.20(d,J=8.4Hz,1H),7.18(s,1H),7.13(t,J=7.6Hz,1H),6.91(d,J=8.2H z,1H),6.78(d,J=6.9Hz,1H),3.18(t,J=5.9Hz,2H),2.91(t,J=5.9Hz,2H),2.61(s,2H),2.57-2.51(m,3H),2.40(s,3H),2.19-2.08(m,4H).

[0264] Compound E51-3 (648 mg, 4.940 mmol) was added to a solution of compound E51-2 (200 mg, 0.988 mmol) in toluene (3 mL) at room temperature. The reaction mixture was stirred at 130°C under a nitrogen atmosphere for 5 hours. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure. The resulting residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: pure water; mobile phase B: acetonitrile) to afford compound E51 (61.6 mg, 19.28%) as a yellow solid. ESI / MS (m / z): 313.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ10.94(s,1H),7.40(d,J=8.1Hz,1H),7.15(s,1H),6.82(dd,J=8.1,1.5Hz,1H), 4.27(s,2H),2.78(t,J=6.0Hz,2H),2.55-2.51(m,2H),2.37(s,3H),1.96(p,J=6.1Hz,2H),1.44(s,9H).

[0265] Example 57: Synthesis of Compound E52

[0266] To a solution of compound E52-1 (10 g, 44.743 mmol) and 1,2-cyclohexanedione (5.5 g, 49.217 mmol) in water (240 mL) was added dropwise concentrated hydrochloric acid (7 mL) at room temperature and stirred at 120°C overnight. The reaction mixture was cooled to room temperature and filtered, and the filter cake was collected and washed with water (3 × 200 mL). The resulting solid was vacuum dried to give compound E52-2 (12 g, crude) as a brown solid. ESI / MS (m / z): 264.1 [M+H] + .

[0267] To a solution of E52-2 (10 g, 18.931 mmol) and triethylamine (5.8 g, 56.793 mmol) in tetrahydrofuran (20 mL) were added 4-dimethylaminopyridine (2.31 g, 18.931 mmol) and di-tert-butyl dicarbonate (8.3 g, 37.862 mmol), and the mixture was stirred at room temperature for 1 hour. The reaction solution was quenched with water (50 mL) and extracted with ethyl acetate (3 × 50 mL). The combined organic phases were washed with saturated sodium chloride solution (100 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to obtain INT-C (1 g, 14.21%) as a light yellow solid. ESI / MS (m / z): 308.0 [M+H-56] + .

[0268] To a solution of INT-C (1 g, 2.581 mmol) and E52-3 (1.15 mL, 3.876 mmol) in 1,4-dioxane (10 mL) were added tetrakistriphenylphosphine palladium (310.92 mg, 0.269 mmol) and potassium carbonate (743.69 mg, 5.382 mmol) portionwise at room temperature. The reaction mixture was allowed to react at 100°C for 2 hours. The mixture was quenched with water at room temperature and extracted with dichloromethane (3 × 30 mL). The combined organic phases were washed sequentially with saturated sodium chloride (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by normal phase silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to afford compound E52-4 (750 mg, 90.23%) as a yellow solid. ESI / MS (m / z): 244.1 [M+H-56] + .

[0269] Trifluoroacetic acid (1 mL) was added dropwise to a solution of compound E52-4 (100 mg, 0.316 mmol) in dichloromethane (10 mL) at room temperature. The reaction mixture was stirred at room temperature for 1 hour and then concentrated under reduced pressure. The residue was purified by normal silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to afford compound E52-5 (22.5 mg, 34.54%) as a pale yellow solid. ESI / MS (m / z): 200.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.52(s,1H),7.19(d,J=8.3Hz,1H),7.13(dd,J=8.4,6.9Hz,1H),6.78 (d, J=6.8Hz, 1H), 3.19 (t, J=6.0Hz, 2H), 2.62 (s, 3H), 2.54-2.51 (m, 2H), 2.15 (p, J=6.3Hz, 2H).

[0270] To a solution of compound E52-5 (150 mg, 0.723 mmol) in toluene (3 mL) was added E52-6 (474.5 mg, 3.615 mmol) at room temperature. The reaction mixture was stirred at 130°C under a nitrogen atmosphere for 5 hours, cooled to room temperature, and concentrated under reduced pressure. The resulting residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: pure water; mobile phase B: acetonitrile) to afford compound E52 (28.6 mg, 11.95%) as a yellow solid. ESI / MS (m / z): 313.1 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ11.01(s,1H),7.18(d,J=8.1Hz,1H),6.98(dd,J=8.3,6.9Hz,1H),6.69(d,J=7.0Hz ,1H),4.28(s,2H),3.08(t,J=6.0Hz,2H),2.59(s,3H),2.49-2.47(m,2H),2.00-1.95(m,2H),1.44(s,9H).

[0271] Example 58: Synthesis of Compound E53

[0272] To a solution of compound E51-2 (100 mg, 0.494 mmol) in toluene (3 mL) was added ethanolamine (75.4 mg, 1.235 mmol) at room temperature. The reaction mixture was stirred at 130°C under a nitrogen atmosphere for 5 hours, cooled to room temperature, and concentrated under reduced pressure. The resulting residue was washed with ethanol (3 × 3 mL) to afford compound E53 (45.1 mg, 36.67%) as a white solid. ESI / MS (m / z): 243.3 [M+H] + . 1 H NMR (300MHz, DMSO-d6) δ10.82(s,1H),7.38(d,J=8.1Hz,1H),7.14(s,1H),6.81(d,J=8.1Hz,1H),4.54(t,J=5.2Hz,1H),3 .65-3.71(m,2H),3.55(t,J=6.3Hz,2H),2.76(t,J=6.0Hz,2H),2.57(t,J=6.3Hz,2H),2.37(s,3H),1.98(q,J=6.2Hz,2H).

[0273] Example 59: Synthesis of Compound E54

[0274] To a solution of compound E52-5 (100 mg, 0.482 mmol) in toluene (3 mL) was added ethanolamine (73.7 mg, 1.206 mmol) at room temperature. The reaction mixture was stirred at 130°C under a nitrogen atmosphere for 5 hours, cooled to room temperature, and concentrated under reduced pressure. The resulting residue was washed with ethanol (2 × 4 mL) to afford compound E54 (27.6 mg, 22.81%) as a yellow solid. ESI / MS (m / z): 243.1 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ10.88(s,1H),7.17(d,J=8.2Hz,1H),6.96(t,J=7.6Hz,1H),6.68(d,J=7.1Hz,1H),4.53(t,J=5.3Hz,1 H), 3.73-3.65 (m, 2H), 3.55 (t, J = 6.3Hz, 2H), 3.06 (t, J = 6.0Hz, 2H), 2.58 (s, 3H), 2.55 (t, J = 6.3Hz, 2H), 1.98 (p, J = 6.2Hz, 2H).

[0275] Example 60: Synthesis of Compound E55

[0276] To a solution of compound INT-A (150 mg, 0.714 mmol) and compound E55-1 (513 mg, 1.499 mmol, tBu: tert-butyl) in toluene (4 mL) were added tetrahydropyrrole (51 mg, 0.714 mmol) and glacial acetic acid (9 mg, 0.143 mmol) at room temperature. The reaction mixture was stirred at 100°C under a nitrogen atmosphere for 6 hours. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure, and the residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to afford compound E55 (36.9 mg, 14.73%) as a yellow solid. ESI / MS (m / z): 427.2 [M+H] + . 1 H NMR (300MHz, DMSO-d6) δ10.83(s,1H),7.30(s,1H),7.27(d,J=8.3Hz,1H),6.99(dd,J=8.4,1.6Hz,1H),4.68(t,J=7.0Hz,1H) ,2.90-2.57(m,2H),2.80(t,J=6.0Hz,2H),2.74-2.65(m,2H),2.36(s,3H),2.00(p,J=5.2Hz,2H),1.38(s,9H),1.36(s,9H).

[0277] Example 61: Synthesis of Compound E56

[0278] Compound E56-1 (608 mg, 3.514 mmol, tBu: tert-butyl) was added to a solution of compound INT-A (200 mg, 1.004 mmol) in toluene (4 mL) at room temperature. The reaction mixture was stirred at 140°C overnight under a nitrogen atmosphere. After cooling to room temperature, the mixture was concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water; mobile phase B: acetonitrile) to afford compound E56 (37.7 mg, 10.43%) as a yellow solid. ESI / MS (m / z): 355.1 [M+H] + . 1 H NMR (300MHz, DMSO-d6) δ10.78(s,1H),7.32-7.27(m,2H),7.03-6.94(m,1H),3.94(d,J=7.1Hz,1H),2.78(t,J=6.0Hz,2H),2.67 -2.55(m,1H),2.44(d,J=6.3Hz,1H),2.36(s,3H),2.26(p,J=6.7Hz,1H),1.97(t,J=6.3Hz,2H),1.40(s,9H),1.00-0.89(m,6H).

[0279] Example 62: Synthesis of Compound E57

[0280] A toluene solution (4 mL) of compound INT-A (199.3 mg, 1.000 mmol) and n-pentylamine (261.5 mg, 3 mmol) was stirred at 135°C for 3 hours. The reaction solution was cooled to room temperature and concentrated in vacuo, followed by the addition of a 4 M solution of hydrogen chloride in ethyl acetate (3 mL). The precipitated solid was slurried with a small amount of a mixed solvent (acetonitrile / water = 2:1) to afford compound E57 (157.6 mg, 51.70%) as a pale yellow solid. ESI / MS (m / z) 269.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.57(s,1H),12.39(s,1H),7.53(s,1H),7.40(d,J=8.5Hz,1H),7.31(d,J=8.6Hz,1H),3.74-3.69(m,2H),3.0 6(t,J=6.2Hz,2H),2.98(t,J=6.1Hz,2H),2.39(s,3H),2.14-2.08(m,2H),1.82-1.76(m,2H),1.41-1.33(m,4H),0.90(t,J=7.1Hz,3H).

[0281] Example 63: Synthesis of Compound E58

[0282] To a solution of compound B10 (150 mg, 0.609 mmol) in toluene (3 mL) at room temperature was added 2-amino-1-butanol (271 mg, 3.045 mmol, racemate). The reaction mixture was stirred at 130°C for 6 hours. After cooling to room temperature, the mixture was concentrated under reduced pressure. The residue was washed with a mixed solvent of ethyl acetate and n-hexane (ethyl acetate:n-hexane = 1:6, 1 mL) to afford compound E58 (74.8 mg, 39.83%, racemate) as a light yellow solid. ESI / MS (m / z): 315.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.25(s,1H),7.66(dd,J=8.1,1.1Hz,1H),7.50(dd,J=7.4 ,1.1Hz,1H),7.20(dd,J=8.1,7.4Hz,1H),4.50(s,1H),3.87(s,3H),3.71-3.61(m,1 H),3.57-3.48(m,1H),3.41(t,J=8.6Hz,1H),2.94(t,J=6.0Hz,2H),2.74-2.52(m,2 H), 1.98-1.87 (m, 2H), 1.74-1.60 (m, 1H), 1.52-1.37 (m, 1H), 0.83 (t, J = 7.4Hz, 3H).

[0283] Example 64: Synthesis of Compound E59

[0284] To a solution of compound B10 (250 mg, 1.028 mmol) in toluene (5 mL) was added dropwise E59-1 (468.17 mg, 5.140 mmol, racemate) at room temperature. The reaction mixture was stirred at 130°C under nitrogen for 1 hour. After cooling to room temperature, the mixture was concentrated under reduced pressure. The residue was washed with ethanol (4 × 5 mL) to afford compound E59 (123.4 mg, 37.30%, racemate) as a pale yellow solid. ESI / MS (m / z): 317.0 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ11.37(s,1H),7.64(dd,J=8.1,1.1Hz,1H),7.50(dd,J=7.4,1.1Hz,1H),7.21(t,J=7.8Hz,1H),4.56(d,J=4.8Hz,1H),4.55 -4.48(m,1H),3.87(s,3H),3.84-3.72(m,J=4.2Hz,1H),3.57-3.49(m,2H ),3.47-3.42(m,2H),2.94(t,J=6.0Hz,2H),2.58-2.54(m,2H),1.96-1.90 (m,2H).

[0285] Example 65: Synthesis of Compound E60

[0286] To a solution of compound B10 (150 mg, 0.617 mmol) in toluene (3 mL) was added dropwise E60-1 (318.07 mg, 3.085 mmol, racemate) at room temperature. The reaction mixture was stirred at 130°C for 1 day. After cooling to room temperature, the mixture was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 2:1) to afford compound E60 (27.6 mg, 12.98%, racemate) as a white solid. ESI / MS (m / z): 329.0 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.18(s,1H),7.68(d,J=8.1Hz,1H),7.50(d,J=7.3Hz,1H),7.20(t,J=7.7Hz,1H),4. 40(s,1H),3.87(s,3H),3.69-3.62(m,1H),3.57-3.38(m,2H),2.94(t,J=5.9Hz,2H),2.72-2.51(m,2H),1.96 -1.90(m,2H),1.90-1.84(m,1H),0.91(d,J=6.7Hz,6H).

[0287] Example 66: Synthesis of Compound E61

[0288] To a solution of compound B10 (150 mg, 0.604 mmol) in toluene (3 mL) was added dropwise E61-1 (269.32 mg, 3.020 mmol) at room temperature. The reaction mixture was stirred at 130°C under nitrogen for 3.5 hours. The mixture was cooled to room temperature and concentrated under reduced pressure. The residue was washed with a mixture of toluene and n-hexane (toluene:n-hexane = 1:5, 3 x 6 mL) to afford compound E61 (54.2 mg, 27.10%) as a yellow solid. ESI / MS (m / z): 315.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.34(s,1H),7.65(dd,J=8.1,1.1Hz,1H),7.51(dd,J=7.4,1.1Hz,1H),7.22(dd,J=8.1,7.4Hz ,1H),4.32(s,1H),3.87(s,3H),3.31(s,2H),2.95(t,J=6.0Hz,2H),2.54-2.51(m,2H),1.96-1.90(m,2H),1.20(s,6H).

[0289] Example 67: Synthesis of Compound E62

[0290] To a solution of B10 (150 mg, 0.609 mmol) in toluene (3 mL) under a nitrogen atmosphere was added E62-1 (347 mg, 3.045 mmol), and the reaction mixture was stirred at 130°C overnight. The reaction mixture was cooled to room temperature and concentrated under reduced pressure. The residue was washed with a mixture of ethyl acetate and n-hexane (ethyl acetate:n-hexane = 1:6, 7 mL) to afford compound E62 (31.1 mg, 14.95%) as a yellow solid. ESI / MS (m / z): 340.1 [M+H] + . 1 H NMR(400MHz, DMSO-d6)δ11.25(s,1H),7.66(dd,J=8.2,1.1Hz,1H),7.49(dd,J=7.4,1.1 Hz,1H),7.23-7.15(m,1H),3.87(d,J=1.0Hz,3H),3.62-3.51(m,1H),2.93 (t,J=6.0Hz,2H),2.87-2.76(m,2H),2.63-2.57(m,2H),2.19(s,3H),2.08 -1.97(m,2H),1.92(t,J=6.2Hz,2H),1.77-1.66(m,2H),1.66-1.56(m,2H).

[0291] Example 68: Synthesis of Compound B18

[0292] To a solution of compound B18-1 (0.5 g, 2.96 mmol) in water (20 mL) at 0-5°C, concentrated hydrochloric acid (1.25 mL) and an aqueous solution of sodium nitrite (0.41 g, 5.92 mmol) in water (5 mL) were added sequentially, and the mixture was stirred for 10 minutes to prepare a diazonium salt reaction solution. To a solution of compound B01-2 (0.45 g, 3.55 mmol) in methanol (10 mL) was added an aqueous solution of sodium acetate (0.53 g, 6.5 mmol) in water (5 mL). The system was cooled to 0-5°C, and the diazonium salt reaction solution prepared above was added dropwise to the reaction system. Stirring was continued for 30 minutes. After the reaction was completed, the solid was filtered, washed with water, and dried to obtain crude orange solid B18-2 (0.56 g, 68%).

[0293] To a solution of compound B18-2 (0.56 g, 2.0 mmol) in acetonitrile (6 mL) was added 1.8 M sulfuric acid (3 mL), and the reaction mixture was stirred at 80°C for 4 hours. The reaction mixture was cooled to room temperature and diluted with ethyl acetate (30 mL). The organic phase was washed with saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to obtain B18 (90 mg, 17.2%) as a pink solid. ESI / MS (m / z) 262.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.53(s,1H),7.62(dd,J=8.2,4.7Hz,1H),7.22(dd,J=10.5, 8.2Hz, 1H), 3.89 (s, 3H), 3.10 (t, J = 6.0Hz, 2H), 2.61-2.59 (m, 2H), 2.142.09 (m, 2H).

[0294] Example 69: Synthesis of Compound B19

[0295] To a solution of compound E52-2 (1 g, 3.654 mmol) and 60% sodium hydride (293 mg, 7.308 mmol) in N,N-dimethylformamide (5 mL) was added 4-methoxybenzyl chloride (858 mg, 5.481 mmol) at 0°C and stirred at room temperature for 1 hour. The mixture was quenched by the addition of saturated ammonium chloride solution (50 mL) and extracted with ethyl acetate (3 x 80 mL). The combined organic phases were washed sequentially with saturated sodium chloride solution (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 7:1) to afford compound INT-B (1.3 g, 82.59%; PMB: 4-methoxybenzyl) as a yellow solid. ESI / MS (m / z): 386.1 [M+H] + .

[0296] Under nitrogen protection, compound B19-1 (99.3 mg, 0.800 mmol), methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl) (2-amino-1,1'-biphenyl-2-yl) palladium (II) (33.5 mg, 0.040 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl (18.7 mg, 0.040 mmol) and sodium tert-butoxide (76.9 mg, 0.800 mmol) were added to a mixture of compound INT-B (153.7 mg, 0.400 mmol) and 1,4-dioxane (4 mL) in sequence. The reaction solution was stirred at 100° C. for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), and the resulting mixture was filtered through celite and concentrated under reduced pressure to obtain crude compound B19-2. A mixture of trifluoromethanesulfonic acid (0.15 mL) and trifluoroacetic acid (3 mL) was added to the crude compound B19-2 and stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase silica gel column chromatography (10-50% acetonitrile / water) to obtain compound B19 (38.3 mg, 31.15%) as a yellow solid. ESI / MS (m / z) 308.0 [M+H] + . 1H NMR (500MHz, DMSO-d6) δ11.69(s,1H),8.53(s,1H),7.21(t,J=7.8Hz,1H),7.14(d,J=8.2Hz,1H),6.71(d,J=7.4Hz,1H ), 4.36 (s, 2H), 4.21 (t, J = 5.5Hz, 2H), 3.63-3.45 (m, 2H), 3.14 (t, J = 5.8Hz, 2H), 2.55-2.52 (m, 2H), 2.10-2.04 (m, 2H).

[0297] Example 70: Synthesis of Compound B20

[0298] Under nitrogen, to a mixture of compound INT-B (76.9 mg, 0.200 mmol; PMB: 4-methoxybenzyl) and 1,4-dioxane (2 mL) were added B20-1 (64.5 mg, 0.400 mmol), tris(dibenzylideneacetone)dipalladium (18.3 mg, 0.020 mmol), 4,5-bis(diphenylphosphino-9,9-dimethylxanthene) (11.6 mg, 0.020 mmol), and sodium tert-butoxide (48.0 mg, 0.500 mmol). The mixture was stirred at 110°C for 8 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), filtered through celite, and concentrated in vacuo to afford crude compound B20-2. A mixture of trifluoromethanesulfonic acid (0.06 mL) and trifluoroacetic acid (3 mL) was added to the crude compound B20-2, and the mixture was stirred at room temperature for 20 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by reverse-phase silica gel column chromatography (10-70% acetonitrile / water) to obtain compound B20 (22.4 mg, 33.29%) as a white solid. ESI / MS (m / z) 337.0 [M+H] + . 1 H NMR (500MHz, CDCl3) δ8.95 (s, 1H), 7.53 (d, J = 5.2Hz, 1H), 7.36 (d, J = 2.7Hz, 1H), 7.35 (s, 1H), 7.17 (d, J = 5.2Hz, 1H), 7.02-6.99 (m, 1H), 4.26-4. 20(m,1H),4.00-3.95(m,1H),3.40-3.33(m,1H),3.26-3.20(m,1H),3.0 6-3.00(m,1H),2.96-2.90(m,1H),2.62-2.56(m,2H),2.22-2.12(m,2H).

[0299] Example 71: Synthesis of Compound B21

[0300] Under nitrogen, compound B21-1 (94.4 mg, 0.400 mmol), [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium dichloromethane complex (8.0 mg, 0.010 mmol), and potassium carbonate (55.3 mg, 0.400 mmol) were added sequentially to a mixture of compound INT-C (72.8 mg, 0.200 mmol; Boc: tert-butyloxycarbonyl) and 1,4-dioxane (3 mL). The mixture was stirred at 80°C for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), the resulting mixture was filtered through celite, and concentrated under reduced pressure to obtain crude compound B21-2. A mixture of trifluoroacetic acid (0.3 mL) and dichloromethane (3 mL) was added to the crude compound B21-2, and the mixture was stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by reverse-phase silica gel column chromatography (10-70% acetonitrile / water) to obtain compound B21 (34.0 mg, 57.95%) as a light yellow solid. ESI / MS (m / z) 294.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ11.67(s,1H),7.96(s,1H),7.59(s,1H),7.33(d,J=8.1Hz,1H),7.29-7.24(m,1H),6.93(d,J= 6.9Hz,1H),4.60-4.52(m,1H),2.73(t,J=5.9Hz,2H),2.53-2.51(m,2H),2.03-1.97(m,2H),1.49(s,3H),1.47(s,3H).

[0301] Example 72: Synthesis of Compound B22

[0302] Under nitrogen protection, compound B22-1 (163.0 mg, 0.800 mmol), methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl) (2-amino-1,1'-biphenyl-2-yl) palladium (II) (33.5 mg, 0.040 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl (18.7 mg, 0.040 mmol) and sodium tert-butoxide (153.8 mg, 1.600 mmol) were added to a mixture of compound INT-B (153.7 mg, 0.400 mmol) and 1,4-dioxane (4 mL) in sequence. The mixture was stirred at 100° C. for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), and the resulting mixture was filtered through celite and concentrated in vacuo to give a crude compound B22-2. A mixture of trifluoromethanesulfonic acid (0.15 mL) and trifluoroacetic acid (3 mL) was added to the crude compound B22-2 and stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase silica gel column chromatography (10-70% acetonitrile / water) to obtain compound B22 (8.0 mg, 5.71%) as a white solid. ESI / MS (m / z) 351.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ11.54(s,1H),7.15(t,J=7.9Hz,1H),7.02(d,J=8.2Hz,1H),6.60(d,J=7.5Hz,1H),3.23 (t,J=5.8Hz,2H),3.00(s,4H),2.55-2.52(m,2H),2.30(t,J=6.7Hz,4H),2.13-2.09(m,2H),1.82-1.73(m,8H).

[0303] Example 73: Synthesis of Compound B23

[0304] Under nitrogen protection, compound B23-1 (39.7 mg, 0.400 mmol), methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl) (2-amino-1,1'-biphenyl-2-yl) palladium (II) (16.7 mg, 0.020 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl (9.3 mg, 0.020 mmol) and sodium tert-butoxide (76.9 mg, 0.800 mmol) were added to a mixture of compound INT-B (76.9 mg, 0.200 mmol) and 1,4-dioxane (2 mL) in sequence. The mixture was stirred at 90 ° C for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), the resulting mixture was filtered through celite and concentrated under reduced pressure to give a crude compound B23-2. A mixture of trifluoromethanesulfonic acid (0.15 mL) and trifluoroacetic acid (3 mL) was added to the crude compound B23-2 and stirred at room temperature for 20 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase silica gel column chromatography (10-50% acetonitrile / water) to obtain compound B23 (7.4 mg, 13.10%) as a yellow solid. ESI / MS (m / z) 283.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ11.48(s,1H),7.08(t,J=7.9Hz,1H),6.90(d,J=8.1Hz,1H),6.44(d,J=7.6Hz,1H),3.30-2.26 (m,2H),3.18(t,J=5.8Hz,2H),2.97(s,2H),2.53-2.51(m,2H),2.10-2.05(m,2H),1.72(t,J=7.0Hz,2H),1.15(s,6H).

[0305] Example 74: Synthesis of Compound B24

[0306] Under nitrogen protection, compound B24-1 (121.3 mg, 0.800 mmol), methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl) (2-amino-1,1'-biphenyl-2-yl) palladium (II) (33.5 mg, 0.040 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl (18.7 mg, 0.040 mmol) and sodium tert-butoxide (153.8 mg, 1.600 mmol) were added to a mixture of compound INT-B (153.7 mg, 0.400 mmol) and 1,4-dioxane (4 mL) in sequence. The mixture was stirred at 100° C. for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), the resulting mixture was filtered through celite and concentrated in vacuo to give the crude compound B24-2. A mixture of trifluoromethanesulfonic acid (0.15 mL) and trifluoroacetic acid (3 mL) was added to the crude compound B24-2 and stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase silica gel column chromatography (10-40% acetonitrile / water) to obtain compound B24 (46.5 mg, 38.96%) as a yellow solid. ESI / MS (m / z) 299.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ11.43(s,1H),7.07(t,J=7.9Hz,1H),6.78(d,J=8.1Hz,1H),6.06(d,J=7.6Hz,1H),4.37(s,1H),3. 92(t,J=7.8Hz,2H),3.84(t,J=7.0Hz,2H),3.08(t,J=5.8Hz,2H),2.70-2.64(m,1H),2.49-2.47(m,2H),2.11-2.05(m,2H), 1.09(s,6H).

[0307] Example 75: Synthesis of Compound B25

[0308] To a mixture of compound B25-1 (25.0 g, 0.12 mol) in anhydrous ethanol (250 mL) was added dropwise thionyl chloride (110 g, 0.93 mol) on ice, and the mixture was heated under reflux for 24 hours. After cooling to room temperature, ethyl acetate (100 mL) was added and the mixture was filtered. The filter cake was rinsed with ethyl acetate and dried to afford compound B25-2 (30.1 g, 92.7%) as a white solid.

[0309] To a solution of compound B25-2 (11.5 g, 41 mmol) in water (150 mL) at 0-5°C, concentrated hydrochloric acid (18 mL) and an aqueous solution of sodium nitrite (4.2 g, 61 mmol) (30 mL) were added sequentially. The mixture was stirred for 10 minutes to obtain a diazonium salt reaction solution. To a solution of compound B01-2 (11.4 g, 90 mmol) in methanol (100 mL) was added an aqueous solution of sodium acetate (7.4 g, 90 mmol) (80 mL). The system was cooled to 0-5°C, and the diazonium salt reaction solution prepared above was added dropwise to the reaction system. Stirring was continued for 30 minutes. After the reaction was completed, the filter cake was washed with water and dried to obtain an orange solid crude product B25-3 (15 g, 100%).

[0310] To a solution of compound B25-3 (15 g, 41 mmol) in acetonitrile (300 mL) was added 1.8 M sulfuric acid (60 mL), and the mixture was allowed to react at 80°C for 4 hours. The reaction solution was cooled to room temperature and diluted with ethyl acetate (200 mL). The organic phase was washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to afford B25-4 (6.4 g, 46%) as an orange-red solid.

[0311] Under nitrogen, a mixture of methanol (42 mL) and ethyl acetate (42 mL) was added to a reaction flask containing compound B25-4 (4.2 g, 12.5 mmol) and palladium on carbon (10% w / w, 0.21 g). The gas was replaced three times with a hydrogen balloon, and triethylamine (1.3 g, 12.5 mmol) was added. The mixture was stirred at room temperature for 4 hours. After the reaction was completed, the mixture was diluted with ethyl acetate (100 mL) and the palladium on carbon was removed by filtration through celite. The filtrate was washed with 0.5 M hydrochloric acid and saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to obtain a crude yellow solid product B25-5 (2.9 g, 90%).

[0312] To a solution of B25-5 (1.26 g, 4.9 mmol) in methanol (50 mL) was added lithium hydroxide (590 mg, 24.5 mmol) in water (10 mL) at room temperature and stirred at 65°C for 1 hour. After the reaction was complete, the mixture was cooled to 0-5°C and the pH was adjusted to 3 with 3M aqueous hydrochloric acid. The mixture was directly filtered, and the filter cake was washed with water and dried to yield INT-D (1.1 g, 98%) as a white solid.

[0313] To a mixture of compound INT-D (50 mg, 0.22 mmol) in n-butanol (0.5 mL) was added 2 drops of concentrated sulfuric acid and stirred at 110°C for 1 hour. After the reaction was completed, the mixture was cooled to room temperature and diluted with ethyl acetate (20 mL). The mixture was washed sequentially with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1:10) to obtain compound B25 (50 mg, 79.6%) as a white solid. MS m / z 286.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.00(s,1H),7.65(dd,J=8.3,0.9Hz,1H),7.59(dd,J=7.3,0.9Hz,1H),7.39-7.36(m,1H),4.33(t,J=6.7 Hz,2H),3.09(t,J=6.0Hz,2H),2.59-2.56(m,2H),2.14-2.09(m,2H),1.76-1.70(m,2H),1.47-1.40(m,2H),0.95(t,J=7.4Hz,3H).

[0314] Example 76: Synthesis of Compound B26

[0315] To a mixture of compound INT-D (50 mg, 0.22 mmol) in dichloromethane (1 mL) were added cyclopropanol (51 mg, 0.88 mmol), 4-dimethylaminopyridine (26.9 mg, 0.22 mmol), and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol), and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1:5) to obtain compound B26 (51 mg, 86.1%) as a white solid. ESI / MS (m / z) 270.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.01(s,1H),7.66(dd,J=8.3,0.9Hz,1H),7.56(dd,J=7.3,0.9Hz,1H),7.37-7.34 (m,1H),4.38-4.34(m,1H),3.09(t,J=6.0Hz,2H),2.62-2.55(m,2H),2.14-2.09(m,2H),0.84-0.82(m,4H).

[0316] Example 77: Synthesis of Compound B27

[0317] To a mixture of compound INT-D (100 mg, 0.44 mmol), compound B27-1 (racemate, 165 mg, 0.88 mmol, Boc: tert-butyloxycarbonyl), and triphenylphosphine (231 mg, 0.88 mmol) in tetrahydrofuran (1 mL) at 0°C under a nitrogen atmosphere was added diethyl azodicarboxylate (153 mg, 0.88 mmol), and stirred at room temperature for 6 hours. After completion of the reaction, the mixture was diluted with ethyl acetate (50 mL), washed sequentially with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B27-2 (250 mg, 100%, racemate) as a white solid.

[0318] Trifluoroacetic acid (0.25 mL) was added to a solution of compound B27-2 (250 mg) in dichloromethane (1 mL) at room temperature, and the mixture was stirred at room temperature for 1 hour. The reaction solution was directly concentrated, and the residue was purified by silica gel column chromatography (dichloromethane:methanol = 15:1) to obtain compound B27 (89 mg, 67.8%, racemate) as a white solid. ESI / MS (m / z) 299.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ11.99(br,1H),7.65(d,J=8.0Hz,1H),7.60(d,J=7.2Hz,1H),7.28-7.35(m,1H),5.38-5.35(m, 1H),3.12-3.08(m,3H),2.97-2.92(m,2H),2.84-2.79(m,1H),2.59-2.56(m,2H),2.14-2.03(m,3H),1.90-1.86(m,1H).

[0319] Example 78: Synthesis of Compound B28

[0320] To a mixture of compound INT-D (50 mg, 0.22 mmol), compound B28-1 (44 mg, 0.44 mmol, racemate), and triphenylphosphine (115 mg, 0.44 mmol) in tetrahydrofuran (1 mL) at 0°C under a nitrogen atmosphere was added diethyl azodicarboxylate (76 mg, 0.44 mmol), and stirred at room temperature for 6 hours. After completion of the reaction, ethyl acetate (30 mL) was added to dilute the mixture, which was then washed with saturated sodium chloride solution. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (dichloromethane:methanol = 15:1) to afford compound B28 (31 mg, 45.1%, racemate) as a white solid. ESI / MS (m / z) 313.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.00(s,1H),7.66(d,J=8.2Hz,1H),7.59(d,J=7.1Hz,1H),7.39-7.36(m,1H),5.39-5.35(m,1 H),3.12-3.10(m,2H),2.84-2.76(m,3H),2.59-2.56(m,2H),2.43-2.30(m,5H),2.14-2.09(m,2H),1.96-1.90(m,1H).

[0321] Example 79: Synthesis of Compound B29

[0322] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B29-1 (44 mg, 0.44 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature, and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B29 (26 mg, 37.7%, mixture of optical isomers) as a white solid. ESI / MS (m / z) 314.0 [M+H] + . 1H NMR(500MHz,DMSO-d6)δ11.98(s,1H),7.66-7.63(m,1H),7.60-7.54(m,1H),7.39-7.34(m,1H),5.45-5.23(m,1H),4.69-4.66(m,1H), 4.32-4.14(m,1H),3.12-3.07(m,2H),2.59-2.56(m,2H),2.37-2.19(m,1H),2.14-2.09(m,2H),2.06-1.90(m,3H),1.81-1.54(m,2H).

[0323] Example 80: Synthesis of Compound B30

[0324] To a mixture of compound INT-D (50 mg, 0.22 mmol), compound B30-1 (45 mg, 0.44 mmol), and triphenylphosphine (115 mg, 0.44 mmol) in tetrahydrofuran (1 mL) at 0°C under a nitrogen atmosphere was added diethyl azodicarboxylate (76 mg, 0.44 mmol), and stirred at room temperature for 6 hours. After the reaction was completed, ethyl acetate (30 mL) was added for dilution, and the mixture was washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B30 (48 mg, 69.7%) as a white solid. ESI / MS (m / z) 314.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.00(s,1H),7.66(d,J=8.3Hz,1H),7.63(d,J=7.3Hz,1H),7.38(t,J=7.8Hz,1H),5.21-5.13(m,1H),3.91- 3.87(m,2H),3.56-3.52(m,2H),3.10(t,J=6.0Hz,2H),2.59-2.56(m,2H),2.14-2.09(m,2H),2.04-2.02(m,2H),1.77-1.70(m,2H).

[0325] Example 81: Synthesis of Compound B31

[0326] To a mixture of compound INT-D (50 mg, 0.22 mmol) and ethylene glycol (0.5 mL) was added 2 drops of concentrated sulfuric acid at room temperature, and the mixture was stirred at 110°C for 1 hour. Upon completion of the reaction, ethyl acetate (30 mL) was added for dilution, followed by washing with saturated sodium chloride solution, drying over anhydrous sodium sulfate, filtering, and concentration under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:3) to afford compound B31 (28 mg, 46.6%) as a white solid. ESI / MS m / z 274.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.00(s,1H),7.67-7.64(m,2H),7.40-7.36(m,1H),4.93(t,J=5.5Hz,1H ),4.35-4.33(m,2H),3.76-3.73(m,2H),3.12-3.09(m,2H),2.59-2.56(m,2H),2.13-2.08(m,2H).

[0327] Example 82: Synthesis of Compound B32

[0328] To a solution of compound B32-1 (2.0 g, 10 mmol) in water (30 mL) at 0-5°C, concentrated hydrochloric acid (4.2 mL) and an aqueous solution of sodium nitrite (1.4 g, 20 mmol) (10 mL) were added sequentially and stirred for 10 minutes to obtain a diazonium salt reaction solution. To a solution of compound B01-2 (1.9 g, 15 mmol) in methanol (20 mL) was added an aqueous solution of sodium acetate (1.8 g, 22 mmol) (20 mL). The system was cooled to 0-5°C and the diazonium salt reaction solution prepared above was added dropwise to the reaction system. Stirring was continued for 30 minutes. After the reaction was completed, the filter cake was washed with water and dried to obtain a reddish-brown solid crude compound B32-2 (3.0 g, 100%).

[0329] To a solution of compound B32-2 (3.0 g, 20 mmol) in acetonitrile (30 mL) was added 1.8 M sulfuric acid (17 mL) at room temperature, and the mixture was stirred at 80°C for 4 hours. The reaction solution was cooled to room temperature, diluted with ethyl acetate (50 mL), washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 12:1) to afford compound B32-3 (1.1 g, 38.4%) as an orange-red solid.

[0330] Under nitrogen, methanol (15 mL) and ethyl acetate (15 mL) were added to a reaction flask containing compound B32-3 (1.1 g, 3.7 mmol) and palladium on carbon (10% w / w, 55 mg). The gas was replaced three times with a hydrogen balloon, and triethylamine (0.38 g, 3.7 mmol) was injected. The mixture was stirred at room temperature for 4 hours. The reaction solution was diluted with ethyl acetate (50 mL) and filtered through celite. The filtrate was washed sequentially with 0.5 M hydrochloric acid and saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to obtain crude compound B32-4 (600 mg, 75%) as a brown solid.

[0331] A mixture of compound B32-4 (500 mg, 2.32 mmol) and 48% aqueous hydrogen bromide solution (10 mL) was stirred at 105°C for 1 hour. After the reaction solution was cooled to room temperature, it was diluted with water (10 mL) and the mixture was extracted with ethyl acetate (20 mL × 3). The organic layer was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to obtain a brown crude product, compound B32-5 (400 mg, 85.7%).

[0332] To a mixture of compound B32-5 (40 mg, 0.2 mmol) and 1-propionic acid (18 mg, 0.24 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (24 mg, 0.2 mmol) and N,N'-dicyclohexylcarbodiimide (62 mg, 0.3 mmol) at room temperature, and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B32 (26 mg, 50.5%) as a white solid. ESI / MS (m / z) 258.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ11.81(s,1H),7.30-7.26(m,2H),6.81-6.78(m,1H),2.93(t,J=6.0 Hz, 2H), 2.72 (q, J = 7.5Hz, 2H), 2.55-2.52 (m, 2H), 2.16-2.11 (m, 2H), 1.20 (t, J = 7.5Hz, 3H).

[0333] Example 83: Synthesis of Compound B33

[0334] To a mixture of compound B32-5 (40 mg, 0.2 mmol) and compound B33-1 (21 mg, 0.24 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (24 mg, 0.2 mmol) and N,N'-dicyclohexylcarbodiimide (62 mg, 0.3 mmol) at room temperature and stirred for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B33 (20 mg, 36.9%) as a white solid. ESI / MS (m / z) 272.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ11.82(s,1H),7.30-7.26(m,2H),6.80-6.76(m,1H),2 .97-2.91(m,3H),2.56-2.54(m,2H),2.17-2.12(m,2H),1.31(d,J=7.0Hz,6H).

[0335] Example 84: Synthesis of Compound B34

[0336] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B34-1 (47 mg, 0.44 mmol) in dichloromethane (1 mL) at room temperature were added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol). The mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B34 (53 mg, 75.4%) as a white solid. ESI / MS (m / z) 320.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.01(s,1H),7.66(dd,J=9.9,7.8Hz,2H),7.51(d,J=7.2Hz,2H),7.43(t,J=7. 3Hz, 2H), 7.41-7.35 (m, 2H), 5.41 (s, 2H), 3.04 (t, J = 6.0Hz, 2H), 2.58-2.53 (m, 2H), 2.12-2.03 (m, 2H).

[0337] Example 85: Synthesis of Compound B35

[0338] Potassium carbonate (91 mg, 0.66 mmol) was added to a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B35-1 (86 mg, 0.33 mmol) in N,N-dimethylformamide (1 mL) at room temperature and stirred at room temperature for 2 hours. After the reaction was completed, ethyl acetate (30 mL) was added to dilute the mixture, and the mixture was washed with a saturated sodium chloride solution, dried with sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (dichloromethane:methanol = 15:1) to obtain compound B35 (17 mg, 23.5%) as a white solid. ESI / MS (m / z) 329.1 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.01(s,1H),7.67-7.61(m,2H),7.38(t,J=7.8Hz,1H),4.38(s,2 H), 3.12 (t, J = 5.9Hz, 2H), 2.79 (s, 2H), 2.53-2.52 (m, 6H), 2.14-2.09 (m, 2H), 0.99 (s, 6H).

[0339] Example 86: Synthesis of Compound B36

[0340] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B36-1 (31 mg, 0.44 mmol, racemate) in dichloromethane (1 mL) were added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature and stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B36 (43 mg, 69.5%, racemate) as a white solid. ESI / MS (m / z) 282.0 [M+H] + . 1H NMR (500MHz, DMSO-d6) δ12.04(s,1H),7.69(d,J=8.2Hz,1H),7.61(d,J=7.3Hz,1H),7.39(t,J=7.8Hz,1H),5.69-5.6 4(m,1H),3.63(d,J=2.1Hz,1H),3.13(t,J=6.0Hz,2H),2.60-2.57(m,2H),2.15-2.11(m,2H),1.60(d,J=6.7Hz,3H).

[0341] Example 87: Synthesis of Compound B37

[0342] To a mixture of dimethylamine hydrochloride (0.33 g, 4 mmol) in tetrahydrofuran (20 mL) at 0°C under a nitrogen atmosphere was added sodium hydroxide (0.32 g, 8 mmol) and stirred for 15 minutes. Compound B37-1 (0.3 g, 2 mol) was added and stirred at room temperature overnight. The reaction mixture was diluted with ethyl acetate (20 mL), filtered, and concentrated under reduced pressure to yield crude compound B37-2 (0.35 g, 74.7%, racemate) as a pale yellow liquid.

[0343] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B37-2 (260 mg, 2.2 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature, and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:4) to obtain compound B37 (20 mg, 27.7%, racemate) as a white solid. ESI / MS (m / z) 329.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.01(s,1H),7.68(d,J=3.7Hz,1H),7.67(d,J=2.8Hz,1H),7.39(t,J=7.8Hz,1H),5.66(q,J=6.7 Hz,1H),3.20-3.15(m,1H),3.10-3.04(m,4H),2.88(s,3H),2.59-2.56(m,2H),2.13-2.08(m,2H),1.48(d,J=6.7Hz,3H).

[0344] Example 88: Synthesis of Compound B38

[0345] To a mixture of compound INT-D (50 mg, 0.22 mmol) in ethylene glycol methyl ether (0.5 mL) was added 2 drops of concentrated sulfuric acid at room temperature, and the mixture was stirred at 120°C for 2 hours. The reaction solution was diluted with ethyl acetate (20 mL), washed sequentially with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:5) to obtain compound B38 (46 mg, 72.8%) as a white solid. ESI / MS m / z 288.1 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.00(s,1H),7.67(dd,J=8.3,0.7Hz,1H),7.63-7.58(m,1H),7.40-7.37(m,1H),4.4 6-4.44(m,2H),3.70-3.69(m,2H),3.32(s,3H),3.10(t,J=6.0Hz,2H),2.59-2.57(m,2H),2.14-2.09(m,2H).

[0346] Example 89: Synthesis of Compound B39

[0347] To a mixture of compound INT-D (50 mg, 0.22 mmol) and phenol (41.4 mg, 0.44 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature and stirred for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to afford compound B39 (51 mg, 75.9%) as a white solid. ESI / MS (m / z) 306.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.11(s,1H),7.89(dd,J=7.3,0.9Hz,1H),7.76(dd,J=8.3,0.9Hz,1H),7.53-7.50 (m,2H),7.48-7.45(m,1H),7.37-7.33(m,3H),3.15(t,J=6.0Hz,2H),2.59-2.57(m,2H),2.13-2.08(m,2H).

[0348] Example 90: Synthesis of Compound B40

[0349] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B40-1 (39 mg, 0.44 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature and stirred for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to afford compound B40 (35 mg, 53.1%) as a white solid. ESI / MS (m / z) 300.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.01(s,1H),7.67(dd,J=8.3,0.8Hz,1H),7.64(dd,J=7.3,0.8Hz,1H),7.41 -7.38(m,1H),4.05(s,2H),3.10(t,J=6.0Hz,2H),2.59-2.56(m,2H),2.13-2.08(m,2H),1.02(s,9H).

[0350] Example 91: Synthesis of Compound B41

[0351] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B41-1 (32 mg, 0.44 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature and stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL) and washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B41 (53 mg, 85%) as a white solid. ESI / MS (m / z) 284.0 [M+H] + . 1H NMR (500MHz, DMSO-d6) δ11.99(s,1H),7.67-7.63(m,1H),7.60(d,J=7.2Hz,1H),7.40-7.35(m,1H),4.17(d,J=7.3Hz,2H ), 3.11(t,J=6.0Hz,2H),2.57-2.54(m,2H),2.14-2.09(m,2H),1.29-1.25(m,1H),0.61-0.58(m,2H),0.40-0.37(m,2H).

[0352] Example 92: Synthesis of Compound B42

[0353] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B42-1 (40 mg, 0.44 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature and stirred for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to afford compound B42 (27 mg, 39.9%) as a white solid. ESI / MS (m / z) 308.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.06(s,1H),7.71-7.67(m,2H),7.43-7.39(m,1H),5.64-5.52(m,1H),4 .91-4.82(m,2H),4.81-4.72(m,2H),3.12(t,J=6.0Hz,2H),2.60-2.57(m,2H),2.15-2.09(m,2H).

[0354] Example 93: Synthesis of Compound B43

[0355] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B43-1 (47 mg, 0.44 mmol) in dichloromethane (1 mL) was added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature and stirred for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to afford compound B43 (45 mg, 60.6%) as a white solid. ESI / MS (m / z) 338.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.01(s,1H),7.66(d,J=8.3Hz,1H),7.63(d,J=7.3Hz,1H),7.59-7.56(m,2H),7.39 -7.36(m,1H),7.27-7.23(m,2H),5.39(s,2H),3.02(t,J=6.0Hz,2H),2.57-2.54(m,2H),2.09-2.04(m,2H).

[0356] Example 94: Synthesis of Compound B44

[0357] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B44-1 (50 mg, 0.44 mmol, racemate) in dichloromethane (1 mL) were added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol) at room temperature and stirred for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B44 (44 mg, 61.5%, racemate) as a white solid. ESI / MS (m / z) 326.0 [M+H] + . 1H NMR (500MHz, DMSO-d6)12.10(s,1H),7.73(d,J=8.3Hz,1H),7.67(d,J=7.2Hz,1H),7.47-7.39(m,1H) ,5.82-5.73(m,1H),3.14-3.06(m,2H),2.62-2.57(m,2H),2.15-2.10(m,2H),1.55(d,J=6.6Hz,3H).

[0358] Example 95: Synthesis of Compound B45

[0359] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B45-1 (47 mg, 0.44 mmol) in dichloromethane (1 mL) were added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol), and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B45 (42 mg, 58.7%) as a white solid. ESI / MS (m / z) 326.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.03(s,1H),7.68(dd,J=8.3,0.6Hz,1H),7.62(d,J=7.3Hz,1H),7.42-7.37(m,1 H), 4.55 (t, J = 6.0 Hz, 2H), 3.11 (t, J = 6.0 Hz, 2H), 2.91-2.78 (m, 2H), 2.61-2.56 (m, 2H), 2.17-2.06 (m, 2H).

[0360] Example 96: Synthesis of Compound B46

[0361] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B46-1 (44 mg, 0.44 mmol) in dichloromethane (1 mL) were added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol), and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid (10 mL) and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:6) to obtain compound B46 (59 mg, 86.2%) as a white solid. ESI / MS (m / z) 312.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.11(s,1H),7.74(dd,J=8.3,0.8Hz,1H),7.69(dd,J=7.3,0.7Hz,1H),7.4 4-7.41(m,1H),5.06(q,J=9.1Hz,2H),3.11(t,J=6.0Hz,2H),2.60-2.58(m,2H),2.14-2.09(m,2H).

[0362] Example 97: Synthesis of Compound B47

[0363] To a mixture of compound INT-D (50 mg, 0.22 mmol) and compound B47-1 (55 mg, 0.44 mmol) in dichloromethane (1 mL) were added 4-dimethylaminopyridine (26.9 mg, 0.22 mmol) and N,N'-dicyclohexylcarbodiimide (91 mg, 0.44 mmol), and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate (30 mL), washed sequentially with 0.5 M aqueous hydrochloric acid and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:1) to afford compound B47 (17 mg, 23.0%) as a white solid. ESI / MS (m / z) 336.0 [M+H] + . 1H NMR (500MHz, DMSO-d6) δ12.03(s,1H),7.69(d,J=3.2Hz,1H),7.67(d,J=2.3Hz,1H),7.39(t,J=7.8Hz,1H),4.69( t,J=5.9Hz,2H),3.70(t,J=5.9Hz,2H),3.13(t,J=6.0Hz,2H),3.07(s,3H),2.60-2.57(m,2H),2.14-2.09(m,2H).

[0364] Example 98: Synthesis of Compound B48

[0365] Under nitrogen, compound B48-1 (110.2 mg, 0.540 mmol), [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium dichloromethane complex (12.2 mg, 0.015 mmol), and potassium carbonate (82.9 mg, 0.600 mmol) were added sequentially to a mixture of compound INT-C (109.3 mg, 0.300 mmol) and 1,4-dioxane (3 mL). The mixture was stirred at 80°C for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), the resulting mixture was filtered through celite, and the filtrate was concentrated under reduced pressure to obtain crude compound B48-2. A mixture of trifluoroacetic acid (0.3 mL) and dichloromethane (3 mL) was added to the crude compound B48-2, and the mixture was stirred at room temperature for 10 minutes. The reaction mixture was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), and then dried over anhydrous sodium sulfate. The mixture was filtered and concentrated under reduced pressure to obtain a crude product, which was then purified by reverse-phase silica gel column chromatography (50-90% acetonitrile / water) to obtain compound B48 (41.0 mg, 52.30%) as a pale yellow solid. ESI / MS (m / z) 262.1 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ11.77(s,1H),7.49-7.45(m,2H),7.45-7.40(m,4H),7.35-7.31(m,1 H), 6.93 (dd, J = 7.0, 0.8Hz, 1H), 2.4-2.47 (m, 2H), 2.40 (t, J = 6.0Hz, 2H), 1.95-1.88 (m, 2H).

[0366] Example 99: Synthesis of Compound B49

[0367] Under nitrogen, compound B49-1 (61.9 mg, 0.240 mmol), [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium dichloromethane complex (8.0 mg, 0.010 mmol), and potassium carbonate (41.5 mg, 0.300 mmol) were added sequentially to a mixture of compound INT-C (72.8 mg, 0.200 mmol) and 1,4-dioxane (3 mL). The mixture was stirred at 80°C for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), filtered through celite, and concentrated in vacuo to afford crude compound B49-2. A mixture of trifluoroacetic acid (0.3 mL) and dichloromethane (3 mL) was added to the crude compound B49-2, and the mixture was stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), and dried over anhydrous sodium sulfate. The mixture was filtered and concentrated under reduced pressure to obtain a crude product, which was then separated and purified by reverse-phase silica gel column chromatography (10-70% acetonitrile / water) to obtain compound B49 (30.0 mg, 47.56%) as a pale yellow solid. ESI / MS (m / z) 316.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ11.82(s,1H),7.68(d,J=8.5Hz,1H),7.66(s,1H),7.52-7.47(m,2H),7.40-7.37(m,1H),7.11(d, J=6.9Hz,1H),7.07(d,J=7.0Hz,1H),4.10(s,3H),2.44(t,J=5.8Hz,2H),2.27(br,1H),2.06-1.90(m,1H),1.81(br,2H).

[0368] Example 100: Synthesis of Compound B50

[0369] Under nitrogen, to a mixture of compound INT-C (109.3 mg, 0.300 mmol) and 1,4-dioxane (3 mL) were added B50-1 (220.6 mg, 0.900 mmol), [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium dichloromethane complex (12.2 mg, 0.015 mmol), and potassium carbonate (124.4 mg, 0.900 mmol), and the mixture was stirred at 80°C for 8 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (100 mL), filtered through celite, and concentrated in vacuo to afford crude compound B50-2. To the crude compound B50-2 was added a mixture of trifluoroacetic acid (0.3 mL) and dichloromethane (3 mL), and stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), and dried over anhydrous sodium sulfate. The mixture was filtered and concentrated under reduced pressure to obtain a crude product, which was separated and purified by reverse phase silica gel column chromatography (10-50% acetonitrile / water) to obtain a light yellow solid compound B50 (13.0 mg, 14.33%). ESI / MS (m / z) 303.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ13.76(s,1H),11.84(s,1H),8.60(d,J=2.0Hz,1H),8.28(d,J=2.0Hz,1H),8.21(s,1H),7.47(d ,J=8.2Hz,1H),7.40-7.36(m,1H),7.03(d,J=7.0Hz,1H),2.49-2.47(m,2H),2.38(t,J=6.0Hz,2H),1.93-1.87(m,2H).

[0370] Example 101: Synthesis of Compound B51

[0371] To a solution of compound B51-1 (2 g, 23.776 mmol) and ethyl formate (3.52 g, 47.552 mmol) in toluene (40 mL) was added 60% sodium hydride (0.86 g, 35.664 mmol) at 0°C and stirred at room temperature for 2 hours. After completion of the reaction, the pH was adjusted to 1 with concentrated hydrochloric acid and extracted with ethyl acetate (3 × 40 mL). The organic phase was washed sequentially with saturated aqueous sodium chloride solution (40 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B51-2 (2.5 g, 73.05%) as a brown oil. ESI / MS (m / z): 113.1 [M+H] + .

[0372] To a solution of compound B51-3 (2.31 g, 15.284 mmol) in concentrated hydrochloric acid (5.7 mL) and water (80 mL) was slowly added a solution of sodium nitrite (2.11 g, 30.568 mmol) in water (30 mL) at 0°C. A solution of compound B51-2 (2.2 g, 15.284 mmol) and sodium acetate (2.76 g, 33.625 mmol) in methanol (80 mL) and water (80 mL) was slowly added to the above solution at 0°C and stirred at room temperature for 1 hour. The reaction mixture was filtered and the filter cake was washed with water (50 mL) and dried to give a red solid compound B51-4 (4.1 g, 54.46%). ESI / MS (m / z): 247.1 [M+H] + .

[0373] To a solution of compound B51-4 (3.6 g, 7.309 mmol) in methanol (100 mL) was added concentrated hydrochloric acid (3.5 mL) at room temperature and stirred at 60°C overnight. The reaction solution was cooled to room temperature, adjusted to pH 7 with saturated aqueous sodium carbonate solution, and extracted with ethyl acetate (3 × 150 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride solution (150 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B51 (33.8 mg, 1.97%) as a yellow solid. ESI / MS (m / z): 230.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.06 (s, 1H), 7.80 (d, J = 7.3Hz, 1H), 7.72 (d, J = 8.3Hz, 1H), 7.45 (t, J = 7.8Hz, 1H), 3.92 (s, 3H), 3.26-3.21 (m, 2H), 2.91-2.84 (m, 2H).

[0374] Example 102: Synthesis of Compound B52

[0375] To a mixture of compound INT-D (100 mg, 0.431 mmol) and ammonium bicarbonate (102 mg, 1.293 mmol) in N,N-dimethylformamide (4 mL) were added triethylamine (180 μL, 1.293 mmol) and 2-(7-nitrobenzotriazole)-N,N,N,N-tetramethyluronium hexafluorophosphate (197 mg, 0.517 mmol), and stirred at room temperature for 2 hours. After completion of the reaction, the mixture was diluted with water (5 mL), filtered, and the filter cake was washed with water (2 × 2 mL). The mixture was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B52 (9.1 mg, 8.97%) as a white solid. ESI / MS (m / z): 229.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.77(s,1H),7.84(s,1H),7.47(dd,J=8.3,1.0Hz,1H),7.41(s,1H),7.29(dd,J=8.3 ,7.1Hz,1H),7.17(dd,J=7.1,1.1Hz,1H),2.99(t,J=6.0Hz,2H),2.54(t,J=6.4Hz,2H),2.10(p,J=6.1Hz,2H).

[0376] Example 103: Synthesis of Compound B53

[0377] To a solution of compound INT-D (130 mg, 0.561 mmol) and methylamine hydrochloride (45 mg, 0.673 mmol) in N,N-dimethylformamide (4 mL) was added 2-(7-nitrobenzotriazole)-N,N,N,N-tetramethyluronium hexafluorophosphate (256 mg, 0.673 mmol) and N,N-diisopropylethylamine (488 μL, 2.805 mmol) at room temperature and stirred for 2 hours. After completion of the reaction, the mixture was diluted with water (10 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated sodium chloride solution (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B53 (52.6 mg, 38.44%) as a white solid. ESI / MS (m / z): 243.2 [M+H] + . 1H NMR (300MHz, DMSO-d6) δ11.80(s,1H),8.31(q,J=4.4Hz,1H),7.47(dd,J=8.4,1.0Hz,1H),7.30(dd,J=8.3,7.1Hz,1H) ,7.11(dd,J=7.1,1.0Hz,1H),2.90(t,J=6.0Hz,2H),2.80(d,J=4.6Hz,3H),2.54(t,J=6.3Hz,2H),2.16-2.03(m,2H).

[0378] Example 104: Synthesis of Compound B54

[0379] To a solution of compound INT-D (130 mg, 0.561 mmol) and dimethylamine hydrochloride (55 mg, 0.673 mmol) in N,N-dimethylformamide (4 mL) was added 2-(7-nitrobenzotriazole)-N,N,N,N-tetramethyluronium hexafluorophosphate (256 mg, 0.673 mmol) and N,N-diisopropylethylamine (488 μL, 2.805 mmol) at room temperature and stirred for 2 hours. After completion of the reaction, the mixture was diluted with water (15 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated sodium chloride solution (15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B54 (97.7 mg, 67.49%) as a white solid. ESI / MS (m / z): 257.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.82(s,1H),7.43(dd,J=8.4,1.0Hz,1H),7.32(dd,J=8.4,7.0Hz,1H),6.93(dd, J=7.1,1.0Hz,1H),3.06(s,3H),2.75(s,3H),2.74-2.71(m,2H),2.59-2.53(m,2H),2.11(p,J=6.1Hz,2H).

[0380] Example 105: Synthesis of Compound B55

[0381] Compound B55-1 (1.1 g, 5.547 mmol) was added dropwise to a solution of compound INT-D (200 mg, 0.860 mmol) in toluene (10 mL) at 100°C and stirred for 1 hour. After cooling to room temperature, the reaction was quenched with water (100 mL) and extracted with ethyl acetate (3 × 50 mL). The resulting organic phase was washed with saturated aqueous sodium chloride (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to afford compound B55 (10 mg, 4.00%) as a white solid. ESI / MS (m / z): 286.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.94(s,1H),7.60(d,J=8.2Hz,1H),7.48(d,J=7.3Hz,1H),7.34(dd,J=8 .3,7.3Hz,1H),3.08(t,J=6.0Hz,2H),2.57(t,J=6.4Hz,2H),2.12(p,J=6.2Hz,2H),1.59(s,9H).

[0382] Example 106: Synthesis of Compound B56

[0383] To a solution of compound INT-D (200 mg, 0.860 mmol) in tetrahydrofuran (10 mL) was added dropwise N,N'-carbonyldiimidazole (418.48 mg, 2.580 mmol) at 0°C and stirred at room temperature for 1 hour. A solution of sodium borohydride (48.82 mg, 1.290 mmol) in water (1 mL) was added at room temperature, stirred for 1 hour, and quenched with water. The mixture was extracted with dichloromethane (2 × 30 mL), and the combined organic phases were washed with saturated sodium chloride aqueous solution (20 mL), dried over anhydrous sodium sulfate, and then directly concentrated under reduced pressure. The residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate = 1:1) to obtain compound B56 as a white solid. ESI / MS (m / z): 216.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.58(s,1H),7.29(d,J=8.3Hz,1H),7.22(d,J=8.3,6.9Hz,1H),7.04(dd,J=6.9,1.1Hz ,1H),5.18(t,J=5.4Hz,1H),4.84(d,J=5.4Hz,2H),3.17(t,J=6.0Hz,2H),2.55-2.51(m,2H),2.16-2.10(m,2H).

[0384] Example 107: Synthesis of Compound B57

[0385] To a solution of compound INT-D (130 mg, 0.561 mmol) and ethylamine hydrochloride (55 mg, 0.673 mmol) in N,N-dimethylformamide (4 mL) was added 2-(7-nitrobenzotriazole)-N,N,N,N-tetramethyluronium hexafluorophosphate (256 mg, 0.673 mmol) and N,N-diisopropylethylamine (488 μL, 2.805 mmol) at room temperature and stirred for 2 hours. The reaction solution was quenched with water (15 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated sodium chloride solution (15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B57 (89.9 mg, 62.23%) as a white solid. ESI / MS (m / z): 257.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.78(s,1H),8.36(t,J=5.5Hz,1H),7.47(d,J=8.3Hz,1H),7.30(t,J=7.7Hz,1H),7.10(d,J=7. 0Hz, 1H), 3.32-3.26 (m, 2H), 2.92 (t, J = 6.0Hz, 2H), 2.54 (t, J = 6.3Hz, 2H), 2.09 (p, J = 6.1Hz, 2H), 1.15 (t, J = 7.2Hz, 3H).

[0386] Example 108: Synthesis of Compound B58

[0387] To a solution of INT-C (200 mg, 0.538 mmol) and compound B58-1 (209 mg, 1.076 mmol) in 1,4-dioxane (8 mL) and water (1.6 mL) was added cesium carbonate (351 mg, 1.076 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (66 mg, 0.081 mmol) under nitrogen. The reaction mixture was stirred at 100°C overnight. The reaction mixture was cooled to room temperature, quenched with water (30 mL), and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated sodium chloride aqueous solution (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:9) to obtain the intermediate compound. The intermediate was redissolved in a 4M solution of hydrogen chloride in 1,4-dioxane (8 mL, 263.302 mmol) and stirred at room temperature for 2 hours. The reaction solution was directly concentrated under reduced pressure and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to obtain compound B58 (26.7 mg, 19.55%) as a white solid. ESI / MS (m / z): 252.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.97(s,1H),11.67(s,1H),7.92(s,1H),7.66(s,1H),7.34(dd,J=8.3,1.1Hz,1H),7.27(d d,J=8.3,7.0Hz,1H),6.93(dd,J=7.1,1.1Hz,1H),2.71(t,J=5.9Hz,2H),2.52-2.49(m,2H),2.00(p,J=6.2Hz,2H).

[0388] Example 109: Synthesis of Compound B59

[0389] To a solution of B59-1 (3 g, 20.41 mmol) and compound B59-2 (6.8 g, 40.85 mmol) in tetrahydrofuran (50 mL) was added 60% sodium hydride (1.6 g, 40.82 mmol) at 0°C under a nitrogen atmosphere. The mixture was stirred at room temperature for 2 hours, quenched with water (50 mL), and extracted with ethyl acetate (3×50 mL). The resulting organic phase was washed with saturated aqueous sodium chloride (3×50 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 3:1) to obtain compound B59-3 (2.67 g, 37.27%) as a colorless oil. ESI / MS (m / z): 277.0 [M+H] + .

[0390] To a solution of compound B59-3 (2.5 g, 9.02 mmol) and compound B59-4 (5.7 g, 22.54 mmol) in 1,4-dioxane (60 mL) were added potassium acetate (2.7 g, 27.06 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (1.5 g, 1.80 mmol) at room temperature under a nitrogen atmosphere. The reaction mixture was stirred at 90°C overnight, cooled to room temperature, and filtered. The filter cake was washed with 1,4-dioxane (3 × 10 mL). The filtrate was concentrated under reduced pressure, and the residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B59-5 (1.6 g, 70.96%) as a brown solid. ESI / MS (m / z): 243.1 [M+H] + .

[0391] To a solution of compound B59-5 (496.4 mg, 2.05 mmol) and compound INT-C (300 mg, 0.82 mmol) in 1,4-dioxane (10 mL) and water (2 mL) was added cesium carbonate (534.4 mg, 1.64 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (98.00 mg, 0.12 mmol) at room temperature under a nitrogen atmosphere. The reaction mixture was stirred at 100°C overnight, cooled to room temperature, quenched with water (20 mL), and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated sodium chloride aqueous solution (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:2) to afford compound B59-6 (220 mg, 70.32%) as a brown oil. ESI / MS (m / z): 382.3 [M+H] + .

[0392] Trifluoroacetic acid (2 mL) was added dropwise to a solution of compound B59-6 (200 mg, 0.52 mmol) in dichloromethane (8 mL) at room temperature and stirred for 5 hours. The reaction solution was directly concentrated under reduced pressure, and the residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.05% trifluoroacetic acid); mobile phase B: acetonitrile) to obtain compound B59 (61.5 g, 32.13%) as a brown solid. ESI / MS (m / z): 252.1 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ14.70(s,2H),12.01(s,1H),9.18(d,J=1.3Hz,1H),7.88(d,J=1.3Hz,1H),7.58(dd,J=8.4,0.9Hz,1H), 7.42(dd,J=8.4,7.2Hz,1H), 7.17(dd,J=7.2,1.0Hz,1H), 2.62(t,J=5.9Hz,2H), 2.58-2.52(m,2H), 2.08-1.99(m,J=5.9Hz,2H).

[0393] Example 110: Synthesis of Compound B60

[0394] To a mixture of compound B60-1 (5 g, 8.775 mmol) and potassium carbonate (16.25 g, 117.550 mmol) in N,N-dimethylformamide (100 mL) was added 4-methoxybenzyl chloride (13.81 g, 88.162 mmol) in portions at room temperature. The reaction mixture was stirred at 80°C overnight. After cooling to room temperature, the mixture was quenched with water (30 mL) and extracted with dichloromethane (2 × 50 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride (50 mL), dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:3) to obtain compound B60-2 (4.1 g, 32.16%) as a white solid. ESI / MS (m / z): 206.2 [M+H] + .

[0395] To a solution of compound B60-2 (2 g, 9.677 mmol) and cuprous iodide (184.31 mg, 0.968 mmol) in tetrahydrofuran (100 mL) was added portionwise diiodomethane (2.85 g, 10.645 mmol) and isoamyl nitrite (5.67 g, 48.385 mmol) at room temperature. The reaction mixture was stirred at 70°C for 2 hours, cooled to room temperature, quenched with water (30 mL), and extracted with dichloromethane (2 × 100 mL). The resulting organic phase was washed with aqueous sodium thiosulfate (50 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to afford compound B60-3 (700 mg, 21.59%) as a yellow solid. ESI / MS (m / z): 316.9 [M+H] + .

[0396] To a solution of compound INT-C (1 g, 2.691 mmol) in 1,4-dioxane (40 mL) under a nitrogen atmosphere was added pinacol diboron (1.71 g, 6.727 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (438.35 mg, 0.538 mmol), and potassium acetate (792.17 mg, 8.073 mmol) at room temperature. The mixture was stirred at 90°C overnight, cooled to room temperature, and filtered through Celite. The filter cake was washed with dichloromethane (3 x 30 mL). The filtrate was concentrated in vacuo, and the residue was separated by normal phase silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to afford compound B60-4 (570 mg, 46.36%) as a yellow solid. ESI / MS (m / z): 412.2 [M+H] + .

[0397] To a solution of compound B60-3 (800 mg, 2.409 mmol) and compound B60-4 (1.6 g, 3.624 mmol) in 1,4-dioxane (10 mL) and water (3 mL) were added [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (196.27 mg, 0.241 mmol) and potassium carbonate (665.97 mg, 4.819 mmol) in portions at room temperature. The reaction mixture was stirred at 100°C for 2 hours, cooled to room temperature, quenched with water, and extracted with dichloromethane (3 x 30 mL). The resulting organic phase was washed with saturated sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to afford compound B60-5 (660 mg, 57.85%) as a yellow solid. ESI / MS(m / z):418.2[M+H-56] + .

[0398] A 4M solution of hydrogen chloride in 1,4-dioxane (1 mL) was added to compound B60-5 (50 mg, 0.106 mmol) at room temperature. The reaction mixture was stirred at 80°C for 30 minutes, cooled to room temperature, and adjusted to pH 8 with sodium hydroxide solution. The mixture was extracted with ethyl acetate (3×30 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B60-6 (31.6 mg, 77.66%) as a white solid. ESI / MS (m / z): 374.0 [M+H] + . 1H NMR(400MHz, DMSO-d6)δ11.94(s,1H),7.58(dd,J=8.0,1.3Hz,1H),7.47-7.45(m,2H),7.44-7.39(m,2H), 7.02-6.96(m,2H),5.95(s,2H),3.76(s,3H),2.60(t,J=6.0Hz,2H),2.53-2.51(m,2H),1.98-1.88(m,2H).

[0399] To a solution of compound B60-6 (130 mg, 0.338 mmol) in trifluoroacetic acid (5 mL) was added dropwise trifluoromethanesulfonic acid (0.5 mL) at room temperature, and the mixture was stirred for 30 minutes. The reaction solution was directly concentrated under reduced pressure, and the residue was purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B60 (34.8 mg, 40.36%) as a white solid. ESI / MS (m / z): 252.2 [MH] - . 1 H NMR (400MHz, DMSO-d6) δ12.04(s,1H),7.64(dd,J=8.3,1.0Hz,1H),7.46(dd,J=8.3,7.2Hz,1 H), 7.35 (dd, J=7.2, 1.0Hz, 1H), 2.70 (t, J=6.0Hz, 2H), 2.58-2.52 (m, 2H), 2.09-1.99 (m, 2H).

[0400] Example 111: Synthesis of Compound B61

[0401] To a solution of INT-C (120 mg, 0.329 mmol) and compound B61-1 (77.4 mg, 0.659 mmol) in N-methylpyrrolidone at room temperature under a nitrogen atmosphere were added 1,1-bis(diphenylphosphino)ferrocene (72.7 mg, 0.132 mmol), zinc powder (4.3 mg, 0.066 mmol), and tris(dibenzylideneacetone)dipalladium (60.5 mg, 0.066 mmol), respectively. The reaction mixture was stirred at 120°C overnight. After cooling to room temperature, the reaction mixture was quenched with water (6 mL) and extracted with ethyl acetate (3 × 15 mL). The combined organic phases were washed with saturated brine (3 × 10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B61 (45.6 mg, 65.93%) as a white solid. ESI / MS (m / z): 211.0 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ12.24(s,1H),7.74(d,J=8.4Hz,1H),7.63(d,J=7.2Hz,1H),7.4 4(t,J=7.8Hz,1H), 3.18(t,J=6.0Hz,2H), 2.62(t,J=6.4Hz,2H), 2.21(p,J=6.2Hz,2H).

[0402] Example 112: Synthesis of Compound B62

[0403] To a solution of compound INT-C (200 mg, 0.538 mmol) and compound B62-1 (226 mg, 1.076 mmol) in 1,4-dioxane (8 mL) and water (1.6 mL) was added cesium carbonate (351 mg, 1.076 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (66 mg, 0.081 mmol) under nitrogen. The reaction mixture was stirred at 100°C overnight. After cooling to room temperature, the mixture was quenched with water (30 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed with saturated sodium chloride solution (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 2:1) to obtain the intermediate compound. The intermediate was redissolved in a 4M solution of hydrogen chloride in 1,4-dioxane (8 mL, 263.302 mmol) and stirred at room temperature for 2 hours. The reaction solution was directly concentrated under reduced pressure, and the residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to obtain compound B62 (59.9 mg, 40.72%) as a white solid. ESI / MS (m / z): 268.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.66(s,1H),7.32(dd,J=8.3,1.1Hz,1H),7.24(dd,J=8.3,7.0Hz,1H),6.84(dd,J=7.1,1.1Hz,1H),5.72-5.70( m,1H),4.24(q,J=2.7Hz,2H),3.88(t,J=5.4Hz,2H),2.95(t,J=6.0Hz,2H),2.53(t,J=6.3Hz,2H),2.43-2.39(m,2H),2.15-2.05(m,2H).

[0404] Example 113: Synthesis of Compound B63

[0405] To a solution of compound INT-C (200 mg, 0.538 mmol) and sodium tert-butoxide (155 mg, 1.614 mmol) in 1,4-dioxane (5 mL) was added methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl)(2-amino-1,1'-biphenyl-2-yl)palladium(II) (90 mg, 0.108 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl (50 mg, 0.108 mmol), and compound B63-1 (141 mg, 1.614 mmol) at room temperature under a nitrogen atmosphere. The reaction mixture was stirred at 100°C for 3 hours, cooled to room temperature, quenched by the addition of water (50 mL), and extracted with ethyl acetate (3×30 mL). The organic phase was washed sequentially with saturated aqueous sodium chloride (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B63 (34.8 mg, 44.30%) as a pale yellow solid. ESI / MS (m / z): 271.3 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.65(s,1H),7.22(t,J=7.8Hz,1H),7.11(d,J=8.2Hz,1H),6.63(d,J=7.5Hz,1H), 3.86(t,J=4.4Hz,4H), 3.25(t,J=5.8Hz,2H), 3.08-2.98(m,4H), 2.58-2.56(m,2H), 2.16(p,J=5.8Hz,2H).

[0406] Example 114: Synthesis of Compound B64

[0407] To a solution of compound INT-C (200 mg, 0.538 mmol) and sodium tert-butoxide (155 mg, 1.614 mmol) in 1,4-dioxane (5 mL) was added methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl)(2-amino-1,1'-biphenyl-2-yl)palladium(II) (90 mg, 0.108 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl (50 mg, 0.108 mmol), and compound B64-1 (162 mg, 1.614 mmol) at room temperature under a nitrogen atmosphere. The reaction mixture was stirred at 100°C overnight, cooled to room temperature, quenched by the addition of water (60 mL), and extracted with ethyl acetate (3×40 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B64 (28.9 mg, 46.13%) as a yellow solid. ESI / MS (m / z): 284.1. [M+H] + . 1 H NMR(400MHz,DMSO-d6)δ11.56(s,1H),7.15(t,J=7.9Hz,1H),7.05-7.01(m,1H),6.56(d,J=7.4Hz,1H),3 .34(s,2H),3.20(t,J=5.9Hz,2H),2.98-2.95(m,4H),2.57-2.51(m,4H),2.26(s,3H),2.14-2.07(m,2H).

[0408] Example 115: Synthesis of Compound B65

[0409] To a solution of compound INT-C (200 mg, 0.538 mmol) and sodium tert-butoxide (155 mg, 1.614 mmol) in 1,4-dioxane (5 mL) was added methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl)(2-amino-1,1'-biphenyl-2-yl)palladium(II) (90 mg, 0.108 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl (50 mg, 0.108 mmol), and a 2M solution of dimethylamine in tetrahydrofuran (1.345 mL, 2.690 mmol) at room temperature under a nitrogen atmosphere. The reaction mixture was stirred at 100°C overnight, cooled to room temperature, quenched with water (70 mL), and extracted with ethyl acetate (3×50 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B65 (41.2 mg, 34.29%) as a pale yellow solid. ESI / MS (m / z): 229.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.53(s,1H),7.21-7.07(m,1H),6.99(d,J=7.5Hz,1H),6.53(d, J=7.2Hz,1H),3.20(t,J=5.9Hz,2H),2.76(s,6H),2.55-2.52(m,2H),2.10-2.07(m,2H).

[0410] Example 116: Synthesis of Compound B66

[0411] To a solution of compound INT-C (200 mg, 0.538 mmol) and sodium tert-butoxide (155 mg, 1.614 mmol) in 1,4-dioxane (5 mL) was added methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl)(2-amino-1,1'-biphenyl-2-yl)palladium(II) (90 mg, 0.108 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl (50 mg, 0.108 mmol), and compound B66-1 (115 mg, 1.614 mmol) at room temperature under a nitrogen atmosphere. The reaction mixture was stirred at 100°C for 3 hours, cooled to room temperature, quenched with water (60 mL), and extracted with ethyl acetate (3×35 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10% ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B66 (85.2 mg, 77.31%) as a pale yellow solid. ESI / MS (m / z): 255.2 [M+H] + . 1 H NMR (300MHz, DMSO-d6) δ11.52(s,1H),7.10(t,J=7.9Hz,1H),6.94(d,J=8.3,0.8Hz,1H),6.48(d,J=7.6,0.9H z,1H),3.19-3.17(m,2H),3.15-3.11(m,4H),2.56-2.51(m,2H),2.07(p,J=6.1Hz,2H),1.90(p,J=3.1Hz,4H).

[0412] Example 117: Synthesis of Compound B67

[0413] To a solution of compound B60-4 (564 mg, 1.234 mmol) and compound B67-1 (100 mg, 0.617 mmol) in 1,4-dioxane (8 mL) and water (1.6 mL) under nitrogen atmosphere were added cesium carbonate (402 mg, 1.234 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (75 mg, 0.093 mmol). The reaction mixture was stirred at 100°C overnight. After cooling to room temperature, the mixture was quenched with water (20 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B67 (62.7 mg, 37.99%) as a white solid. ESI / MS (m / z): 267.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.82(s,1H),8.00(s,1H),7.47(dd,J=8.4,1.0Hz,1H),7.35(dd,J=8.3,7.1Hz,1 H),7.15(dd,J=7.1,1.0Hz,1H),4.25(s,3H),2.75(t,J=6.0Hz,2H),2.58-2.51(m,2H),2.07-1.97(m,2H).

[0414] Example 118: Synthesis of Compound B68

[0415] To a solution of compound INT-C (500 mg, 1.373 mmol) and compound B68-1 (1.4 g, 13.73 mmol) in tetrahydrofuran (10 mL) under a nitrogen atmosphere were added triethylamine (3 mL), bistriphenylphosphine palladium dichloride (96.2 mg, 0.137 mmol), cuprous iodide (26.1 mg, 0.137 mmol), and triphenylphosphine (71.9 mg, 0.274 mmol), respectively. The reaction mixture was stirred at 70°C for 4 hours. After cooling to room temperature, the reaction mixture was quenched with water (30 mL) and extracted with ethyl acetate (3 × 30 mL). The combined organic phases were washed with saturated sodium chloride solution (3 × 10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to afford compound B68-2 (310 mg, 59.17%) as a light yellow solid. ESI / MS(m / z):326.1[M+H-56] + .

[0416] Potassium carbonate (72.5 mg, 0.524 mmol) was added to a solution of compound B68-2 (100 mg, 0.262 mmol) in methanol (6 mL) at room temperature. The reaction mixture was stirred at room temperature for 1 hour and then filtered. The filter cake was washed with methanol (3 × 5 mL), and the filtrate was concentrated under vacuum. The resulting residue was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 4:1) to obtain compound B68 (31.3 mg, 57.09%) as a white solid. ESI / MS (m / z): 210.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.84(s,1H),7.44(dd,J=8.2,1.1Hz,1H),7.27(t,J=7.7Hz,1H),7.21(dd, J=7.2,1.1Hz,1H),4.43(s,1H),3.25(t,J=6.1Hz,2H),2.56(t,J=6.1Hz,2H),2.16(p,J=6.1Hz,2H).

[0417] Example 119: Synthesis of Compound B69

[0418] To a solution of compound INT-D (200 mg, 0.860 mmol) and compound B69-1 (127 mg, 1.720 mmol) in N,N-dimethylformamide (5 mL) was added 2-(7-nitrobenzotriazole)-N,N,N,N-tetramethyluronium hexafluorophosphate (491 mg, 0.673 mmol) and N,N-diisopropylethylamine (334 mg, 2.580 mmol) at room temperature and stirred for 30 minutes. The reaction solution was quenched with water (15 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated sodium chloride solution (15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B69-2 (160 mg, 65.19%) as a white solid. ESI / MS (m / z): 286 [M+H] + .

[0419] A solution of compound B69-2 (140 mg, 0.491 mmol) in toluene (6 mL) was stirred at 120°C overnight, cooled to room temperature, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B69 (8.8 mg, 6.68%) as a white solid. ESI / MS (m / z): 268.1 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ12.17(s,1H),7.74(dd,J=4.8,1.0Hz,1H),7.73-7.71(m,1H),7.48(dd ,J=8.2,7.4Hz,1H),3.07(t,J=6.0Hz,2H),2.65-2.55(m,2H),2.47(s,3H),2.16-2.06(m,2H).

[0420] Example 120: Synthesis of Compound B70

[0421] To a solution of compound B60-4 (549 mg, 1.228 mmol) and compound B70-1 (100 mg, 0.614 mmol) in 1,4-dioxane (8 mL) and water (1.6 mL) under nitrogen was added cesium carbonate (400 mg, 1.228 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (75 mg, 0.093 mmol). The mixture was stirred at 100°C overnight. After cooling to room temperature, the mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated sodium chloride solution (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B70 (5.3 mg, 3.09%) as a light yellow solid. ESI / MS (m / z): 268.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.08(s,1H),7.67(dd,J=8.3,1.0Hz,1H),7.58(dd,J=7.3,1.0Hz ,1H),7.45(dd,J=8.3,7.3Hz,1H),3.07(t,J=6.0Hz,2H),2.63(s,3H),2.60-2.54(m,2H), 2.17-2.04(m,2H).

[0422] Example 121: Synthesis of Compound B71

[0423] To a solution of compound B60-4 (499 mg, 1.118 mmol) and compound B71-1 (100 mg, 0.559 mmol) in 1,4-dioxane (8 mL) and water (1.6 mL) under nitrogen was added cesium carbonate (364 mg, 1.118 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (68 mg, 0.084 mmol). The mixture was stirred at 100°C overnight. After cooling to room temperature, the reaction mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed sequentially with saturated sodium chloride solution (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B71 (76.2 mg, 45.79%) as a light yellow solid. ESI / MS (m / z): 284.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.09 (s, 1H), 7.65 (dd, J = 7.2, 2.1Hz, 1H), 7.45-7.41 (m, 1H), 7.4 1-7.38(m,1H),2.86(t,J=6.0Hz,2H),2.71(s,3H),2.59-2.53(m,2H),2.11-2.01(m,2H).

[0424] Example 122: Synthesis of Compound B72

[0425] To a solution of compound INT-B (200 mg, 0.464 mmol) and sodium tert-butoxide (134 mg, 1.392 mmol) in toluene (6 mL) under a nitrogen atmosphere were added tris(dibenzylideneacetone)dipalladium (85.1 mg, 0.093 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (54 mg, 0.093 mmol), and compound B72-1 (121.3 mg, 1.392 mmol) at room temperature. The mixture was stirred at 110°C for 2 hours. After cooling to room temperature, the mixture was quenched with water (60 mL) and extracted with ethyl acetate (3 × 60 mL). The combined organic phases were washed sequentially with saturated sodium chloride aqueous solution (50 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 4:1) to afford compound B72-2 (160 mg, 45.55%) as a light yellow solid. ESI / MS(m / z):391.1.[M+H] + .

[0426] Trifluoromethanesulfonic acid (0.3 mL) was added to a solution of compound B72-2 (140 mg, 0.185 mmol) in trifluoroacetic acid (3 mL) at room temperature and stirred for 10 minutes. After completion of the reaction, the mixture was concentrated under reduced pressure. The residue was purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B72 (42.5 mg, 84.81%) as a pale yellow solid. ESI / MS (m / z): 271.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.82(s,1H),7.39(d,J=8.5Hz,1H),7.32(t,J=7.8Hz,1H),7.07(d,J=7.2Hz,1H), 4.54(t,J=7.8Hz,2H), 4.05(t,J=7.9Hz,2H), 3.00(t,J=6.0Hz,2H), 2.58-2.53(m,2H), 2.18-2.09(m,2H).

[0427] Example 123: Synthesis of Compound B73

[0428] To a solution of compound INT-B (200 mg, 0.520 mmol) and compound B73-1 (122 mg, 1.560 mmol) in ethanol (8 mL) under a nitrogen atmosphere were added tricyclohexylphosphine fluoroborate (38 mg, 0.104 mmol) and tricyclohexylphosphine-(2'-amino-1,1'-biphenyl-2-yl)palladium(II) methanesulfonic acid (68 mg, 0.104 mmol), and the mixture was stirred at 100°C overnight. The reaction mixture was cooled to room temperature and filtered, and the filter cake was washed with ethanol (5 mL). The combined filtrate was concentrated under reduced pressure, and the residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B73-2 (100 mg, 48.86%) as a white solid. ESI / MS (m / z): 382.1 [M+H] + .

[0429] To a solution of compound B73-2 (80 mg, 0.203 mmol) in trifluoroacetic acid (2 mL) was added trifluoromethanesulfonic acid (200 μL) at room temperature and stirred for 10 minutes. The reaction solution was directly concentrated under reduced pressure, and the residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to obtain compound B73 (22.4 mg, 41.93%) as a white solid. ESI / MS (m / z): 262.2 [M+H] + . 1H NMR(400MHz,DMSO-d6)δ12.02(s,1H),7.66-7.61(m,1H),7.41-7.37(m,1H),7.37-7.34(m ,1H),3.45-3.39(m,2H),2.61-2.55(m,2H),2.17-2.08(m,2H),1.80(s,3H),1.77(s,3H).

[0430] Example 124: Synthesis of Compound B74

[0431] To a solution of compound B74-1 (1.4 g, 8.177 mmol) in water (32 mL) and concentrated hydrochloric acid (2.3 mL) was slowly added a solution of sodium nitrite (0.85 g, 12.265 mmol) in water (8 mL) at 0°C. A solution of compound B01-2 (1.27 g, 9.812 mmol) in methanol (32 mL) and a solution of sodium acetate (1.48 g, 17.989 mmol) in water (32 mL) were slowly added dropwise at 0°C. The mixture was stirred at room temperature for 1 hour, filtered, and the filter cake was washed with water (30 mL). After drying, a brown solid compound B74-2 (1.5 g, 54.44%) was obtained. ESI / MS (m / z): 281.1 [M+H] + .

[0432] To a solution of compound B74-2 (1.5 g, 4.446 mmol) in methanol (100 mL) was added concentrated hydrochloric acid (5 mL) at room temperature and stirred at 60°C for 2 hours. The mixture was cooled to room temperature and adjusted to pH 7 with saturated potassium hydroxide solution. The mixture was extracted with ethyl acetate (3 × 100 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B74 (52.4 mg, 4.43%) as a white solid. ESI / MS (m / z): 264.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.38(s,1H),7.80(dd,J=8.3,1.0Hz,1H),7.74(dd,J=7.4,1.0Hz,1H) ,7.49(t,J=7.9Hz,1H),3.31(s,3H),3.30-3.26(m,2H),2.64-2.57(m,2H),2.24-2.13(m,2H).

[0433] Example 125: Synthesis of Compound B75

[0434] Under nitrogen atmosphere, to a solution of compound INT-B (300 mg, 0.696 mmol) and compound B75-1 (167 mg, 0.696 mmol) in isopropanol (10 mL) were added dichlorodi-tert-butyl-(4-dimethylaminophenyl)phosphine palladium (II) (98.6 mg, 0.139 mmol) and compound B75-2 (408 mg, 2.088 mmol), and the mixture was stirred at 110°C for 2 hours. The reaction solution was cooled to room temperature and concentrated under reduced pressure. The resulting residue was separated and purified by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to give compound B75-3 (105 mg, 38.32%) as a light yellow solid. ESI / MS (m / z): 370.1 [M+H] + .

[0435] To a solution of compound B75-3 (85 mg, 0.216 mmol) in isopropanol (3 mL) was added sodium acetate (89 mg, 1.080 mmol) in water (6 mL) and compound B75-4 (122 mg, 1.080 mmol), and the mixture was stirred at room temperature overnight. The reaction solution was extracted with ethyl acetate (3 × 5 mL), and the organic phase was washed with saturated sodium chloride aqueous solution (5 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to obtain compound B75-5 (56 mg, 59.40%) as a white solid. ESI / MS (m / z): 385.1. [M+H] + .

[0436] To a solution of compound B75-5 (50 mg, 0.115 mmol) in trifluoroacetic acid (3 mL) was added trifluoromethanesulfonic acid (0.3 mL), and the mixture was stirred at room temperature for 10 minutes. The reaction solution was concentrated under reduced pressure, and the residue was purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to afford compound B75 (17.6 mg, 57.59%) as a white solid. ESI / MS (m / z): 265.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.15(s,1H),7.65(d,J=8.3Hz,1H),7.62(d,J=7.3Hz,1H),7.54( s,2H),7.41(t,J=7.8Hz,1H),3.26(t,J=6.0Hz,2H),2.63-2.54(m,2H),2.19-2.08(m,2H).

[0437] Example 126: Synthesis of Compound B76

[0438] To a solution of compound B76-1 (1.8 g, 8.988 mmol) in water (36 mL) and concentrated hydrochloric acid (0.3 mL) was slowly added a solution of sodium nitrite (0.93 g, 13.482 mmol) in water (9 mL) at 0°C. A solution of compound B01-2 (1.40 g, 10.786 mmol) in methanol (36 mL) and an aqueous solution of sodium acetate (1.62 g, 19.774 mmol) in water (36 mL) were slowly added to the above solution at 0°C. The reaction solution was stirred at room temperature for 1 hour and filtered. The filter cake was washed with water (30 mL) and dried to obtain compound B76-2 (1.9 g, 59.31%) as a brown solid. ESI / MS (m / z): 310.0 [M+H] + .

[0439] To a solution of compound B76-2 (1.55 g, 4.349 mmol) in methanol (100 mL) was added concentrated hydrochloric acid (5 mL) at room temperature and stirred at 60°C for 2 hours. After cooling to room temperature, the reaction solution was adjusted to pH 7 with saturated potassium hydroxide solution and extracted with ethyl acetate (3 × 100 mL). The organic phase was washed sequentially with saturated sodium chloride aqueous solution (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to obtain compound B76 (76 mg, 5.95%) as a white solid. ESI / MS (m / z): 293.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.27(s,1H),7.74(dd,J=8.2,1.0Hz,1H),7.53(dd,J=7.4,1.0Hz,1H),7.4 4(dd,J=8.3,7.4Hz,1H),3.22(t,J=6.0Hz,2H),2.83(s,6H),2.63-2.55(m,2H),2.17-2.14(m,2H).

[0440] Example 127: Synthesis of Compound B77

[0441] To a solution of compound INT-C (1 g, 2.581 mmol) and sodium tert-butoxide (744.1 mg, 7.743 mmol) in 1,4-dioxane (15 mL) under a nitrogen atmosphere were added methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl)(2-amino-1,1'-biphenyl-2-yl)palladium(II) (0.43 g, 0.516 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl (240.86 mg, 0.516 mmol), and compound B77-1 (1.40 g, 7.743 mmol). The reaction mixture was stirred at 100°C for 3 hours, cooled to room temperature, and quenched with water (200 mL). 5M hydrochloric acid (15 mL) was added to the mixture, stirred for 2 hours, and extracted with ethyl acetate (3 x 100 mL). The remaining aqueous phase was neutralized with saturated aqueous sodium bicarbonate to pH 8 and extracted with ethyl acetate (3 x 150 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B77-2 (340 mg, 62.90%) as a yellow solid. ESI / MS (m / z): 201.0. [M+H] + .

[0442] Compound B77-3 (246.08 mg, 2.148 mmol) was added to a solution of compound B77-2 (150 mg, 0.716 mmol) and pyridine (113.29 mg, 1.432 mmol) in dichloromethane (5 mL) at room temperature. The reaction solution was stirred at room temperature overnight, quenched with water (15 mL), and extracted with ethyl acetate (3×15 mL). The organic phase was washed sequentially with saturated aqueous sodium chloride solution (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to obtain compound B77 (28.1 mg, 14.00%) as a white solid. ESI / MS (m / z): 279.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.69(s,1H),9.29(s,1H),7.31(dd,J=8.3,1.1Hz,1H),7.26(dd,J=8.3,7.2Hz,1 H), 6.97 (dd, J = 7.2, 1.1 Hz, 1H), 3.22 (t, J = 6.0 Hz, 2H), 3.03 (s, 3H), 2.56-2.52 (m, 2H), 2.16-2.08 (m, 2H).

[0443] Example 128: Synthesis of Compound B78

[0444] To a solution of compound B77-2 (200 mg, 0.955 mmol) and pyridine (151.06 mg, 1.910 mmol) in dichloromethane (10 mL) was added acetic anhydride (107.23 mg, 1.050 mmol) and stirred at room temperature overnight. The reaction solution was quenched with water (20 mL) and extracted with ethyl acetate (3×15 mL). The organic phase was washed sequentially with saturated aqueous sodium chloride solution (15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to obtain compound B78 (42.1 mg, 18.16%) as a white solid. ESI / MS (m / z): 243.2 [M+H] + . 1 H NMR(400MHz,DMSO-d6)δ11.63(s,1H),9.61(s,1H),7.23(s,1H),7.22(s,1H),6.95(t,J =4.2Hz,1H),3.08(t,J=6.0Hz,2H),2.56-2.51(m,2H),2.13-2.10(m,2H),2.09(s,3H).

[0445] Example 129: Synthesis of Compound B79

[0446] To a solution of compound INT-B (500 mg, 1.161 mmol) and copper acetate (422 mg, 2.322 mmol) in dimethyl sulfoxide (5 mL) under a nitrogen atmosphere was added cuprous iodide (55 mg, 0.290 mmol) and stirred at 135°C for 3 hours. After cooling to room temperature, the reaction solution was quenched with water (20 mL) and extracted with ethyl acetate (3 × 50 mL). The combined organic phases were washed sequentially with saturated sodium chloride aqueous solution (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to obtain B79-1 (115 mg, 28.19%) as a yellow solid. ESI / MS (m / z): 352.1 [M+H] + .

[0447] Iodophenyldiacetic acid (165 mg, 0.512 mmol) was added to a solution of compound B79-1 (100 mg, 0.256 mmol) and compound B79-2 (80 mg, 1.024 mmol) in methanol (5 mL), and the mixture was stirred at room temperature for 1 hour. The reaction solution was directly concentrated under reduced pressure, and the residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to obtain compound B79-3 (60 mg, 61.26%) as a gray solid. ESI / MS (m / z): 383.0 [M+H] + .

[0448] To a solution of compound B79-3 (50 mg, 0.131 mmol) in trifluoroacetic acid (1 mL) was added trifluoromethanesulfonic acid (100 μL), and the mixture was stirred at room temperature for 10 minutes. The reaction solution was directly concentrated under reduced pressure, and the residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to obtain compound B79 (24.9 mg, 72.25%) as a white solid. ESI / MS (m / z): 263.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ9.92(br,1H),7.77(d,J=7.4Hz,1H),7.72(d,J=8.2Hz,1H),7.45(t,J= 7.8Hz,1H),4.40(s,1H),3.51-3.38(m,2H),3.18(s,3H),2.63-2.55(m,2H),2.21-2.09(m,2H).

[0449] Example 130: Synthesis of Compound B80

[0450] To a solution of compound INT-C (200 mg, 0.516 mmol) and sodium tert-butoxide (148.81 mg, 1.548 mmol) in 1,4-dioxane (5 mL) was added methanesulfonic acid (2-dicyclohexylphosphino-2',6'-diisopropoxy-1,1'-biphenyl)(2-amino-1,1'-biphenyl-2-yl)palladium(II) (86.34 mg, 0.103 mmol), 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl (48.17 mg, 0.103 mmol), and compound B80-1 (144.22 mg, 1.548 mmol) at room temperature under a nitrogen atmosphere. The reaction mixture was stirred at 100°C overnight, cooled to room temperature, and quenched with water (60 mL). The mixture was extracted with ethyl acetate (3 x 60 mL), and the organic phase was washed sequentially with saturated aqueous sodium chloride (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to afford compound B80 (40.2 mg, 28.04%) as a yellow solid. ESI / MS (m / z): 277.2. [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.30(s,1H),7.05(dd,J=8.2,7.5Hz,1H),6.87(dd,J=8.2,0.8Hz,1H),6.6 0(dd,J=7.5,0.8Hz,1H),3.26(s,6H),3.19(t,J=6.0Hz,2H),2.49-2.45(m,2H),2.12-2.07(m,2H).

[0451] Example 131: Synthesis of Compound B81

[0452] Compound B81-1 (93.93 mg, 0.745 mmol) was added to a solution of compound B77-2 (130 mg, 0.621 mmol) and pyridine (98.19 mg, 1.242 mmol) in dichloromethane (4 mL) and stirred at room temperature overnight. The reaction solution was quenched with water (10 mL) and extracted with ethyl acetate (3×10 mL). The organic phase was washed with saturated sodium chloride aqueous solution (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by reverse phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate); mobile phase B: acetonitrile) to obtain compound B81 (26.2 mg, 16.45%) as a white solid. ESI / MS (m / z): 255.2 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ11.66(br,1H),9.86(s,1H),7.27-7.26(m,1H),7.25(d,J=1.7Hz,1H),7.04-7.00(m,1H),6.52(dd,J=17.1,1 0.2Hz, 1H), 6.27 (dd, J = 17.1, 2.0Hz, 1H), 5.78 (dd, J = 10.2, 2.1Hz, 1H), 3.04 (t, J = 6.0Hz, 2H), 2.55-2.51 (m, 2H), 2.13-2.05 (m, 2H).

[0453] Example 132: Synthesis of Compound B82

[0454] To a solution of compound INT-C (200 mg, 0.516 mmol) and potassium carbonate (214.00 mg, 1.548 mmol) in 1,4-dioxane (6 mL) under a nitrogen atmosphere were added tris(dibenzylideneacetone)dipalladium (94.53 mg, 0.103 mmol), 1,3-bis(diphenylphosphine)propane (42.58 mg, 0.103 mmol), and compound B82-1 (155.09 mg, 1.548 mmol). The mixture was stirred at 110°C for 3 hours. After cooling to room temperature, the mixture was quenched with water (70 mL) and extracted with ethyl acetate (3 x 50 mL). The combined organic phases were washed sequentially with saturated sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was isolated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 3:1) to afford compound B82-2 (86 mg, 49.62%) as a yellow solid. ESI / MS(m / z):328.1.[M+H] + .

[0455] To a solution of compound B82-2 (66 mg, 0.197 mmol) in 1,4-dioxane (3 mL) was added a 4 M solution of hydrogen chloride in 1,4-dioxane (1 mL) at room temperature and stirred for 1 hour. The reaction solution was directly concentrated under reduced pressure, and the residue was separated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to obtain compound B82 (11.2 mg, 24.95%) as a pale yellow solid. ESI / MS (m / z): 228.2 [M+H] + . 1H NMR(300MHz,DMSO-d6)δ11.96(s,1H),7.66-7.64(m,1H),7.63-7.61(m,1H),7.38(dd,J=8 .4,7.2Hz,1H),2.97(t,J=6.0Hz,2H),2.66(s,3H),2.59-2.53(m,2H),2.12-2.03(m,2H).

[0456] Example 133: Synthesis of Compound B83 and Compound B84

[0457] To a solution of compound B83-1 (0.5 g, 2.76 mmol) in water (20 mL) at 0°C were added concentrated hydrochloric acid (1.25 mL) and an aqueous solution (5 mL) of sodium nitrite (0.41 g, 5.92 mmol) and stirred for 10 minutes. To a solution of compound B01-2 (0.45 g, 3.55 mmol) in methanol (10 mL) was added an aqueous solution (5 mL) of sodium acetate (0.53 g, 6.5 mmol). The mixture was cooled to 0°C and the diazonium salt reaction solution prepared above was added dropwise to the reaction system. The mixture was stirred at 0°C for 30 minutes. A solid precipitated, which was filtered, and the filter cake was washed with water and dried to yield compound B83-2 (0.55 g, 66.8%) as an orange solid.

[0458] To a solution of compound B83-2 (0.55 g, 2.0 mmol) in acetonitrile (6 mL) was added 1.8 M sulfuric acid (3 mL), and the mixture was stirred at 80°C for 3 hours. The reaction solution was cooled to room temperature and diluted with ethyl acetate (30 mL). The organic phase was washed sequentially with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to obtain compound B83 (60 mg, 11.5%) and compound B84 (38 mg, 7.3%) as a white solid.

[0459] Compound B83: ESI / MS (m / z) 262.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ12.10(s,1H),7.41(dd,J=9.9,2.4Hz,1H),7.38(dd,J=9.1,2 .4Hz,1H),3.92(s,3H),3.05(t,J=6.0Hz,2H),2.58-2.56(m,2H),2.13-2.08(m,2H).

[0460] Compound B84: ESI / MS (m / z) 262.0 [M+H] + .1 H NMR (500MHz, DMSO-d6) δ12.34(s,1H),7.88(d,J=0.8Hz,1H),7.28(dd,J=11.4,0.7 Hz, 1H), 3.88 (s, 3H), 3.08 (t, J = 6.0Hz, 2H), 2.62-2.60 (m, 2H), 2.21-2.16 (m, 2H).

[0461] Example 134: Synthesis of Compound B85 and Compound B86

[0462] To a solution of compound B85-1 (0.5 g, 2.96 mmol) in water (20 mL) at 0°C were added concentrated hydrochloric acid (1.25 mL) and an aqueous solution (5 mL) of sodium nitrite (0.41 g, 5.92 mmol) and stirred for 10 minutes. To a solution of compound B01-2 (0.45 g, 3.6 mmol) in methanol (10 mL) was added an aqueous solution (5 mL) of sodium acetate (0.53 g, 6.5 mmol). The system was cooled to 0°C, and the diazonium salt reaction solution prepared above was added dropwise to the reaction system. The mixture was stirred for 30 minutes. A solid precipitated, which was filtered, and the filter cake was washed with water and dried to yield crude compound B85-2 (0.38 g, 46.1%) as an orange solid.

[0463] To a solution of compound B85-2 (0.38 g, 1.36 mmol) in methanol (6 mL) was added concentrated hydrochloric acid (0.2 mL) and stirred at 60°C for 1 hour. After cooling to room temperature, the reaction solution was extracted with ethyl acetate (30 mL). The resulting organic phase was washed sequentially with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The resulting crude product was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to obtain a mixture. The mixture was separated by reverse phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to obtain compound B85 (21.9 mg, 73.22%) and compound B86 (8.5 mg, 28.77%) as a pale yellow solid.

[0464] B85:ESI / MS(m / z):262.2[M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.06(s,1H),7.58(dd,J=9.1,4.4Hz,1H),7.27(dd,J=10.4,9. 0Hz, 1H), 3.94 (s, 3H), 2.81 (t, J = 6.0Hz, 2H), 2.62-2.54 (m, 2H), 2.12 (p, J = 6.3Hz, 2H).

[0465] B86:ESI / MS(m / z):262.2[M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.95(s,1H),7.95(d,J=6.0Hz,1H),7.61(d,J=11.7Hz ,1H),3.87(s,3H),2.94(t,J=6.0Hz,2H),2.64-2.57(m,2H),2.20-2.13(m,2H).

[0466] Example 135: Synthesis of Compound B87 and Compound B88

[0467] To a solution of compound B87-1 (0.5 g, 3.0 mmol) in water (20 mL) at 0°C were added concentrated hydrochloric acid (1.25 mL) and an aqueous solution of sodium nitrite (0.41 g, 6.0 mmol) (5 mL) in sequence, and the mixture was stirred for 10 minutes. To a solution of compound B01-2 (0.45 g, 3.6 mmol) in methanol (10 mL) was added an aqueous solution of sodium acetate (0.54 g, 6.6 mmol) (5 mL). The reaction mixture was cooled to 0°C, and the diazonium salt solution prepared above was added dropwise to the reaction system. Stirring was continued for 30 minutes. A solid precipitated, which was filtered, and the filter cake was washed with water and dried to yield crude compound B87-2 (0.61 g, 74.2%) as a red solid.

[0468] To a solution of compound B87-2 (0.61 g, 2.2 mmol) in methanol (6 mL) was added concentrated hydrochloric acid (0.2 mL) and the mixture was allowed to react at 60°C for 1 hour. After cooling the reaction mixture to room temperature, ethyl acetate (30 mL) was added, the mixture was washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to afford a brown solid mixture. The mixture was separated by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to afford compound B87 (25.2 mg, 72.86%) and compound B88 (12.4 mg, 35.71%) as a pale yellow solid.

[0469] Compound B87: ESI / MS (m / z): 258.2 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ11.79(s,1H),7.42(d,J=8.5Hz,1H),7.20(d,J=8.5Hz,1H),3 .92(s,3H),2.75(t,J=6.0Hz,2H),2.59-2.51(m,2H),2.34(s,3H),2.15-2.06(m,2H).

[0470] Compound B88: ESI / MS (m / z): 258.2 [M+H] + . 1 H NMR(400MHz,DMSO-d6)δ11.79(s,1H),7.95(s,1H),7.58(s,1H),3.84(s,3H ), 2.94 (t, J = 6.0 Hz, 2H), 2.62-2.58 (m, 2H), 2.57 (s, 3H), 2.21-2.12 (m, 2H).

[0471] Example 136: Synthesis of Compound B89 and Compound B90

[0472] To a solution of compound B89-1 (0.5 g, 2.69 mmol) in water (20 mL) at 0°C were added concentrated hydrochloric acid (1.1 mL) and an aqueous solution (5 mL) of sodium nitrite (0.37 g, 5.4 mmol) and stirred for 10 minutes. To a solution of compound B01-2 (0.41 g, 3.2 mmol) in methanol (10 mL) was added an aqueous solution (5 mL) of sodium acetate (0.48 g, 5.9 mmol). The system was cooled to 0°C, and the diazonium salt reaction solution prepared above was added dropwise to the reaction system. Stirring was continued for 30 minutes. A solid precipitated, which was filtered, and the filter cake was washed with water and dried to yield crude brown solid B89-2 (0.56 g, 70.6%).

[0473] To a solution of compound B89-2 (0.56 g, 1.9 mmol) in methanol (6 mL) was added concentrated hydrochloric acid (0.2 mL) and stirred at 60°C for 1 hour. After cooling the reaction solution to room temperature, ethyl acetate (30 mL) was added for dilution. The organic phase was washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 10:1) to afford a brown solid mixture. The mixture was separated by reverse-phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to afford compound B89 (22.4 mg, 53.57%) and compound B90 (12.3 mg, 29.38%) as a pale yellow solid.

[0474] Compound B89 (22.4 mg, 53.57%). ESI / MS (m / z): 278.1 [M+H] + . 1 H NMR(400MHz, DMSO-d6) δ11.97(s,1H),7.53(d,J=8.9Hz,1H),7.39(d,J=8.8Hz,1H),3.96(s,3H),2.74(t,J=6.0Hz,2H),2.63-2.53(m,2H),2.13(p,J=6.2Hz,2H).

[0475] Compound B90 (12.3 mg, 29.38%). ESI / MS (m / z): 278.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.08(s,1H),7.91(s,1H),7.87(s,1H),3.87(s,3H),2.96(t,J=6.0Hz,2H),2.66-2.55(m,2H),2.23-2.12(m,2H).

[0476] Example 137: Synthesis of Compound B91 and Compound B92

[0477] To a solution of compound B91-1 (0.5 g, 2.76 mmol) in water (20 mL) at 0°C were added concentrated hydrochloric acid (1.25 mL) and an aqueous solution of sodium nitrite (0.38 g, 5.5 mmol) (5 mL) in sequence, and the mixture was stirred for 10 minutes. To a solution of compound B01-2 (0.42 g, 3.31 mmol) in methanol (15 mL) was added an aqueous solution of sodium acetate (0.53 g, 6.1 mmol) (10 mL). The temperature was lowered to 0°C, and the diazonium salt reaction solution prepared above was added dropwise to the reaction system. Stirring was continued for 30 minutes. A solid precipitated, which was filtered, and the filter cake was washed with water and dried to yield compound B91-2 (0.45 g, 56.1%) as a reddish-brown solid.

[0478] To a solution of compound B91-2 (0.45 g, 1.55 mmol) in acetonitrile (5 mL) was added 1.8 M sulfuric acid (2 mL), and the mixture was stirred at 80° C. for 3 hours. After the reaction solution was cooled to room temperature, ethyl acetate (30 mL) was added for dilution. The organic phase was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated and purified by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to obtain compound B91 (60 mg, 14.2%) and compound B92 (50 mg, 11.8%) as a pale yellow solid.

[0479] Compound B91: 1 H NMR(500MHz,DMSO-d6)δ11.73(s,1H),7.49(d,J=9.1Hz,1H),7.24(d,J=9.1Hz,1H),3 .97(s,3H),3.81(s,3H),2.72(t,J=6.0Hz,2H),2.58-2.54(m,2H),2.13-2.08(m,2H). ESI / MS(m / z)274.0[M+H] + .

[0480] Compound B92: 1 H NMR(500MHz,DMSO-d6)δ11.70(s,1H),7.71(s,1H),7.28(s,1H),3.84(s,3H ), 3.81 (s, 3H), 2.95 (t, J = 6.0Hz, 2H), 2.60-2.57 (m, 2H), 2.19-2.14 (m, 2H). ESI / MS(m / z)274.0[M+H] + .

[0481] Example 138: Synthesis of Compound B93

[0482] To a solution of compound B93-1 (1.0 g, 4.35 mmol) in water (20 mL) at 0°C were added concentrated hydrochloric acid (1.8 mL) and an aqueous solution (5 mL) of sodium nitrite (0.6 g, 8.70 mmol) and stirred for 10 minutes. To a solution of compound B01-2 (0.66 g, 5.22 mmol) in methanol (10 mL) was added an aqueous solution (10 mL) of sodium acetate (0.78 g, 9.57 mmol). The reaction mixture was cooled to 0°C and the diazonium salt solution prepared above was added dropwise to the reaction system. Stirring was continued in an ice bath for 30 minutes. A solid precipitated, which was filtered, and the filter cake was washed with water and dried to yield crude compound B93-2 (0.91 g, 61.7%) as an orange solid.

[0483] To a solution of compound B93-2 (0.91 g, 2.68 mmol) in acetonitrile (30 mL) was added 1.8 M sulfuric acid (15 mL), and the mixture was stirred at 80°C for 3 hours. After the reaction solution was cooled to room temperature, ethyl acetate (50 mL) was added for dilution. The organic phase was washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to obtain compound B93 (0.47 g, 54.4%) as an orange-red solid. ESI / MS m / z 322.0 & 323.8 [M+H] + . 1H NMR(500MHz,DMSO-d6)δ12.05(s,1H),7.65(d,J=7.9Hz,1H),7.50(d,J=7.9Hz, 1H), 3.91 (s, 3H), 3.06 (t, J = 6.0Hz, 2H), 2.63-2.59 (m, 2H), 2.15-2.08 (m, 2H).

[0484] Example 139: Synthesis of Compound B94

[0485] To a solution of compound B94-1 (5 g, 8.775 mmol) and potassium carbonate (16.25 g, 117.550 mmol) in N,N-dimethylformamide (100 mL) was added 4-methoxybenzyl chloride (13.81 g, 88.162 mmol) in portions at room temperature. The reaction mixture was stirred at 80°C overnight, cooled to room temperature, quenched with water (30 mL), and extracted with dichloromethane (2 × 50 mL). The combined organic phases were washed with saturated aqueous sodium chloride solution (50 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:3) to obtain compound B94-2 (4.1 g, 32.16%) as a white solid. ESI / MS (m / z): 206.2 [M+H] + .

[0486] To a solution of compound B94-2 (2 g, 9.677 mmol) and cuprous iodide (184.31 mg, 0.968 mmol) in tetrahydrofuran (100 mL) was added diiodomethane (2.85 g, 10.645 mmol) and isoamyl nitrite (5.67 g, 48.385 mmol) in portions at room temperature. The reaction mixture was stirred at 70°C for 2 hours, cooled to room temperature, quenched with water (30 mL), and extracted with dichloromethane (2 × 100 mL). The combined organic phases were washed with sodium thiosulfate solution (50 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to obtain compound B94-3 (700 mg, 21.59%) as a yellow solid. ESI / MS (m / z): 316.9 [M+H] + .

[0487] To a solution of compound B94-3 (800 mg, 2.409 mmol) and compound B60-4 (1.62 g, 3.624 mmol) in 1,4-dioxane (10 mL) and water (3 mL) were added [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (196.27 mg, 0.241 mmol) and potassium carbonate (665.97 mg, 4.819 mmol) in portions at room temperature. The reaction mixture was stirred at 100°C for 2 hours, cooled to room temperature, and quenched with water. The mixture was extracted with dichloromethane (3 × 30 mL), and the combined organic phases were washed with saturated sodium chloride solution (30 mL). The organic phases were dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was isolated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B94-4 (660 mg, 57.85%) as a yellow solid. ESI / MS(m / z):418.2[M+H-56] + .

[0488] A 4M solution of hydrogen chloride in 1,4-dioxane (1 mL) was added to compound B94-4 (50 mg, 0.106 mmol) at room temperature. The reaction mixture was stirred at 80°C for 30 minutes, cooled to room temperature, and basified with sodium hydroxide solution to pH 8. The mixture was extracted with ethyl acetate (3 × 30 mL), and the combined organic phases were washed sequentially with saturated aqueous sodium chloride (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B94 (31.6 mg, 77.66%) as a white solid. ESI / MS (m / z): 374.0 [M+H] + . 1 H NMR(400MHz, DMSO-d6)δ11.94(s,1H),7.58(dd,J=8.0,1.3Hz,1H),7.47-7.45(m,2H),7.44-7.39(m,2H), 7.02-6.96(m,2H),5.95(s,2H),3.76(s,3H),2.60(t,J=6.0Hz,2H),2.53-2.51(m,2H),1.98-1.88(m,2H).

[0489] Example 140: Synthesis of Compound E63

[0490] A toluene solution (5 mL) of compound INT-A (498.1 mg, 2.500 mmol) and (R)-(-)-2-amino-1-butanol (668.6 mg, 7.500 mmol) was stirred at 130°C for 4 hours. The reaction mixture was cooled to room temperature and concentrated in vacuo to remove the solvent. The mixture was dissolved in a small amount of ethanol and added to a large amount of water. The precipitated solid was filtered and dried in vacuo to yield compound E63 (277.3 mg, 41.02%) as a pale yellow solid. ESI / MS (m / z) 271.0 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ10.70(s,1H),7.28(s,1H),7.27(d,J=6.1Hz,1H),6.95(d d,J=8.5,1.1Hz,1H),4.49(s,1H),3.67-3.59(m,1H),3.54-3.47(m,1H),3.42-3.3 7(m,1H),2.76(t,J=6.0Hz,2H),2.70-2.61(m,1H),2.59-2.51(m,1H),2.36(s,3H ), 2.01-1.91 (m, 2H), 1.72-1.61 (m, 1H), 1.47-1.36 (m, 1H), 0.82 (t, J = 7.4Hz, 3H).

[0491] Example 141: Synthesis of Compound E64

[0492] A toluene solution (5 mL) of compound INT-A (498.1 mg, 2.500 mmol) and (S)-(+)-2-amino-1-butanol (668.6 mg, 7.500 mmol) was stirred at 130°C for 4 hours. The reaction mixture was cooled to room temperature and concentrated in vacuo to remove the solvent. The mixture was dissolved in a small amount of ethanol and added to a large amount of water. The precipitated solid was filtered and dried in vacuo to yield compound E64 (217.0 mg, 32.10%) as a pale yellow solid. ESI / MS (m / z) 271.0 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ10.70 (s, 1H), 7.28 (s, 1H), 7.27 (d, J = 6.4Hz, 1H), 6.97-6 .92(m,1H),4.49(t,J=5.3Hz,1H),3.66-3.59(m,1H),3.53-3.47(m,1H),3.42-3.3 6(m,1H),2.76(t,J=5.9Hz,2H),2.70-2.62(m,1H),2.59-2.51(m,1H),2.35(s,3H ), 2.01-1.93 (m, 2H), 1.72-1.61 (m, 1H), 1.48-1.36 (m, 1H), 0.82 (t, J = 7.4Hz, 3H).

[0493] Example 142: Synthesis of Compound E65

[0494] To a solution of compound E65-1 (900 mg, 4.200 mmol) and compound E65-2 (1.95 g, 8.400 mmol) in tetrahydrofuran (15 mL) was slowly added dropwise triethylamine (1.27 g, 12.66 mmol) at room temperature. The reaction solution was stirred at 60°C for 3 hours. After cooling to room temperature, the reaction solution was concentrated under reduced pressure. The residue was separated by reverse phase preparative chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to give compound E65-3 (1.15 g, 91.39%) as a white solid. ESI / MS (m / z): 297.0 [M+H] + .

[0495] To a solution of compound E65-3 (1 g, 3.337 mmol) in 1,4-dioxane (5 mL) was slowly added dropwise a 4 M solution of hydrogen chloride in 1,4-dioxane (13.5 mL, 20.000 mmol) at room temperature. The reaction solution was stirred at room temperature for 2 hours, and n-hexane (30 mL) was added. The filter cake was collected by filtration and washed with n-hexane (3×10 mL). The resulting solid was vacuum dried to give compound E65-4 (870 mg, crude product) as a white solid. It was used directly in the next reaction without further purification. ESI / MS (m / z): 197.1 [M+H] + .

[0496] Tetraethyl titanate (454 mg, 1.906 mmol) was added to a toluene (5 mL) solution of compound E65-4 (452 ​​mg, 1.906 mmol) and compound INT-A (200 mg, 0.953 mmol) at room temperature. The reaction solution was stirred at 100°C for 6 hours, cooled to room temperature, diluted with water (20 mL) and dichloromethane (20 mL), filtered, and the filter cake was washed with dichloromethane (10 mL). The filtrate was extracted with dichloromethane (20 mL). The organic phase was washed with saturated sodium chloride aqueous solution (10 mL), dried over anhydrous sodium sulfate, concentrated and dried, and the residue was washed with ethanol (10 mL). The resulting solid was vacuum dried to give compound E65 (85.8 mg, 23.53%) as a yellow solid. ESI / MS (m / z): 378.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.74 (s, 1H), 12.44 (d, J = 8.7Hz, 1H), 7.54 (s, 1H), 7. 39(d,J=8.5Hz,1H),7.32(d,J=8.6Hz,1H),3.87-3.74(m,1H),3.24(q,J=10.2H z,2H),3.16-3.06(m,2H),3.01-2.98(m,4H),2.54-2.48(m,1H),2.40(s,3H),2 .28-2.17(m,2H),2.14-2.11(m,2H),2.00-1.87(m,2H),0.88(d,J=6.0Hz,3H).

[0497] Example 143: Synthesis of Compound E66

[0498] To a solution of compound E66-1 (900 mg, 4.200 mmol) and compound E66-2 (1.2 g, 8.400 mmol) in dichloromethane (15 mL) was slowly added dropwise N,N-diisopropylethylamine (1.6 g, 12.600 mmol) at 0°C and stirred overnight at room temperature. The reaction solution was quenched with water (30 mL) and the mixture was extracted with dichloromethane (3 × 30 mL). The organic phases were combined, washed sequentially with saturated sodium chloride aqueous solution (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 2:1) to obtain compound E66-3 (830 mg, 57.98%) as a light yellow solid. ESI / MS (m / z): 265.1 [M+H-56] + .

[0499] To a solution of compound E66-3 (780 mg, 2.434 mmol) in 1,4-dioxane (3 mL) was slowly added dropwise a 4M solution of hydrogen chloride in 1,4-dioxane (14.1 mL, 56.399 mmol) at room temperature. After stirring for 2 hours, n-hexane (30 mL) was added. The filter cake was collected by filtration and washed with n-hexane (3 × 10 mL). The resulting solid was dried under vacuum to give compound E66-4 (630 mg, crude) as a white solid. ESI / MS (m / z): 221.2 [M+H] + .

[0500] Tetraethyl titanate (344 mg, 1.506 mmol) was slowly added dropwise to a toluene (4 mL) solution of compound E66-4 (387 mg, 1.506 mmol) and compound INT-A (150 mg, 0.753 mmol) at room temperature, and the temperature was raised to 100 ° C and stirred for 6 hours. After the reaction solution was cooled to room temperature, it was diluted with water (20 mL) and dichloromethane (20 mL), filtered, and the filter cake was washed with dichloromethane (10 mL). The filtrate was extracted with dichloromethane (20 mL). The organic phase was washed with saturated sodium chloride aqueous solution (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure, and the residue was slurried with diethyl ether (10 mL). The obtained solid was vacuum dried to give a brown solid compound E66 (89.0 mg, 26.98%). ESI / MS (m / z): 402.1[M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.57(s,1H),12.39(d,J=8.7Hz,1H),7.55(s,1H),7.41(d, J=8.5Hz,1H),7.33(d,J=8.5Hz,1H),4.04-4.01(m,1H),3.78-3.71(m,2H),3.41-3.1 5(m,2H),3.11-3.03(m,2H),3.02-2.95(m,2H),2.75(t,J=12.0Hz,1H),2.40(s,3H) ,2.19-2.05(m,4H),1.92-1.77(m,1H),1.25(d,J=6.8Hz,6H),0.92(d,J=6.5Hz,3H).

[0501] Example 144: Synthesis of Compound E67

[0502] A toluene solution (5 mL) of compound INT-A (199.3 mg, 1.000 mmol) and compound E67-1 (480.7 mg, 3.000 mmol) was stirred at 135°C for 5 hours, cooled to room temperature, and concentrated in vacuo. The crude product was purified by reverse phase column chromatography (10-90% acetonitrile / water) to obtain compound E67 (220.0 mg, 64.43%) as a white solid. ESI / MS (m / z) 342.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ10.81(s,1H),7.28(s,1H),7.24(d,J=8.3Hz,1H),6.96(d,J=8.3Hz,1H),6.78(t,J=5.2Hz,1H),3.49 (t,J=6.7Hz,2H),3.26-3.19(m,2H),2.76(t,J=6.0Hz,2H),2.56-2.52(m,2H),2.36(s,3H),2.00-1.94(m,2H),1.39(s,9H).

[0503] Example 145: Synthesis of Compound E68

[0504] Compound E67 (90.0 mg, 0.264 mmol) was added to a 4M solution of hydrogen chloride in ethyl acetate (3 mL) at room temperature and stirred for 10 minutes. After filtration, compound E68 was obtained as a yellow solid. ESI / MS (m / z) 242.1 [M+H] + . 1 HNMR(500MHz,DMSO-d6)δ12.69(s,1H),12.43(s,1H),8.35(s,3H),7.55(s,1H),7.41(d,J=8.5Hz,1H),7.33(d,J=8.5Hz,1 H), 4.05 (t, J = 6.2Hz, 2H), 3.28-3.33 (m, 2H), 3.07 (t, J = 5.6Hz, 2H), 3.00 (t, J = 6.1Hz, 2H), 2.40 (s, 3H), 2.16-2.11 (m, 2H).

[0505] Example 146: Synthesis of Compound E69

[0506] A solution of compound B10 (243.3 mg, 1.000 mmol), (S)-1,1,1-trifluoroisopropylamine hydrochloride (448.6 mg, 3.000 mmol), sodium acetate (98.4 mg, 1.200 mmol), and tetrahydropyrrole (71.1 mg, 1.000 mmol) in 2-methyltetrahydrofuran (5 mL) was stirred at 90°C for 3 hours. The reaction solution was diluted with ethyl acetate (100 mL), washed with pure water (20 mL), and dried over anhydrous sodium sulfate. The organic phase was concentrated in vacuo and separated by reverse-phase silica gel column chromatography (10% to 90% acetonitrile / water) to obtain compound E69 (34.1 mg, 10.08%) as a pale yellow solid. ESI / MS (m / z) 339.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ11.31(s,1H),7.71(dd,J=8.2,0.9Hz,1H),7.52(dd,J=7.3,0.9Hz,1H),7.26-7.22(m,1H),4.56-4. 47(m,1H),3.87(s,3H),3.00-2.94(m,2H),2.76-2.69(m,1H),2.62-2.55(m,1H),2.00-1.92(m,2H),1.29(d,J=6.6Hz,3H).

[0507] Example 147: Synthesis of Compound E70

[0508] A solution of compound B10 (243.3 mg, 1.000 mmol), (R)-1,1,1-trifluoroisopropylamine hydrochloride (448.6 mg, 3.000 mmol), sodium acetate (98.4 mg, 1.200 mmol), and tetrahydropyrrole (71.1 mg, 1.000 mmol) in 2-methyltetrahydrofuran (5 mL) was stirred at 90°C for 3 hours. The reaction solution was diluted with ethyl acetate (100 mL), washed with pure water (20 mL), and dried over anhydrous sodium sulfate. After vacuum concentration, the mixture was separated by reverse-phase silica gel column chromatography (acetonitrile:water = 10% to 90%) to obtain compound E70 (31.4 mg, 9.28%) as a pale yellow solid. ESI / MS (m / z) 339.0 [M+H] + . 1H NMR (500MHz, DMSO-d6) δ11.31(s,1H),7.71(d,J=8.0Hz,1H),7.52(d,J=7.2Hz,1H),7.24(t,J=7.8Hz,1H),4.55-4.48( m,1H),3.87(s,3H),3.01-2.94(m,2H),2.75-2.69(m,1H),2.62-2.55(m,1H),2.00-1.90(m,2H),1.29(d,J=6.6Hz,3H).

[0509] Example 148: Synthesis of Compound E71

[0510] To a solution of compound INT-A (200 mg, 0.953 mmol) in toluene (4 mL) under a nitrogen atmosphere, compound E71-1 (514 mg, 2.478 mmol) was added, and the mixture was heated to 140°C and stirred overnight. After cooling to room temperature, the reaction solution was concentrated under reduced pressure, and the residue was separated by reverse-phase preparative chromatography (mobile phase A: water, mobile phase B: acetonitrile) to afford compound E71 (50.6 mg, 13.18%) as a reddish-brown solid. ESI / MS (m / z): 387.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ10.84(s,1H),7.30(s,1H),7.27(d,J=8.3Hz,1H),6. 99(d,J=8.3Hz,1H),4.42(dd,J=7.9,5.0Hz,1H),2.79(t,J=6.0Hz,2H),2.68 -2.59(m,1H),2.53(t,J=7.2Hz,2H),2.36(s,3H),2.18-2.12(m,1H),2.18-2 .07(m,2H),2.06(s,3H),2.01-2.05(m,1H),1.98-1.95(m,2H),1.40(s,9H).

[0511] Example 149: Synthesis of Compound E72

[0512] A solution of compound B10 (243.3 mg, 1.000 mmol), methylamine hydrochloride (202.6 mg, 3.000 mmol) and sodium acetate (98.4 mg, 3.000 mmol) in 2-methyltetrahydrofuran (4 mL) was stirred at 90°C for 4 hours. The reaction solution was diluted with ethyl acetate (100 mL), washed with pure water (20 mL), and dried over anhydrous sodium sulfate. The organic phase was concentrated in vacuo and the residue was washed with acetonitrile (5 mL) to obtain compound E72 (71.2 mg, 27.78%) as a pale yellow solid. ESI / MS (m / z) 257.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ12.84(s,1H),7.75(d,J=8.3Hz,1H),7.64(d,J=6.7Hz,1H),7.52-7.48(m ,1H),3.91(s,3H),3.35(s,3H),3.09(t,J=6.1Hz,2H),3.01(t,J=6.1Hz,2H),2.08-2.03(m,2H).

[0513] Example 150: Synthesis of Compound B95

[0514] To a mixture of compound INT-D (50 mg, 0.22 mmol), compound B95-1 (32 mg, 0.44 mmol), and triphenylphosphine (115 mg, 0.44 mmol) in tetrahydrofuran (1 mL) at 0°C under a nitrogen atmosphere was added diethyl azodicarboxylate (76 mg, 0.44 mmol), and the mixture was warmed to room temperature and stirred for 6 hours. Ethyl acetate (30 mL) was added to the reaction solution to dilute it, and the mixture was washed with a saturated aqueous sodium chloride solution. The resulting organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was separated and purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1:6) to obtain compound B95 (6 mg, 9.6%) as a white solid. ESI / MS (m / z) 284.0 [M+H] + .

[0515] Example 151: Synthesis of Compound B96

[0516] To a solution of compound INT-C (36.4 mg, 0.100 mmol) in 1,4-dioxane (0.8 mL) were added compound B96-1 (24.6 mg, 0.200 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (4.0 mg, 0.005 mmol), potassium carbonate (27.6 mg, 0.200 mmol), and water (0.2 mL) under a nitrogen atmosphere. The mixture was heated to 80°C and stirred for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (30 mL). The resulting organic phase was washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by reverse-phase silica gel column chromatography (10-50% acetonitrile / water) to afford compound B96-2 as a white solid. A mixture of compound B96-2 in trifluoroacetic acid (0.3 mL) and dichloromethane (3 mL) was stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain compound B96 (4.2 mg, 16.01%) as a white solid. ESI / MS (m / z) 263.0 [M+H] + .

[0517] Example 152: Synthesis of Compound B97

[0518] To a solution of compound INT-C (36.4 mg, 0.100 mmol) in 1,4-dioxane (0.8 mL) were added compound B97-1 (27.4 mg, 0.200 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (4.0 mg, 0.005 mmol), potassium carbonate (27.6 mg, 0.200 mmol), and water (0.2 mL) under a nitrogen atmosphere. The mixture was heated to 80°C and stirred for 3 hours. After cooling to room temperature, the reaction solution was diluted with ethyl acetate (30 mL). The resulting organic phase was washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by reverse-phase silica gel column chromatography (acetonitrile:water = 10-50%) to afford compound B97-2 as a white solid. A mixture of compound B97-2 in trifluoroacetic acid (0.3 mL) and dichloromethane (3 mL) was stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate (100 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (30 mL) and saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain compound B97 (5.1 mg, 18.46%) as a white solid. ESI / MS (m / z) 277.0 [M+H] + .

[0519] Example 153: Synthesis of Compound B98

[0520] To a solution of compound B98-1 (1 g, 6.572 mmol) in toluene (30 mL) was added 1,2-cyclohexanedione (740 mg, 6.600 mmol) at room temperature. The reaction mixture was stirred at 120°C overnight, cooled to room temperature, and concentrated under reduced pressure. The residue was separated by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B98-2 (800 mg, 49.43%) as a yellow solid. ESI / MS (m / z): 246.9 [M+H] + .

[0521] To a solution of compound B98-2 (200 mg, 0.812 mmol) in acetic anhydride (6 mL) was added [bis(trifluoroacetoxy)iodo]benzene (384.17 mg, 0.893 mmol) at room temperature. The reaction solution was stirred at room temperature for 1 hour and quenched with water. The mixture was extracted with ethyl acetate (3×30 mL), and the organic phases were combined and washed with saturated aqueous sodium chloride solution (20 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to give compound B98 (4.2 mg, 2.10%) as a yellow solid. ESI / MS (m / z): 245.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.26(s,1H),8.97(s,1H),8.29(s,1H),3.91(s,3H),3.06-3.01(m,2H),2.69-2.64(m,2H),2.23-2.16(m,2H).

[0522] Example 154: Synthesis of Compound B99

[0523] Compound B99-2 (1.88 g, 27.004 mmol) was added to a solution of compound B99-1 (2 g, 13.50 mmol) and triethylamine (2.73 g, 27.00 mmol) in ethanol (50 mL) at room temperature. The reaction solution was stirred at room temperature for 4 hours and then concentrated under reduced pressure. The residue was redissolved in ethyl acetate (100 mL), washed with 1N aqueous hydrochloric acid solution (30 mL), saturated aqueous sodium bicarbonate solution (30 mL) and saturated brine (50 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo to give compound B99-3 (2.2 g, 89.04%) as a yellow solid. ESI / MS (m / z): 182.0 [M+H] + .

[0524] To a solution of compound B99-3 (2 g, 10.93 mmol) and N,N-diisopropylethylamine (7.06 g, 54.65 mmol) in dichloromethane (50 mL) was slowly added compound B99-4 (1.67 g, 16.40 mmol) at 0°C and stirred for 1 hour. The reaction solution was washed with 1N aqueous hydrochloric acid solution (30 mL), saturated aqueous sodium bicarbonate solution (30 mL), and saturated aqueous sodium chloride solution (80 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo to give compound B99-5 (1.9 g, 77.11%) as a white solid. ESI / MS (m / z): 224.0 [M+H] + .

[0525] A solution of compound B99-5 (1.7 g, 7.54 mmol) in toluene (50 mL) was stirred at 120°C overnight. The reaction solution was cooled to room temperature and concentrated under reduced pressure. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 3:1) to obtain compound B99-6 (1.4 g, 87.77%) as a white solid. ESI / MS (m / z): 206.1 [M+H] + .

[0526] To a solution of compound B99-6 (1.3 g, 6.15 mmol) and zinc powder (2.01 g, 30.73 mmol) in ethanol (50 mL) was added acetic acid (3.69 g, 61.46 mmol) at 0°C. The reaction mixture was stirred at room temperature for 1 hour and then filtered. The filter cake was washed with ethanol (3 × 10 mL), and the filtrate was concentrated under reduced pressure. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B99-7 (1.05 g, 93.62%) as a white solid. ESI / MS (m / z): 217.1 [M+H+CH3CN] + .

[0527] To a solution of compound B99-7 (950 mg, 5.21 mmol) in water (72 mL) was slowly added concentrated hydrochloric acid (2 mL, 65.83 mmol) and an aqueous solution (9 mL) of sodium nitrite (718 mg, 10.41 mmol) at 0°C. After stirring the reaction mixture at 0°C for 0.5 hours, a solution of compound B01-2 (812 mg, 6.25 mmol) in methanol (34 mL) and a solution of sodium acetate (940 mg, 11.45 mmol) in water (72 mL) were added, respectively. The mixture was warmed to room temperature and stirred for 2 hours. The filter cake was filtered, washed with water (3×15 mL), and dried under vacuum to obtain compound B99-8 (1.4 g, 87.02%) as a brown solid. ESI / MS (m / z): 285.4 [M+H] + .

[0528] To a solution of compound B99-8 (1.3 g, 4.21 mmol) in acetonitrile (40 mL) was added concentrated sulfuric acid (2 mL, 37.52 mmol) at 0°C. The reaction mixture was stirred at room temperature for 1 hour and then concentrated under reduced pressure. The resulting residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B99 (89.3 mg, 7.80%) as a pale yellow solid. ESI / MS (m / z): 268.0 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.08(s,1H),7.67(dd,J=8.3,1.0Hz,1H),7.58(dd,J=7.3,1.0Hz,1H),7.4 5(dd,J=8.3,7.3Hz,1H),3.07(t,J=6.0Hz,2H),2.63(s,3H),2.60-2.54(m,2H),2.17-2.04(m,2H).

[0529] Example 155: Synthesis of Compound B100

[0530] To a solution of compound B100-1 (1 g, 7.087 mmol) and compound B100-2 (1.77 g, 21.261 mmol) in dimethyl sulfoxide (8 mL) was added cesium carbonate (5.8 g, 17.709 mmol) at room temperature, and the temperature was raised to 100°C and stirred overnight. After the reaction solution was cooled to room temperature, it was quenched by adding water (100 mL). The mixture was extracted with ethyl acetate (3 × 80 mL), and the resulting organic phase was washed with saturated sodium chloride aqueous solution (60 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was separated by reverse phase preparative chromatography (mobile phase A: water (5 mmol ammonium bicarbonate), mobile phase B: acetonitrile) to give compound B100-3 (560 mg, 38.70%) as a light yellow solid. ESI / MS (m / z): 205.0 [M+H] + .

[0531] To a solution of compound B100-3 (560 mg, 2.743 mmol) and zinc powder (0.90 g, 13.715 mmol) in ethanol (8 mL) was added acetic acid (1.65 g, 27.430 mmol) at room temperature. The reaction mixture was stirred at room temperature for 3 hours. The reaction mixture was filtered, and the solid was washed with ethanol (3 × 20 ml). The filtrate was concentrated under reduced pressure to obtain a light yellow solid compound B100-4 (520 mg, 73.68%). ESI / MS (m / z): 175.3 [M+H] + .

[0532] To a solution of compound B100-4 (520 mg, 2.790 mmol) in water (15 mL) and concentrated hydrochloric acid (0.8 mL) at 0°C was slowly added a solution of sodium nitrite (385 mg, 5.580 mmol) in water (4 mL). The mixture was stirred for 30 minutes. A solution of compound B01-2 (427 mg, 3.348 mmol) in methanol (16 mL) and a solution of sodium acetate (504 mg, 6.038 mmol) in water (16 mL) were then slowly added to the above solution. The mixture was stirred at room temperature for 1 hour. The reaction mixture was filtered, and the filter cake was washed with water (3 × 20 mL) and dried in vacuo to obtain compound B100-5 (300 mg, 34.42%) as a yellow solid. ESI / MS (m / z): 284.2 [M+H] + .

[0533] To a solution of compound B100-5 (300 mg, 0.960 mmol) in acetonitrile (10 mL) was added concentrated sulfuric acid (0.5 mL) at room temperature. The reaction mixture was stirred at room temperature for 1 hour and then concentrated under reduced pressure. The residue was separated by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: methanol) to afford compound B100 (11.6 mg, 4.46%) as a white solid. ESI / MS (m / z): 267.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.07(s,1H),8.78(s,1H),7.56(d,J=8.3Hz,1H),7.40(dd,J=8.4,7.4Hz,1 H),7.16(d,J=7.3Hz,1H),2.55-2.51(m,2H),2.43(t,J=6.0Hz,2H),2.39(s,3H),2.05-1.95(m,2H).

[0534] Example 156: Synthesis of Compound E73

[0535] A toluene solution (5 mL) of compound INT-A (199.3 mg, 1.000 mmol) and DL-2-amino-3-phenyl-1-propanol (378.0 mg, 2.500 mmol) was stirred at 130°C for 4 hours. The reaction solution was cooled to room temperature and concentrated under reduced pressure. The residue was dissolved in a small amount of acetonitrile and added to a large amount of water. The precipitated solid was washed with acetonitrile to obtain compound E73 (59.7 mg, 41.84%) as a brown solid. ESI / MS (m / z) 333.1 [M+H] + . 1H NMR(500MHz, DMSO-d6)δ10.72(s,1H),7.28(d,J=8.3Hz,1H),7.24(s,1H),7.22-7.19(m,2H),7.18-7.11(m,3H), 6.96(d,J=8.3Hz,1H),4.60(t,J=5.3Hz,1H),3.96-3.90(m,1H),3.60-3.55(m,1H),3.51-3.46(m,1H),3.02(dd,J =13.1,4.0Hz,1H),2.67-2.62(m,3H),2.43-2.35(m,4H),1.98-1.92(m,1H),1.80-1.74(m,1H),1.62-1.56(m,1H).

[0536] Example 157: Synthesis of Compound C01

[0537] Under nitrogen protection, 60% sodium hydride (123.31 mg, 3.083 mmol, 60%) was added to a solution of compound B10 (300 mg, 1.233 mmol) in dichloromethane (10 mL) at 0°C. The reaction solution was stirred at 0°C for 30 minutes, and a solution of acetyl chloride (125.85 mg, 1.603 mmol) in dichloromethane (1 mL) was added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the mixture was quenched with water and extracted with ethyl acetate (3×30 mL). The combined organic phases were washed sequentially with saturated aqueous sodium chloride (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was isolated and purified by reverse-phase preparative chromatography (mobile phase A: water (0.1% formic acid); mobile phase B: acetonitrile) to obtain compound C01 (66.2 mg, 18.65%) as a white solid. ESI / MS (m / z): 286.0 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ8.20 (dd, J=8.5, 1.1Hz, 1H), 7.71 (dd, J=7.5, 1.0Hz, 1H), 7.60 (dd, J=8.5, 7.4Hz, 1H), 3.93 (s, 3H), 3.03 (t, J = 6.0Hz, 2H), 2.70-2.61 (m, 2H), 2.54 (s, 3H), 2.19-2.08 (m, 2H).

[0538] Example 158: Synthesis of Compound C02

[0539] A mixture of compound INT-A (199.3 mg, 1.000 mmol), cesium carbonate (651.6 mg, 2.000 mmol) and 2,2,2-trifluoroethyltrifluoromethanesulfonic acid (464.2 mg, 2.000 mmol) in N,N-dimethylformamide (4 mL) was stirred at room temperature for 3 hours and quenched with water (10 mL). The mixture was extracted with ethyl acetate (3×20 mL). The organic layer was washed with saturated sodium chloride aqueous solution (4×30 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was separated and purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1:20) to give a white solid compound C02 (216.0 mg, 76.79%). ESI / MS (m / z) 282.0 [M+H] + . 1 H NMR(500MHz,DMSO-d6)δ7.57(d,J=8.6Hz,1H),7.52(s,1H),7.29(dd,J=8.6,1.3Hz,1H),5.4 8(q,J=9.1Hz,2H),2.97(t,J=6.1Hz,2H),2.60-2.57(m,2H),2.41(s,3H),2.15-2.10(m,2H).

[0540] Example 159: Synthesis of Compound C03

[0541] Compound B16 (0.1280 g, 0.50 mmol) was dissolved in tetrahydrofuran (5 mL) and replaced with nitrogen. The mixture was cooled to -5 ° C, 60% sodium hydride (0.0597 g, 1.49 mmol) was added, and stirring was continued for 10 minutes. Acryloyl chloride (0.0675 g, 0.75 mmol) was added to the above mixture and stirred at -5 ° C for 5 hours. After the reaction was completed, saturated ammonium chloride solution was added to quench the reaction and extracted with dichloromethane (30 mL). The organic phase was washed with water (10 mL × 2), dried over anhydrous sodium sulfate, filtered and concentrated. The residue was purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1:4) to give a white solid compound C03 (0.0060 g, 0.018 mmol). ESI / MS (m / z) 312.0 [M+H] + . 1H NMR (500MHz, DMSO-d6) δ8.18(dd,J=8.4,1.0Hz,1H),7.74(dd,J=7.4,1.0Hz,1H),7.64-7.59(m,1H),6.68-6.61(m,1H),6.33(dd,J=16.9,1.3Hz,1H ),5.91(dd,J=6.3,1.3Hz,1H),4.40(q,J=7.2Hz,2H),3.07(t,J=6.0Hz,2 H), 2.63 (t, J = 10.0, 5.7 Hz, 2H), 2.20-2.10 (m, 2H), 1.37 (t, J = 7.1 Hz, 3H).

[0542] Example 160: Synthesis of Compound C04

[0543] Compound B16 (0.1280 g, 0.50 mmol) was dissolved in tetrahydrofuran (5 mL) and replaced with nitrogen. The mixture was cooled to -5 ° C, 60% sodium hydride (0.0597 g, 1.49 mmol) was added, and stirring was continued for 10 minutes. Benzoyl chloride (0.1049 g, 0.75 mmol) was added to the above mixture and stirred at room temperature for 5 hours. After the reaction was completed, saturated ammonium chloride solution was added to quench the mixture and extracted with dichloromethane (30 mL). The organic phase was washed with water (10 mL × 2), dried over anhydrous sodium sulfate, filtered and concentrated. The residue was purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1:4) to obtain white solid compound C04 (0.053 g, 0.15 mmol). ESI / MS (m / z) 362.0 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ7.88-7.84(m,1H),7.78-7.74(m,1H),7.66(t,J=7.4Hz,1H),7.63-7.60(m,2H),7.60-7.55(m,1H),7. 50(t,J=7.7Hz,2H),4.43(q,J=7.1Hz,2H),3.13(t,J=6.0Hz,2H),2.49-2.45(m,2H),2.18-2.09(m,2H),1.40(t,J=7.1Hz,3H).

[0544] Example 161: Synthesis of Compound C05

[0545] Compound B16 (0.1280 g, 0.50 mmol) was dissolved in dichloromethane (5 mL) and cooled to -5°C. 60% sodium hydride (0.0597 g, 1.49 mmol) was added, and after stirring for 10 minutes, hexanoyl chloride (0.1004 g, 0.75 mmol) was added. The reaction solution was stirred at room temperature for 5 hours, quenched with saturated ammonium chloride solution, and extracted with dichloromethane (30 mL). The organic phase was washed with water (10 mL × 2), dried over anhydrous sodium sulfate, filtered, and concentrated. The residue was purified by preparative thin layer chromatography (ethyl acetate: petroleum ether = 1:4) to obtain a light yellow oil C05 (0.0870 g, 0.24 mmol). ESI / MS (m / z) 356.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ8.09 (dd, J=8.5Hz, J=1.0Hz, 1H), 7.71 (dd, J=7.4Hz, J=1.0Hz, 1H), 7.60 (dd, J=8.5, 7.4Hz, 1H), 4.40 (q, J=7.1Hz, 2H), 3.06 (t, J= 6.0Hz,2H),2.83(t,J=7.4Hz,2H),2.69-2.62(m,2H),2.18-2.11(m,2H),1.6 7-1.59(m,2H),1.37(t,J=7.1Hz,3H),1.26-1.19(m,4H),0.85-0.78(m,3H).

[0546] Example 162: Synthesis of Compound C06

[0547] Compound B16 (0.1280 g, 0.50 mmol) was dissolved in N,N-dimethylformamide (3 mL), and 2,2,2-trifluoroethyl trifluoromethanesulfonate (0.2309 g, 0.99 mmol) and cesium carbonate (0.4862 g, 1.49 mmol) were added respectively. The reaction solution was stirred at room temperature for 2 hours, quenched with saturated ammonium chloride solution, and extracted with dichloromethane (30 mL). The organic phase was washed with water (10 mL × 2), dried over anhydrous sodium sulfate, filtered, and concentrated. The residue was purified by silica gel column chromatography (ethyl acetate: dichloromethane = 1:1) to obtain compound C06 (0.1140 g, 0.31 mmol) as a white solid. ESI / MS (m / z) 340.0 [M+H] + . 1H NMR(500MHz,DMSO-d6)δ7.99(d,J=8.5Hz,1H),7.65(dd,J=7.3,0.9Hz,1H),7.57-7.51(m,1H),5.64(q,J=9.0Hz ,2H),4.39(q,J=7.1Hz,2H),3.08(t,J=6.1Hz,2H),2.67-2.53(m,2H),2.14-2.05(m,2H),1.37(t,J=7.1Hz,3H).

[0548] Example 163: Synthesis of Compound C07

[0549] Compound B16 (0.1280 g, 0.50 mmol) was dissolved in tetrahydrofuran (5 mL) and replaced with nitrogen. After cooling to -5°C, sodium hydride (0.0597 g, 1.49 mmol) was added and stirred for 10 minutes. Methyl iodide (0.1103 g, 0.75 mmol) was then added and stirred at -5°C for 5 hours. The reaction solution was quenched with saturated ammonium chloride solution and extracted with dichloromethane (30 mL). The combined organic phases were washed with water (10 mL x 2), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:4) to obtain C07 (0.0650 g, 0.24 mmol) as a white solid. ESI / MS (m / z) 272.1 [M+H] + . 1 H NMR (500MHz, DMSO-d6) δ7.82(d,J=8.4Hz,1H),7.59(d,J=7.2Hz,1H),7.48-7.44(m,1H),4.38(q,J=7.1H z, 2H), 4.06 (s, 3H), 3.06 (t, J = 6.0Hz, 2H), 2.62-2.56 (m, 2H), 2.12-2.04 (m, 2H), 1.36 (t, J = 7.1Hz, 3H).

[0550] Example 164: Synthesis of Compound C08

[0551] Compound B16 (0.1280 g, 0.50 mmol) was dissolved in tetrahydrofuran (5 mL), purged with nitrogen, and cooled to -5°C. Sodium hydride (0.0597 g, 1.49 mmol) was added, and after stirring for 10 minutes, N,N-dimethylaminoethyl bromide hydrobromide (0.1738 g, 0.75 mmol) was added, and the reaction solution was stirred at -5°C for 5 hours. The reaction solution was quenched with saturated ammonium chloride solution and extracted with dichloromethane (30 mL). The organic phase was washed with water (10 mL × 2), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was purified by silica gel preparative thin layer chromatography (dichloromethane:anhydrous methanol = 20:1) to obtain C08 (0.0080 g, 0.23 mmol) as a white solid. ESI / MS (m / z) 329.1 [M+H] + ; 1 H NMR (500MHz, DMSO-d6) δ7.83(d,J=8.4Hz,1H),7.57(d,J=7.2Hz,1H),7.47-7.43(m,1H),4.66(t,J=7.0Hz,2H),4.37(q,J=7. 1Hz,2H),3.05(t,J=6.0Hz,2H),2.62-2.57(m,2H),2.49-2.46(m,2H),2.19(s,6H),2.11-2.03(m,2H),1.36(t,J=7.1Hz,3H).

[0552] Example 165: Synthesis of Compound B103

[0553] At room temperature, n-butylamine (22 mg, 0.30 mmol) was added to a solution of compound INT-G (50 mg, 0.15 mmol, racemate) in N,N-dimethylformamide (1 mL). The reaction solution was stirred for 2 hours and diluted with ethyl acetate (20 mL). The organic phase was washed with water (10 mL × 2), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase preparative chromatography (acetonitrile / water / trifluoroacetic acid system) to obtain the trifluoroacetate salt of compound B103 (11 mg, 0.024 mmol, racemate) as a white solid. ESI / MS (m / z) 329.1 [M+H] + ; 1H NMR(500MHz,DMSO-d6)δ12.36(s,1H),9.05(d,J=69.9Hz,2H),7.70(dd,J=8.4,1.0Hz, 1H),7.67(dd,J=7.2,1.0Hz,1H),7.46(dd,J=8.4,7.3Hz,1H),4.54(d,J=13.4Hz,1H),4 .44-4.32(m,2H),3.43-3.39(m,1H),3.24-3.16(m,1H),3.13-3.00(m,2H),2.65-2.57( m,1H),2.22-2.10(m,1H),1.77-1.58(m,2H),1.43-1.34(m,5H),0.94(t,J=7.3Hz,3H).

[0554] Example 166: Synthesis of Compound B104

[0555] To a mixture of compound INT-D (120.0 mg, 0.516 mmol) and compound B104-1 (72.0 mg, 0.619 mmol) in dichloromethane (4 mL) and N,N-dimethylformamide (4 mL) at room temperature were added N,N'-dicyclohexylcarbodiimide (160.0 mg, 0.774 mmol) and 4-dimethylaminopyridine (63.0 mg, 0.516 mmol). The reaction mixture was stirred at room temperature for 4 hours and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to give compound B104 (16.2 mg, 9.46%) as a white solid. ESI / MS (m / z): 328.2 [M+H] + .

[0556] Example 167: Synthesis of Compound B105

[0557] To a solution of compound B105-1 (2.0 g, 14.579 mmol) in water (60 mL) and concentrated hydrochloric acid (4.3 mL) at 0°C was slowly added dropwise a solution of sodium nitrite (2.0 g, 29.158 mmol) in water (17 mL). The mixture was stirred at 0°C for 30 minutes. A solution of compound B105-2 (2.23 g, 17.495 mmol) in methanol (70 mL) and a solution of sodium acetate (2.63 g, 32.074 mmol) in water (70 mL) were then slowly added. The reaction mixture was stirred at room temperature for 1 hour. The resulting mixture was extracted with ethyl acetate (3 × 80 mL), and the organic phase was washed with saturated sodium chloride aqueous solution (60 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to give a light yellow solid compound B105-3 (430 mg, 11.63%). ESI / MS (m / z): 247.3 [M+H] + .

[0558] To a solution of compound B105-3 (200 mg, 0.788 mmol) in acetonitrile (3 mL) was added concentrated hydrochloric acid (0.15 mL) at room temperature. The reaction mixture was stirred at room temperature for 2 hours and concentrated in vacuo. The residue was separated by reverse phase preparative chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B105 (24.2 mg, 13.29%) as a white solid. ESI / MS (m / z): 230.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.61(s,1H),7.26(d,J=1.9Hz,1H),7.23(d,J=8.2Hz,1H),7.17(dd,J=6.5,1.8Hz,1H),5.35 -5.28(m,1H),5.18(d,J=4.0Hz,1H),3.22-3.07(m,2H),2.56-2.51(m,2H),2.19-2.11(m,2H),1.42(d,J=6.4Hz,3H).

[0559] Example 168: Synthesis of Compound B106

[0560] To a solution of compound B106-1 (10 g, 51.008 mmol) in N,N-dimethylformamide (100 mL) at 0°C, trifluoroacetic anhydride (13.9 g, 66.323 mmol) was slowly added. The reaction solution was stirred at room temperature for 20 hours, diluted with water (100 mL), and extracted with ethyl acetate (3×300 mL). The resulting organic phase was washed with saturated aqueous sodium chloride solution (300 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to obtain compound B106-2 (9 g, 59.81%) as a pink solid. ESI / MS (m / z): 292.1 [M+H] + .

[0561] To a solution of compound B106-2 (9 g, 30.508 mmol) in N,N-dimethylformamide (100 mL) at 0°C was added 60% sodium hydride (1.83 g, 45.762 mmol). After stirring for 30 minutes, p-methoxybenzyl chloride (9.56 g, 61.016 mmol, PMBCl) was added. The reaction mixture was stirred at room temperature for 4 hours, diluted with water (150 mL), and extracted with ethyl acetate (3 × 200 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (150 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 6:1) to obtain compound B106-3 (10 g, 72.36%) as a brown oil. ESI / MS (m / z): 412.0 [M+H] + .

[0562] At 0 ° C, water (50 mL) was added to a solution of compound B106-3 (10 g, 19.893 mmol) and sodium hydroxide (19.9 g, 497.325 mmol) in ethanol (120 mL). The mixture was heated to 60 ° C and stirred for 5 hours. The reaction solution was cooled to room temperature, adjusted to pH = 5 with dilute hydrochloric acid, and the mixture was extracted with ethyl acetate (3×100 mL). The obtained organic phase was dried over anhydrous sodium sulfate and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 1:2) to obtain yellow solid compound B106-4 (7.5 g, 95.25%). ESI / MS (m / z): 362.0 [M+H] + .

[0563] At room temperature, diphenylphosphoryl azide (6.2 g, 22.446 mmol) was slowly added to a solution of compound B106-4 (7.5 g, 20.405 mmol) and triethylamine (4.1 g, 40.810 mmol) in tetrahydrofuran (130 mL). The reaction solution was stirred at room temperature for 24 hours and concentrated in vacuo. Tert-butanol (100 mL) was added to the residue and stirred at 85°C for 24 hours. The reaction solution was cooled to room temperature and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to give brown solid compound B106-5 (2.5 g, 26.70%). ESI / MS (m / z): 375.8 [M+H-56] + .

[0564] A 4M solution of 1,4-dioxane (50 mL) of hydrogen chloride was added to compound B106-5 (2.5 g, 5.448 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 hours and concentrated in vacuo. The residue was a gray solid, compound B106-6 (1.7 g, 87.61%). ESI / MS (m / z): 330.8 [M+H] + .

[0565] To a solution of compound B106-6 (1.7 g, 4.773 mmol) in water (100 mL) at room temperature was added B106-7 (688 mg, 9.546 mmol), and the mixture was heated to 100°C and stirred overnight. The reaction mixture was cooled to room temperature and filtered. The resulting filter cake was washed with water (10 mL) and separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B106-8 (200 mg, 10.33%) as a yellow solid. ESI / MS (m / z): 385.1 [M+H] + .

[0566] To a solution of compound B106-8 (200 mg, 0.493 mmol) in N,N-dimethylformamide (6 mL) was added 60% sodium hydride (30 mg, 0.740 mmol) at 0°C. After stirring for 30 minutes, iodomethane (70 mg, 0.493 mmol) was added. The reaction solution was stirred at room temperature for 2 hours, quenched with water (30 mL), and the mixture was extracted with ethyl acetate (3×30 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (20 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo to give a yellow solid compound B106-9 (210 mg, 92.78%). ESI / MS (m / z): 399.1 [M+H] + .

[0567] In an autoclave, [1,1-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (37 mg, 0.046 mmol) was added to a solution of compound B106-9 (210 mg, 0.458 mmol) and triethylamine (231 mg, 2.290 mmol) in methanol (15 mL). Carbon monoxide was introduced to 10 atmospheres, and the reaction solution was stirred at 80°C overnight. The reaction solution was cooled to room temperature and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B106-10 (90 mg, 50.94%) as a yellow oil. ESI / MS (m / z): 378.9 [M+H] + .

[0568] To a solution of compound B106-10 (80 mg, 0.207 mmol) in trifluoroacetic acid (3 mL) was added trifluoromethanesulfonic acid (0.3 mL) at room temperature. The reaction mixture was stirred at room temperature for 10 minutes, concentrated in vacuo, and the residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B106 (21.1 mg, 38.96%) as a yellow solid. ESI / MS (m / z): 259.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.57(s,1H),7.55(dd,J=8.1,1.0Hz,1H),7.40(dd,J=7.4,1.0Hz,1H ),7.13-7.07(m,1H),3.82(s,3H),2.99(s,3H),2.95(t,J=7.2Hz,2H),2.68(t,J=7.2Hz,2H).

[0569] Example 169: Synthesis of Compound B107

[0570] To a solution of compound B107-1 (1 g, 8.607 mmol) and sodium methoxide (1.4 g, 25.822 mmol) in 1,4-dioxane (30 mL) was added ethyl formate (3.8 g, 51.645 mmol) at 0°C and stirred for 2 hours. The reaction solution was adjusted to pH 6 with aqueous citric acid at 0°C, and the mixture was extracted with ethyl acetate (3 × 60 mL). The resulting organic phase was washed with saturated aqueous sodium chloride (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 1:1) to obtain compound B107-2 (1.5 g, 52.33%) as a brown oil. ESI / MS (m / z): 145.0 [M+H] + .

[0571] At 0 ° C, a solution of sodium nitrite (0.67 g, 9.686 mmol) in water (5 mL) was slowly added to a solution of compound B107-3 (0.8 g, 4.843 mmol) in concentrated hydrochloric acid (3 mL) and water (30 mL) and stirred for 30 minutes. A solution of compound B107-2 (1.40 g, 9.686 mmol) in methanol (30 mL) and a solution of sodium acetate (0.87 g, 10.655 mmol) in water (30 mL) were slowly added to the above solution at 0 ° C. The reaction solution was stirred at room temperature for 2 hours and extracted with ethyl acetate (3×80 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (60 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to give a brown oily compound B107-4 (0.8 g, crude product). ESI / MS (m / z): 293.1 [M+H] + .

[0572] To a solution of compound B107-4 (650 mg, crude product) in acetonitrile (5 mL) at room temperature was added concentrated hydrochloric acid (250 μL). The reaction mixture was stirred at room temperature for 1 hour and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B107 (16.3 mg, 3.6%) as a yellow solid. ESI / MS (m / z): 276.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.23(s,1H),7.67(dd,J=8.4,1.1Hz,1H),7.58(dd,J=7.3,1.1Hz,1H),7.41(dd ,J=8.2,7.4Hz,1H),4.38(q,J=7.1Hz,2H),3.27-3.17(m,2H),2.89-2.78(m,2H),1.37(t,J=7.1Hz,3H).

[0573] Example 170: Synthesis of Compound B108

[0574] To a solution of compound B108-1 (500 mg, 2.346 mmol) in tetrahydrofuran (13 mL) was added a 2M solution of lithium diisopropylamide in tetrahydrofuran (2.4 mL) at -78°C. The reaction mixture was stirred at -78°C for 30 minutes. A solution of iodine (1.19 g, 4.692 mmol) in tetrahydrofuran (3 mL) was added dropwise and stirring continued for 1 hour. The reaction mixture was warmed to room temperature, quenched with water (30 mL), and extracted with dichloromethane (2 x 30 mL). The resulting organic phase was washed with a saturated aqueous sodium chloride solution (20 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was a light yellow solid compound B108-2 (600 mg, 72.42%).

[0575] To a solution of compound B108-2 (500 mg, 1.416 mmol) in tetrahydrofuran (10 mL) at -78°C was added a 2.5 M solution of n-butyllithium in n-hexane (623.0 2) dropwise and stirred for 1 hour. Compound B108-3 (119.1 mg, 1.699 mmol) was added dropwise to the reaction mixture and stirred for 1 hour. The reaction mixture was warmed to room temperature, quenched with water (30 mL), and extracted with dichloromethane (3 × 30 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (20 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 5:1) to obtain compound B108-4 (250 mg, 46.45%) as a brown oil.

[0576] To a solution of compound B108-4 (240 mg, 0.631 mmol) in acetonitrile (1 mL) and water (1 mL) at 0°C was added cerium ammonium nitrate (868.6 mg, 1.578 mmol) and stirred for 30 minutes. The reaction solution was warmed to room temperature, quenched with water (30 mL), and extracted with dichloromethane (3×30 mL). The resulting organic phase was washed with saturated aqueous sodium chloride solution (10 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 4:1) to obtain compound B108-5 (150 mg, 68.69%) as a yellow solid. ESI / MS (m / z): 280.8 [M+H] + .

[0577] In an autoclave, [1,1-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (33.0 mg, 0.041 mmol) and triethylamine (409.6 mg, 4.050 mmol) were added to a solution of compound B108-5 (140 mg, 0.405 mmol) in ethanol (20 mL). Carbon monoxide was introduced to 10 atmospheres, and the temperature was raised to 80°C and stirred overnight. The reaction solution was concentrated in vacuo, and the residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to obtain compound B108 (57.3 mg, 50.67%) as a white solid. ESI / MS (m / z): 274.9 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ8.27(dd,J=8.1,1.2Hz,1H),7.70(dd,J=7.3,1.1Hz,1H),7.62(dd,J=8.1,7.3Hz,1 H), 4.47-4.37 (m, 2H), 2.96 (t, J = 6.0Hz, 2H), 2.73-2.66 (m, 2H), 2.21-2.11 (m, 2H), 1.37 (t, J = 7.1Hz, 3H).

[0578] Example 171: Synthesis of Compound B109

[0579] To a mixture of compound INT-D (100 mg, 0.436 mmol) and compound B109-1 (115.3 mg, 0.872 mmol) in dichloromethane (3 mL) and N,N-dimethylformamide (3 mL) at room temperature were added N,N'-dicyclohexylcarbodiimide (135.0 mg, 0.654 mmol) and N,N-dimethylaminopyridine (64.0 mg, 0.523 mmol). The reaction mixture was stirred at room temperature for 2 hours, quenched with water (30 mL), and extracted with dichloromethane (2 x 30 mL). The resulting organic phase was washed with saturated aqueous sodium chloride (20 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B109 (60.5 mg, 40.11%, racemic) as a white solid. ESI / MS (m / z): 344.1 [M+H] + . 1H NMR(400MHz,DMSO-d6)δ12.06(s,1H),7.72-7.60(m,4H),7.51-7.43(m,3H),7.42-7.35(m,1 H),6.75(s,1H),3.94-3.90(m,1H),3.08-3.00(m,2H),2.60-2.53(m,2H),2.13-2.00(m,2H).

[0580] Example 172: Synthesis of Compound B110

[0581] To a mixture of compound INT-D (200 mg, 0.872 mmol) and N,N-dimethylaminopyridine (127.9 mg, 1.046 mmol) in dichloromethane (10 mL) and N,N-dimethylformamide (3 mL) at room temperature were added N,N'-dicyclohexylcarbodiimide (270.0 mg, 1.308 mmol) and compound B110-1 (171.3 mg, 1.744 mmol). The reaction mixture was stirred at room temperature for 3 hours, quenched with water (30 mL), and extracted with dichloromethane (3 x 40 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to afford compound B110 (75.6 mg, 27.95%, racemic) as a white solid. ESI / MS (m / z): 310.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.03(s,1H),7.66(dd,J=8.3,1.1Hz,1H),7.58(dd,J=7.3,1.1Hz,1H),7.42-7.34(m,1H),5.71-5.62(m ,1H),3.15-3.09(m,2H),2.61-2.55(m,2H),2.30-2.20(m,2H),2.16-2.06(m,2H),1.56(d,J=6.6Hz,3H),1.07(t,J=7.5Hz,3H).

[0582] Example 173: Synthesis of Compound B111

[0583] To a mixture of compound INT-D (150 mg, 0.654 mmol) and N,N-dimethylaminopyridine (95.9 mg, 0.785 mmol) in dichloromethane (10 mL) and N,N-dimethylformamide (3 mL) at room temperature were added N,N'-dicyclohexylcarbodiimide (202.5 mg, 0.981 mmol) and compound B111-1 (149.4 mg, 1.308 mmol). The reaction mixture was stirred at room temperature overnight, quenched with water (30 mL), and extracted with dichloromethane (3 x 40 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B111 (26.4 mg, 12.33%, racemic) as a white solid. ESI / MS(m / z):326.0.[M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.00(s,1H),7.65(d,J=8.3Hz,1H),7.58(d,J=7.5Hz,1H),7.41-7.33(m,1H),5.33-5.24(m,1H),4.24-4 .18(m,2H),3.70-3.64(m,2H),3.50-3.44(m,1H),3.14-3.06(m,2H),2.61-2.54(m,2H),2.16-2.09(m,2H),1.33(d,J=6.4Hz,3H).

[0584] Example 174: Synthesis of Compound B112

[0585] To a mixture of compound INT-D (200 mg, 0.860 mmol) and compound B112-1 (193.0 mg, 1.720 mmol) in dichloromethane (5 mL) and N,N-dimethylformamide (5 mL) at room temperature were added N,N-dimethylaminopyridine (126.1 mg, 1.032 mmol) and N,N'-dicyclohexylcarbodiimide (266.3 mg, 1.290 mmol). The reaction mixture was stirred at room temperature for 2 hours, quenched with water (30 mL), and extracted with dichloromethane (3 x 30 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: methanol) to obtain compound B112 (54.2 mg, 19.19%, racemic) as a white solid. ESI / MS (m / z): 324.2 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ12.02(s,1H),7.69(d,J=8.3Hz,1H),7.61(d,J=7.3Hz,1H),7.43-7.35(m,1H),5.67-5.58(m,1H),3.66-3.63 (m,1H),3.13(t,J=6.0Hz,2H),2.59(t,J=6.5Hz,2H),2.18-2.07(m,2H),1.90-1.80(m,2H),1.81-1.70(m,1H),0.96(d,J=5.7Hz,6H).

[0586] Example 175: Synthesis of Compound B113

[0587] To a mixture of compound INT-D (200 mg, 0.860 mmol) and compound B113-1 (227.4 mg, 1.720 mmol) in dichloromethane (5 mL) and N,N-dimethylformamide (5 mL) at room temperature were added N,N-dimethylaminopyridine (126.1 mg, 1.032 mmol) and N,N'-dicyclohexylcarbodiimide (266.3 mg, 1.290 mmol). The reaction mixture was stirred at room temperature for 2 hours, quenched with water (30 mL), and extracted with dichloromethane (3 x 30 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to afford compound B113 (56.1 mg, 19.27%, racemic) as a white solid. ESI / MS (m / z): 338.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.02(s,1H),7.69(dd,J=8.3,1.0Hz,1H),7.60(dd,J=7.3,1.0Hz,1H),7.39(dd,J=8.3,7.3Hz,1H),5.61-5.56(m,1H),3.62(d, J=2.1Hz,1H),3.12(t,J=6.0Hz,2H),2.62-2.54(m,2H),2.15-2.08(m,2H), 1.95-1.81(m,2H),1.53-1.44(m,2H),1.36-1.25(m,4H),0.90-0.84(m,3H).

[0588] Example 176: Synthesis of Compound B114

[0589] To a mixture of compound INT-D (200 mg, 0.860 mmol) and compound B114-1 (144.7 mg, 1.720 mmol) in dichloromethane (5 mL) and N,N-dimethylformamide (5 mL) at room temperature were added N,N-dimethylaminopyridine (126.1 mg, 1.032 mmol) and N,N'-dicyclohexylcarbodiimide (266.3 mg, 1.290 mmol). The reaction mixture was stirred at room temperature for 5 hours, quenched with water (30 mL), and extracted with dichloromethane (3 x 30 mL). The resulting organic phase was washed with saturated aqueous sodium chloride (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to afford compound B114 (21 mg, 8.26%, racemic) as a white solid. ESI / MS (m / z): 296.1 [M+H] + . 1 H NMR (400 MHz, DMSO-d6) δ 12.00 (s, 1H), 7.66 (dd, J = 8.3, 1.0 Hz, 1H), 7.61 (dd, J = 7.3, 1.0 Hz, 1H), 7.40-7.34 (m, 1H), 5.24-5.15 (m, 1H), 3.12 (t, J = 6.0 Hz, 2H), 2.95-2.92 (m, 1H), 2.68-2.63 (m, 2H), 2.60-2.54 (m, 2H), 2.15-2.08 (m, 2H), 1.43 (d, J = 6.3 Hz, 3H). Compound B114 can be chirally resolved to give compound B114R and compound B114S. Compound B114R and compound B114S can also be synthesized from the corresponding chiral starting materials.

[0590] Example 177: Synthesis of Compound B115

[0591] To a mixture of compound INT-D (200 mg, 0.860 mmol) and compound B115-1 (227.4 mg, 1.720 mmol) in dichloromethane (5 mL) and N,N-dimethylformamide (5 mL) at room temperature were added N,N-dimethylaminopyridine (126.1 mg, 1.032 mmol) and N,N'-dicyclohexylcarbodiimide (266.3 mg, 1.290 mmol). The reaction mixture was stirred at room temperature for 2 hours, quenched with water (30 mL), and extracted with dichloromethane (3 x 30 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: methanol) to afford compound B115 (56.6 mg, 18.82%) as a white solid. ESI / MS (m / z): 344.1 [M+H] + . 1 H NMR(400MHz,DMSO-d6)δ12.02(s,1H),7.70-7.68(m,1H),7.68-7.65(m,1H),7.61-7.57(m,2H),7.50-7.45(m, 1H),7.43-7.36(m,2H),5.51(s,2H),4.51(s,1H),3.05(t,J=6.0Hz,2H),2.58-2.52(m,2H),2.12-2.03(m,2H).

[0592] Example 178: Synthesis of Compound B116

[0593] To a mixture of compound INT-D (100 mg, 0.430 mmol) and 4-dimethylaminopyridine (63.1 mg, 0.516 mmol) in dichloromethane (10 mL) and N,N-dimethylformamide (3 mL) at room temperature were added N,N'-dicyclohexylcarbodiimide (133.1 mg, 0.645 mmol) and compound B116-1 (44.8 mg, 0.860 mmol). The reaction mixture was stirred at room temperature overnight, quenched with water (30 mL), and extracted with dichloromethane (3 x 40 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to afford compound B116 (23.5 mg, 20.72%) as a white solid. ESI / MS (m / z): 263.2 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ11.99(s,1H),7.65(dd,J=8.3,1.1Hz,1H),7.58(dd,J=7.3,1.0Hz, 1H), 7.36 (dd, J = 8.3, 7.3Hz, 1H), 3.12-3.04 (m, 2H), 2.61-2.53 (m, 2H), 2.13-2.07 (m, 2H).

[0594] Example 179: Synthesis of Compound B117

[0595] At 0 ° C, a solution of sodium nitrite (1.15 g, 16.740 mmol) in water (10 mL) and concentrated hydrochloric acid (4.9 mL, 55.912 mmol) was slowly added to a solution of compound B117-1 (2 g, 11.160 mmol) in water (50 mL). The reaction solution was stirred for 10 minutes, and a solution of methanol (60 mL) of compound B117-2 (1.76 g, 13.392 mmol) and a solution of sodium acetate (2.01 g, 24.552 mmol) in water (40 mL) were slowly added. The reaction solution was stirred for 2 hours at 0 ° C and filtered. The resulting filter cake was washed with water (40 mL) and dried in vacuo to give an orange solid compound B117-3 (3.2 g, 86.72%). ESI / MS (m / z): 288.9 [M+H] + .

[0596] At 0°C, 10% dilute sulfuric acid (33 mL) was added to a solution of compound B117-3 (3 g, 9.072 mmol) in acetonitrile (100 mL), and the temperature was raised to 75°C and stirred for 4 hours. The reaction solution was cooled to room temperature and adjusted to pH = 7 with saturated sodium carbonate solution. The mixture was concentrated in vacuo and extracted with ethyl acetate (3×100 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (100 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1) to obtain compound B117 (180.3 mg, 7.13%) as a yellow solid. ESI / MS (m / z): 272.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.79(s,1H),7.41(d,J=8.5Hz,1H),7.20(d,J=8.6Hz,1H),4.40(q,J=7.1Hz,2 H), 2.77 (t, J = 6.0Hz, 2H), 2.55 (t, J = 6.4Hz, 2H), 2.34 (s, 3H), 2.15-2.07 (m, 2H), 1.35 (t, J = 7.1Hz, 3H).

[0597] Example 180: Synthesis of Compounds B118 and B125

[0598] To a solution of compound B118-1 (10 g, 58.282 mmol) in ethanol (100 mL) was added concentrated sulfuric acid (3 mL) at 0°C, and the temperature was raised to 80°C and stirred for 24 hours. The reaction solution was cooled to room temperature and concentrated in vacuo. The residue was adjusted to pH = 8 with saturated sodium carbonate solution and extracted with ethyl acetate (3×150 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (100 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo to give compound B118-2 (9.5 g, 80.02%) as a black solid. ESI / MS (m / z): 200.0 [M+H] + .

[0599] At 0 ° C, a solution of sodium nitrite (0.76 g, 11.046 mmol) in water (10 mL) and concentrated hydrochloric acid (3.7 mL, 36.820 mmol) was slowly added to a solution of compound B118-2 (1.5 g, 7.364 mmol) in water (40 mL). The reaction solution was stirred for 10 minutes, and a solution of methanol (60 mL) of compound B118-3 (1.16 g, 8.837 mmol) and a solution of sodium acetate (1.33 g, 16.201 mmol) in water (30 mL) were slowly added. The reaction solution was stirred for 2 hours at 0 ° C and filtered. The resulting filter cake was washed with water (30 mL) and dried in vacuo to give an orange solid compound B118-4 (1.8 g, 63.34%). ESI / MS (m / z): 309.1 [M+H] + .

[0600] To a solution of compound B118-4 (1.8 g, 4.664 mmol) in acetonitrile (50 mL) was added 10% dilute sulfuric acid (15 mL) at 0°C, and the temperature was raised to 75°C and stirred for 4 hours. The reaction solution was cooled to room temperature and adjusted to pH = 7 with saturated sodium carbonate solution. The mixture was concentrated in vacuo and extracted with ethyl acetate (3×100 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (100 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to give compound B118 (69.8 mg) and compound B125 (11.8 mg) as white solids.

[0601] Compound B118: ESI / MS (m / z): 292.1 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ12.13(s,1H),7.52(d,J=8.9Hz,1H),7.38(d,J=8.9Hz,1H),4.44(q, J=7.1Hz,2H),2.77(t,J=6.0Hz,2H),2.58(t,2H),2.19-2.08(m,2H),1.36(t,J=7.1Hz,3H).

[0602] Compound B125: ESI / MS (m / z): 292.1 [M+H] + . 1 H NMR(400MHz,DMSO-d6)δ12.06(s,1H),7.91(s,1H),7.85(s,1H),4.34(q,J=7.1Hz,2H), 2.96(t,J=6.0Hz,2H), 2.61(t,J=6.3Hz,2H), 2.22-2.11(m,2H), 1.34(t,J=7.1Hz,3H).

[0603] Example 181: Synthesis of Compound B119

[0604] At room temperature, N,N-dimethylaminopyridine (94.6 mg, 0.774 mmol) and N,N'-dicyclohexylcarbodiimide (199.7 mg, 0.968 mmol) were added to a mixture of compound INT-D (150 mg, 0.645 mmol) and compound B119-1 (89.2 mg, 0.645 mmol) in dichloromethane (5 mL) and N,N-dimethylformamide (5 mL). The reaction solution was stirred at room temperature overnight and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to give a white solid compound B119 (25.6 mg, 11.34%, racemate). ESI / MS (m / z): 350.1 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ12.04(s,1H),7.69(dd,J=8.3,1.0Hz,1H),7.61(dd,J =7.3,1.0Hz,1H),7.40(dd,J=8.3,7.3Hz,1H),5.44(dd,J=5.9,2.2Hz,1H),3.6 2(d,J=2.1Hz,1H),3.12(t,J=6.0Hz,2H),2.62-2.54(m,2H),2.15-2.06(m,2H ),1.95-1.79(m,3H),1.78-1.69(m,2H),1.68-1.59(m,1H),1.32-1.09(m,5H).

[0605] Example 182: Synthesis of Compound B120

[0606] To a mixture of compound INT-D (150 mg, 0.654 mmol) and N,N-dimethylaminopyridine (95.9 mg, 0.785 mmol) in dichloromethane (10 mL) and N,N-dimethylformamide (3 mL) at room temperature were added N,N'-dicyclohexylcarbodiimide (202.5 mg, 0.981 mmol) and compound B120-1 (89.2 mg, 0.645 mmol). The reaction mixture was stirred at room temperature overnight, quenched with water (30 mL), and extracted with dichloromethane (3 x 40 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B120 (10.3 mg, 4.56%) as an off-white solid. ESI / MS (m / z): 350.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.02(s,1H),7.67(d,J=8.3Hz,1H),7.61(d,J=7.3Hz,1H),7.41-7.34(m,1H),7.30(d,J=3. 7Hz,1H),7.24(d,J=3.7Hz,1H),5.54(s,2H),4.59(s,1H),3.10-3.02(m,2H),2.60-2.53(m,2H),2.14-2.03(m,2H).

[0607] Example 183: Synthesis of Compound B121

[0608] At 0 ° C, to a solution of compound B121-1 (2 g, 13.930 mmol) in water (50 mL) and concentrated hydrochloric acid (6.1 mL, 69.650 mmol) was slowly added a solution of sodium nitrite (1.44 g, 20.895 mmol) in water (10 mL). The reaction solution was stirred for 10 minutes, and a solution of compound B121-2 (2.19 g, 16.716 mmol) in methanol (60 mL) and a solution of sodium acetate (2.51 g, 30.646 mmol) in water (40 mL) were slowly added. The mixture was stirred for 2 hours at 0 ° C, filtered, the filter cake was washed with water (40 mL), and vacuum dried to give a gray solid compound B121-3 (2.8 g, 62.04%). ESI / MS (m / z): 252.9 [M+H] + .

[0609] At 0 ° C, 10% dilute sulfuric acid (33 mL) was added to a solution of compound B121-3 (2.6 g, 8.025 mmol) in acetonitrile (100 mL). The temperature was raised to 75 ° C and stirred for 4 hours. The reaction solution was cooled to room temperature, adjusted to pH = 7 with saturated sodium carbonate solution, concentrated in vacuo, and extracted with ethyl acetate (3×100 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (100 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1) to give a gray solid compound B121-4 (1.2 g, 63.45%). ESI / MS (m / z): 235.9 [M+H] + .

[0610] Under a nitrogen atmosphere, triethylamine (689 mg, 6.807 mmol) and methanol (40 mL) were added to a solution of compound B121-4 (1.15 g, 4.538 mmol) and 10% palladium carbon (724 mg, 0.681 mmol) in ethyl acetate (40 mL). The reaction solution was replaced with hydrogen three times and stirred at room temperature for 3 hours. The reaction solution was filtered and the filter cake was washed with ethyl acetate (20 mL). The filtrate was concentrated in vacuo, and the residue was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 1: 1) to give a yellow solid compound B121-5 (650 mg, 64.77%). ESI / MS (m / z): 201.9 [M+H] + .

[0611] At room temperature, N,N'-dicyclohexylcarbodiimide (202 mg, 0.977 mmol) was added to a solution of compound B121-5 (180 mg, 0.814 mmol) and compound B121-6 (108 mg, 0.977 mmol) in dichloromethane (10 mL). The reaction solution was stirred at room temperature for 3 hours, quenched with water (20 mL), and extracted with ethyl acetate (3×30 mL). The resulting organic phase was washed with saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to give compound B121 (60.6 mg, 25.15%) as a white solid. ESI / MS (m / z): 294.2 [M+H] + .

[0612] Example 184: Synthesis of Compound B122

[0613] At room temperature, N,N'-dicyclohexylcarbodiimide (202 mg, 0.977 mmol) was added to a mixture of compound B121-5 (180 mg, 0.814 mmol) and compound B122-1 (84 mg, 0.977 mmol) in dichloromethane (10 mL). The reaction solution was stirred at room temperature for 3 hours, quenched with water (20 mL), and extracted with ethyl acetate (3×30 mL). The resulting organic phase was washed with saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to give compound B122 (73.9 mg, 33.48%) as a white solid. ESI / MS (m / z): 270.4 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.82 (s, 1H), 7.30-7.24 (m, 2H), 6.79 (dd, J = 6.0, 2.4Hz, 1H), 2.95 (t, J = 6.0Hz, 2H), 2.55(t,J=6.3Hz,2H),2.20-2.09(m,2H),2.06-1.95(m,1H),1.15-1.09(m,2H),1.09-1.04(m,2H).

[0614] Example 185: Synthesis of Compound B123

[0615] Under a nitrogen atmosphere, cesium carbonate (334 mg, 1.02 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (83 mg, 0.10 mmol) were added to a solution of compound B60-4 (400 mg, 0.77 mmol) and compound B123-1 (90 mg, 0.51 mmol) in 1,4-dioxane (8 mL) and water (1.6 mL). The mixture was heated to 100°C and stirred overnight. The reaction mixture was cooled to room temperature, quenched with water (20 mL), and extracted with ethyl acetate (3 × 20 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (20 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to afford compound B123 (28.9 mg, 20.08%) as a white solid. ESI / MS (m / z): 281.1 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ11.82(s,1H),8.00(s,1H),7.47(dd,J=8.3,1.0Hz,1H),7.35(dd,J=8.3,7.1Hz,1H),7.16(dd,J=7 .2,1.0Hz,1H),4.54(q,J=7.3Hz,2H),2.76(t,J=6.0Hz,2H),2.56-2.51(m,2H),2.06-2.98(m,2H),1.53(t,J=7.3Hz,3H).

[0616] Example 186: Synthesis of Compound B124

[0617] Under a nitrogen atmosphere, cesium carbonate (463 mg, 1.42 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (77 mg, 0.10 mmol) were added to a solution of compound B60-4 (321 mg, 0.71 mmol) and compound B124-1 (90 mg, 0.47 mmol) in 1,4-dioxane (8 mL) and water (2 mL). The mixture was heated to 100°C and stirred overnight. The reaction mixture was cooled to room temperature, quenched with water (20 mL), and extracted with ethyl acetate (3 × 20 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (20 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to afford compound B124 (50.2 mg, 35.94%) as a white solid. ESI / MS (m / z): 295.2 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ11.81(s,1H),8.00(s,1H),7.47(dd,J=8.3,1.0Hz,1H),7.35(dd,J=8.3,7.1Hz,1H),7.17(dd,J =7.1,1.0Hz,1H),4.96-4.84(m,1H),2.77(t,J=6.0Hz,2H),2.56-2.51(m,2H),2.07-1.97(m,2H),1.57(d,J=6.7Hz,6H).

[0618] Example 187: Synthesis of Compound B126

[0619] Under a nitrogen atmosphere, to a solution of compound INT-C (100 mg, 0.269 mmol) and compound B126-1 (101.9 mg, 0.807 mmol) in N,N-dimethylacetamide (4 mL) were added cuprous iodide (5.1 mg, 0.027 mmol), palladium acetate (6.1 mg, 0.027 mmol), 1,1'-bis(diphenylphosphino)ferrocene (14.9 mg, 0.027 mmol), and cesium carbonate (175.3 mg, 0.538 mmol). The mixture was heated to 80°C and stirred for 2 hours. The reaction mixture was cooled to room temperature, quenched with water (80 mL), and extracted with ethyl acetate (3 × 30 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (20 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether:ethyl acetate = 4:1) to give compound B126-2 (80 mg, 65.74%) as a brown oil. ESI / MS (m / z): 338.3 [M+H] + .

[0620] To compound B126-2 (70 mg, 0.155 mmol) was added 4 M hydrogen chloride in ethyl acetate (3 mL) at room temperature. The reaction mixture was stirred for 30 minutes and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (0.1% formic acid), mobile phase B: acetonitrile) to afford compound B126 (7.7 mg, 20.84%) as a white solid. ESI / MS (m / z): 238.3 [M+H] + . 1H NMR (400MHz, DMSO-d6) δ11.74(s,1H),7.36(d,J=8.2Hz,1H),7.22(dd,J=8.3,7.2Hz,1H),7.07(d,J=7.1H z,1H),3.30-3.18(m,2H),2.58-2.53(m,2H),2.52-2.47(m,2H),2.21-2.10(m,2H),1.22(t,J=7.5Hz,3H).

[0621] Example 188: Synthesis of Compound B127

[0622] At 0 ° C, diisopropyl azodicarboxylate (130.5 mg, 0.645 mmol) was added dropwise to a mixture of compound INT-D (100 mg, 0.430 mmol), compound B127-1 (58.70 mg, 0.473 mmol) and triphenylphosphine (169.2 mg, 0.645 mmol) in tetrahydrofuran (4 mL). The reaction solution was stirred at room temperature for 30 minutes, quenched with water (20 mL), and extracted with dichloromethane (3×20 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (10 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by reverse phase chromatography (mobile phase A: water (10 mmol / L ammonium bicarbonate), mobile phase B: acetonitrile) to give a white solid compound B127 (14.8 mg, 2.33%). ESI / MS (m / z): 336.2 [M+H] + . 1 H NMR (400MHz, DMSO-d6) δ12.08(s,1H),7.71(dd,J=8.2,1.0Hz,1H),7.65(dd,J=7.4,1.1Hz,1H),7.40 (dd,J=8.3,7.3Hz,1H),5.33-5.26(m,2H),3.14-3.05(m,2H),2.63-2.54(m,2H),2.16-2.04(m,2H).

[0623] Example 189: Synthesis of Compound B128

[0624] To a solution of 60% sodium hydride (482 mg, 12.034 mmol) and compound B128-1 (900 mg, 8.023 mmol) in toluene (30 mL) was added a solution of ethyl formate (1.19 g, 16.046 mmol) in methanol (0.5 mL) at 0°C and stirred at room temperature for 1 hour. The reaction solution was adjusted to pH = 3 with dilute hydrochloric acid and extracted with ethyl acetate (3 × 150 mL). The resulting organic phase was washed with saturated sodium chloride aqueous solution (100 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was separated by silica gel column chromatography (petroleum ether: ethyl acetate = 5:1) to obtain compound B128-2 (900 mg, 76.82%) as a colorless oil. ESI / MS (m / z): 141.0 [M+H] + .

[0625] At 0 ° C, a solution of compound B128-3 (1 g, 4.779 mmol) in water (20 mL) and concentrated hydrochloric acid (2.07 mL, 23.895 mmol) was slowly added with a solution of sodium nitrite (0.49 g, 7.168 mmol) in water (10 mL). The reaction solution was stirred for 10 minutes, and a solution of compound B128-2 (0.84 g, 5.735 mmol) in methanol (40 mL) and a solution of sodium acetate (0.86...

Claims

1. A compound represented by formula (I) or formula (II), its stereoisomer, geometric isomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof, in, Ring A is selected from the group consisting of a C3-C7 saturated or partially unsaturated carbocyclic ring, a 3-8 membered saturated or partially unsaturated heterocyclic ring, a C6-C 10 Aromatic ring, 5-12 membered heteroaromatic ring; Ring A can be a monocyclic, spirocyclic, fused or bridged ring structure; Y1 and Y2 are each independently selected from the following groups: a chemical bond, a C1-C6 alkylene group, a C3-C 10 Saturated or partially unsaturated carbocyclic ring, 3-10 membered saturated or partially unsaturated heterocyclic ring, C6-C 10 Aromatic ring, 5-12 membered heteroaromatic ring, -NH-, O or S; and Y1, Y2 are each independently optionally substituted by 0-4 substituents selected from the group consisting of deuterium, hydroxyl, halogen, oxo (=O), carboxyl, NH2, mercapto, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C4 acyl, C2-C6 ester, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 haloalkyl, C2-C4 haloacyl, C1-C4 haloalkoxy, C1-C4 haloalkylthio, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, C5-C 12 heteroaryl; R1 is selected from the following group: hydrogen, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkylamino (C1-C6 alkyl-NH-), C1-C6 alkoxy, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C1-C6 haloalkylamino, C1-C6 haloalkoxy, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl, C1-C4 alkyl-C3-C7 saturated or partially unsaturated carbocyclic group, C1-C4 alkyl-3-8 membered saturated or partially unsaturated heterocyclic group, C1-C4 alkyl-C6-C 10 wherein the alkyl, alkenyl, alkynyl, alkylamino, alkoxy, haloalkyl, haloalkenyl, haloalkynyl, haloalkylamino, haloalkoxy, carbocyclic group, heterocyclic group, aryl, heteroaryl are each independently and optionally substituted by 0, 1, 2, 3 or 4 substituents selected from the group consisting of deuterium, hydroxyl, halogen, oxygen, oxadiazole, cyclopentadiazole, cyclohex ... substituted alkyl (=O), carboxyl, NH2, mercapto, C1-C4 alkyl, C2-C4 acyl, C2-C6 ester, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 haloalkyl, C2-C4 haloacyl, C1-C4 haloalkoxy, C1-C4 haloalkylthio, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, C5-C 12 Heteroaryl; the carbocyclic group, heterocyclic group, aryl group, heteroaryl group may be a monocyclic, spirocyclic, fused or bridged ring structure; X1 is selected from the following group: O, NR2, S; wherein R2 is selected from the following group: H, C1-C4 alkyl, S(=O)2R 11 、S(=O)2(C1-C6 alkylene)R 11 、C(O)R 11 、C(O)(C1-C6 alkylene)R 11 , 3-12 membered saturated or partially unsaturated heterocyclic group, 5-12 membered heteroaryl; and one or more hydrogen atoms on R2 may be optionally substituted by a substituent selected from the group consisting of C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, -C0-C4 alkylene-C6-C 10 Aryl; or two substituents on R2 together form -(CH2) s - structure; said s is 2 or 3; X2 is selected from the following group: CH2, CD2, CHR b , NH, NR b , S, S(=O), S(=O)2, S(=O)(=NH); Each R a Each is independently selected from the following groups: deuterium, hydroxyl, halogen, amino, nitro, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C6 ester, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclic group, -NH-CH2-5-12 membered heteroaryl, -P(O)R c1 R d1 、-S(O)2R c1 、-S(O)2NH2、-S(O)(NH2)(R c1 )、-C(O)C(O)2R c1 、-C(O)NHR c1 、-NH-C(O)R c1 、-C(O)OR c1 、-NH-S(O)2R c1 、-N=S(O)R c1 R d1 、-CH2-S(O)(NH)(R c1 ),-NR c1 R d1 , Among them, the R c1 , R d1 Each is independently selected from the following group: deuterium, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl; or, R c1 , R d1 and the atoms to which they are connected together form a 3-8 membered saturated or partially unsaturated heterocyclic group or a 5-12 membered heteroaryl group; wherein R a One or more hydrogen atoms on the alkyl group may be optionally substituted by a substituent selected from the group consisting of a deuterium atom, a hydroxyl group, a halogen group, an oxo group (═O), C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, S(O)2CH3, C3-C7 saturated or partially unsaturated carbocyclic group, -C(O)N(C1-C4 alkyl)2, -N(C1-C4 alkyl)2; Each R a 'are each independently selected from the following group: deuterium, hydroxyl, halogen, amino, nitro, cyano, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C6 ester, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C4 amide, C3-C7 saturated or partially unsaturated carbocyclic group, 3-12 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclic group, -NH-CH2-5-12 membered heteroaryl, -P(O)R c R d 、-S(O)2R c 、-S(O)2NH2、-S(O)(NH2)(R c )、-C(O)C(O)2R c 、-C(O)NHR c 、-C(O)NR c R d 、-NH-C(O)R c 、-OC(O)R c 、-C(O)OR c 、-C(O)O(C1-C4 alkylene)R c 、-NH-S(O)2R c 、-C(O)NH(C1-C4alkylene)R c 、-N=S(O)R c R d 、-CH2-S(O)(NH)(R c ),-NR c R d , Among them, the R c , R d Each independently selected from the following group: deuterium, C1-C4 alkyl, C1-C4 alkoxy, C2-C4 alkenyl, C2-C4 alkynyl, C3-C7 saturated or partially unsaturated carbocyclic group, 3-8 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 8-12 membered fused bicyclic, 5-12 membered heteroaryl, -N(C1-C4 alkyl)2, -CONH2, -CON(C1-C4 alkyl)2; or, R c , R d and the N atom to which it is connected together form a 3-8 membered saturated or partially unsaturated heterocyclic group or a 5-12 membered heteroaryl group; wherein R a One or more hydrogen atoms on the ' may be optionally substituted by a substituent selected from the group consisting of a deuterium atom, a hydroxyl group, a halogen, an amino group, a cyano group, a carboxylic acid, an oxo group (=O), C1-C4 haloalkyl, C1-C4 haloalkyl, C1-C4 alkyl, C2-C4 alkynyl, C1-C4 alkoxy, C1-C4 alkylthio, HO-(C1-C4 alkylene)-, C2-C4 alkenyl, C2-C6 ester, S(O)2CH3, C3-C7 saturated or partially unsaturated carbocyclic group, -C(O)N(C1-C4 alkyl)2, -N(C1-C4 alkyl)2, C6-C 10 Aryl; n is 0, 1, 2, 3 or 4; Each R b Each is independently selected from the following group: deuterium, hydroxyl, halogen, amino, nitro, oxo (=O), C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, -NH-(C1-C4 alkyl), -NH-(C1-C4 alkylhydroxyl), 4-7 membered heterocyclyl; or, two R b and the carbon atoms connected thereto together constitute a C3-C7 saturated or partially unsaturated carbocyclic group, a 3-8 membered saturated or partially unsaturated heterocyclic group, a C6-C 10 Aryl, 5-12 membered heteroaryl; R 11 Selected from the following group: amino, C1-C 10 Alkyl, C1-C 10 Alkoxy, C2-C 10 Alkenyl, C2-C 10 Alkynyl, C3-C7 saturated or partially unsaturated carbocyclic group, -3-12-membered saturated or partially unsaturated heterocyclic group, -C2-C4 alkynylene-3-12-membered saturated or partially unsaturated heterocyclic group, -0-3-12-membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, -C2-C4 alkenylene-C6-C 10 Aryl, 5-12 membered heteroaryl, 8-12 membered fused bicyclic, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclic, -NH-CH2-5-12 membered heteroaryl; wherein R 11 One or more hydrogen atoms on the alkyl group may be optionally substituted by a substituent selected from the group consisting of a deuterium atom, a hydroxyl group, a halogen, an amino group, a carboxylic acid, an oxo group (═O), C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C4 alkyl, C2-C4 alkynyl, C1-C4 alkoxy, C1-C4 alkylthio, C2-C4 alkenyl, C2-C6 ester, S(O)2CH3, C3-C7 saturated or partially unsaturated carbocyclic group, -C(O)N(C1-C4 alkyl)2, -N(C1-C4 alkyl)2, C6-C 10 Aryl, 3-12 membered saturated or partially unsaturated heterocyclic group; m is 0, 1, 2, 3 or 4; p is 0, 1, 2 or 3; And, when R a is methyl, n is 1 and m is 0, -Y1-Y2-R1 is not a group selected from the group consisting of OH, NH2, 2. The compound according to claim 1, its stereoisomer, geometric isomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof, characterized in that: Ring A is C6-C 10 Aromatic ring or 5-12 membered heteroaromatic ring; Preferably, ring A is a benzene ring, a pyrimidine ring or a pyridine ring.

3. The compound according to claim 1, its stereoisomer, geometric isomer, hydrate, prodrug, or pharmaceutically acceptable salt thereof, characterized in that: R1 is selected from the following group: C1-C5 alkyl, C1-C5 alkylamino, C1-C5 alkoxy, C1-C5 haloalkyl, C3-C6 saturated or partially unsaturated carbocyclic group, 4-7 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-10 membered heteroaryl, C1-C4 alkyl-C3-C6 saturated or partially unsaturated carbocyclic group, C1-C4 alkyl-4-7 membered saturated or partially unsaturated heterocyclic group, C1-C4 alkyl-C6-C 10 wherein the alkyl, haloalkyl, alkylamino, carbocyclyl, heterocyclyl, aryl, and heteroaryl are each independently and optionally substituted by 0-4 substituents selected from the group consisting of deuterium, hydroxyl, halogen, oxo (=O), carboxyl, thiol, C1-C4 alkyl, C2-C4 acyl, C1-C4 alkoxy, C1-C4 alkylthio, C3-C6 saturated or partially unsaturated carbocyclyl, 4-7 membered saturated or partially unsaturated heterocyclyl, C6-C 10 Aryl, C5-C 10 heteroaryl; Preferably, Y1 and Y2 are chemical bonds, and R1 is selected from the group consisting of a 4-7 membered saturated or partially unsaturated heterocyclic group, a 5-10 membered heteroaryl group, a C1-C4 alkyl-4-7 membered saturated or partially unsaturated heterocyclic group, a C1-C4 alkyl-5-10 membered heteroaryl group; More preferably, Y is wherein q is 0, 1, 2 or 3, and R1 is not H; Further preferably, R1 has a structure selected from the following group:

4. The compound according to claim 1, its stereoisomer, geometric isomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof, characterized in that: X1 is NH; X2 is CH2, S or NH.

5. The compound according to claim 1, its stereoisomer, geometric isomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof, characterized in that: The compound has a structure as described in Formula (IA), Formula (IVA) or Formula (IIA): Among them, Y1, Y2, R1, R2, R a , R a '、R b , X2, m, p are defined as in claim 1; X4, X5 and X6 are each independently selected from the group consisting of: CR a1 , N; wherein said R a1 Selected from the group consisting of H, D, hydroxy, halogen, amino, nitro, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl; Preferably, R a Having a structure selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, -C(O)OR c 、-NR c1 R d1 ; where R c1 , R d1 The definition of is as in claim 1; Preferably, R a 'having a structure selected from the group consisting of deuterium, hydroxyl, halogen, amino, nitro, cyano, C1-C4 alkyl, C2-C6 ester, C1-C4 haloalkyl, C3-C7 saturated or partially unsaturated carbocyclic group, 3-12 membered saturated or partially unsaturated heterocyclic group, C6-C 10 Aryl, 5-12 membered heteroaryl, -NH-CH2-3-12 membered saturated or partially unsaturated heterocyclic group, -NH-CH2-5-12 membered saturated or partially unsaturated heteroaryl, -P(O)R c R d 、-S(O)2R c 、-S(O)2NH2、-S(O)(NH2)(R c )、-NH-S(O)2R c 、-N=S(O)R c R d 、-CH2-S(O)(NH)(R c )、-C(O)NHR c 、-C(O)NR c R d 、-OC(O)R c 、-C(O)OR c 、-C(O)O(CH2)R c 、-C(O)NH(C1-C4alkylene)R c 、-NR c R d ; where R c , R d The definition of is as in claim 1; Among them, R a1 , R a and R a One or more hydrogen atoms on the ' may be optionally substituted by a substituent selected from the group consisting of a deuterium atom, a hydroxyl group, a halogen, an amino group, a cyano group, a carboxylic acid, an oxo group (=O), C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, HO-(C1-C4 alkylene)-, C1-C4 alkylthio, C2-C4 alkenyl, C2-C6 ester, S(O)2CH3, C3-C7 saturated or partially unsaturated carbocyclic group, -C(O)N(C1-C4 alkyl)2, -N(C1-C4 alkyl)2, C6-C 10 Aryl.

6. The compound according to claim 1, its stereoisomer, geometric isomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof, characterized in that: The compound has a structure as described in formula (IIIA) or formula (IVA): Among them, Y1, Y2, R1, R2, R a , R a '、R b , X2, m, p are defined as described in claim 1; and X4, X5, X6 are defined as described in claim 5.

7. The compound according to claim 1, its stereoisomer, geometric isomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof, characterized in that: The compound has a structure selected from the group consisting of: The "*" is the chiral center.

8. A pharmaceutical composition, characterized in that Include: (1) the compound according to any one of claims 1 to 7, its stereoisomer, geometric isomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof; and Optional (2) pharmaceutically acceptable carriers, excipients or other active drugs; Preferably, the pharmaceutical composition further comprises a second therapeutic component, and the second therapeutic component is selected from the following group: PARP (poly ADP ribose polymerase) inhibitors, proteasome inhibitors, kinase inhibitors, DNA methyltransferase inhibitors, histone deacetylase inhibitors, nucleoside drugs that interfere with the metabolism of tumor cell, virus and bacterial nucleic acid, chemotherapy drugs that inhibit tumor cell DNA replication such as platinum drugs, paclitaxel and its derivatives, drugs and treatment regimens that inhibit the intake and metabolism of glucose, amino acids, fatty acids, etc., or other therapeutic components and treatment regimens that can produce synergistic anti-tumor effects with the tetrahydrocarbazole compounds in the above claims; More preferably, the PARP inhibitor is Olaparib, Rucaparib, Niraparib, Talazoparib, Fluzoparib, Pamiparib, Saruparib; The proteasome inhibitors are Ixazomib and Bortezomib; The kinase inhibitor is a MEK inhibitor; the MEK inhibitor is Cobimetinib; The DNA methyltransferase inhibitor is SGI-1027; The histone deacetylase inhibitor is Trichostatin A; The nucleoside drug is 6-Mercaptopurine (6-MP); The chemotherapy drugs are Cisplatin and Cabazitaxel; The metabolic inhibitors are GLUT1 / GLUT3 inhibitors KL-11743 and BAY-876; the metabolic treatment regimen is intermittent fasting.

9. Use of the compound according to any one of claims 1 to 7, its stereoisomer, geometric isomer, hydrate, solvate, prodrug or pharmaceutically acceptable salt, or the pharmaceutical composition according to claim 8, characterized in that: For the preparation of a medicament for treating and / or preventing cancer; Preferably, the cancer is selected from the group consisting of liver cancer, lung cancer, breast cancer, pancreatic cancer, gastric cancer, colorectal cancer, kidney cancer, prostate cancer, cervical cancer, ovarian cancer, anal and perianal cancer, vulvar cancer, vaginal cancer, penile cancer, head and neck cancer, Glioma, skin cancer, mesothelioma, muscle cancer, leukemia, lymphoma, as well as cancers and related lesions caused by oncogenic viruses such as herpes virus, adenovirus, hepatitis virus, retrovirus, and papovavirus family.

10. The use according to claim 9, characterized in that The treatment and / or prevention of cancer comprises: using the compound represented by formula (I) or formula (II) according to any one of claims 1 to 7, its stereoisomers, geometric isomers, hydrates, solvates, prodrugs or pharmaceutically acceptable salts, or the pharmaceutical composition according to claim 8 in combination with a component selected from the following group: PARP inhibitors, proteasome inhibitors, MEK inhibitors, DNA methyltransferase inhibitors, histone deacetylase inhibitors, nucleoside drugs that interfere with the metabolism of tumor cell, virus and bacterial nucleic acid, chemotherapy drugs such as platinum drugs that inhibit tumor cell DNA replication, paclitaxel and its derivatives, drugs and treatment plans that inhibit the intake and metabolism of glucose, amino acids, fatty acids, etc., or other therapeutic components and treatment plans that can produce synergistic anti-tumor effects with the compound of formula I.

11. The use according to claim 9, characterized in that The PARP inhibitors are Olaparib, Rucaparib, Niraparib, Talazoparib, Fluzoparib, Pamiparib, and Saruparib; the proteasome inhibitors are Ixazomib and Bortezomib; the kinase inhibitor is Cobimetinib; the DNA methyltransferase inhibitor is SGI-1027; the histone deacetylase inhibitor is Trichostatin A; the nucleoside drug is 6-Mercaptopurine (6-MP); the chemotherapy drugs are cisplatin and Cabazitaxel; the metabolic inhibitors are GLUT1 / GLUT3 inhibitors KL-11743 and BAY-876, and the metabolic treatment plan is intermittent fasting.

Citation Information

Patent Citations

  • Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

    WO2006065480A2

  • Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production

    CN101103000A

  • Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors

    US20050137220A1

  • Anti-Cytokine Heterocyclic Compounds

    US20100190773A1

  • Tetrahydrocarbazole compound, and pharmaceutical composition and use thereof

    WO2023088388A1